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1. Summary 
1.1. Summary (English) 
The integrity of our genome is continuously endangered by DNA damaging factors. Several cellular 
mechanisms have evolved to recognize and remove different types of DNA lesions. Despite the wealth of 
information on the three-dimensional structure and the catalytic mechanism of DNA repair enzymes, the 
essential process of target site search and identification remains more elusive. How can a small number 
of repair proteins find and detect the rare sites of damage rapidly and efficiently over an excess of 
millions of undamaged bases?  
To address this pivotal question in DNA repair, I focused on the central players from the two DNA 
damage excision repair pathways in my studies: nucleotide excision repair (NER) and base excision repair 
(BER). As examples for completely different approaches of damage search, recognition and verification, I 
compared the NER protein Xeroderma pigmentosum group D (XPD) with the BER proteins human 
thymine DNA glycosylase (hTDG) and human 8-oxoguanine glycosylase (hOgg1).  
In particular, the single molecule approach of atomic force microscopy (AFM) imaging and 
complementary biochemical and biophysical techniques were applied. I established a simple, optimized 
preparation approach, which yields homogeneous and pure samples of long (several hundreds to 
thousands of base pairs) DNA substrates suitable for the AFM studies with DNA repair proteins. Via this 
sample preparation, a single target site of interest can be introduced into DNA at a known position, 
which allows separate analysis of specific protein-DNA complexes bound to the lesion site and 
nonspecific complexes bound to non-damaged DNA.  
The first part of the thesis investigates the XPD protein involved in eukaryotic NER. In general, the NER 
mechanism removes helix-distorting lesions – carcinogenic UV light induced photoproducts, such as 
cyclobutane pyrimidine dimers (CPDs) as well as bulky DNA adducts. The 5’-3’ helicase XPD has been 
proposed to be one of the key players in DNA damage verification in eukaryotic NER, which is still a 
matter of hot debate. In the studies, I focused on XPD from the archaeal species Thermoplasma 
acidophilum (taXPD), which shares a relatively high sequence homology with the sequence of the human 
protein and may serve as a good model for its eukaryotic counterpart. Based on AFM experiments and 
accompanying DNA binding affinity measurements with the biosensor technology Biolayer 
Interferometry (BLI), a clear role of XPD in damage verification was deciphered. Specifically, the data 
suggested that the ATP-dependent 5’-3’ helicase activity of XPD was blocked by the presence of damage 
leading to stalled XPD-DNA damage verification complexes at the lesion sites. 
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Successful damage verification led to ATP-dependent conformational changes visible by a significant 
transition in DNA bend angles from ~ 50° to ~ 65° at the site of the bound protein. Remarkably, this DNA 
bend angle shift was observed both in the presence of ATP and ATPγs (non-hydrolyzable ATP analog) 
indicating that ATP-binding instead of ATP hydrolysis was sufficient to induce repair competent 
conformational changes of XPD. Most importantly, detailed protein binding position and DNA bend angle 
analyses revealed for the first time that XPD preferably recognizes a bulky fluorescein lesion on the 
translocated strand, whereas a CPD lesion is preferentially detected on the opposite, non-translocated 
strand. Despite the different recognition strategies for both types of damages, they share a common 
verification complex conformation, which may serve as a signal for the recruitment of further NER 
factors. 
In the second part of the thesis, AFM imaging and a 2-Aminopurine fluorescence-based base-flipping 
assay were combined to investigate damage search and recognition by DNA glycosylases in BER. 
Exemplarily, I chose to study hTDG as a representative of the vast glycosylase family. hTDG excises 
thymine and uracil from mutagenic G:T and G:U mispairs contributing to cancer and genetic disease. The 
AFM data suggested that hTDG uses the intrinsic flexibility of G:T and G:U wobble pairs for initial damage 
sensing, while scanning DNA as a search complex (SC, slightly bent DNA). Remarkably, hTDG has been 
indicated to continuously switch between the search and interrogation conformation (IC, stronger bent 
DNA) during damage search. In the IC, target bases are interrogated by extrahelical base flipping, which 
is facilitated by protein-induced DNA bending and enhanced DNA flexibility at mismatches. AFM and 
fluorescence analyses revealed that the flipped base is stabilized via hTDG’s arginine finger. Correct 
target bases are perfectly stabilized within the enzyme’s catalytic pocket resulting in prolonged 
residence time and enhanced excision probability. To test for the generalizability of the proposed hTDG 
damage search model to BER glycosylases, identical studies were performed with a second glycosylase, 
hOgg1. The data on hOgg1, which removes structurally more stable 8-oxoguanine lesions, supported the 
hypothesis developed for lesion recognition by hTDG as a common strategy employed by BER 
glycosylases.  
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1.2. Zusammenfassung (Deutsch) 
Die Stabilität des menschlichen Genoms wird durch DNA-schädigende Faktoren ständig bedroht. 
Mehrere zelluläre Mechanismen haben sich entwickelt, um verschiedene Typen von DNS-Schädigungen 
zu erkennen und zu entfernen. Obwohl zahlreiche und vielfältige Informationen über die drei-
dimensionalen Strukturen und katalytischen Mechanismen von DNS-Reparaturenzymen vorhanden sind, 
ist der essentielle Prozess der Suche und Identifikation von Läsionen kaum verstanden. Wie ist es 
möglich, dass eine kleine Anzahl an Reparaturenzymen die seltenen DNS-Schadensstellen unter 
Millionen von unbeschädigten Basen schnell und effizient finden kann? 
Diese zentrale Frage der DNS-Reparatur habe ich mit Hilfe von Schlüssel-Proteinen aus zwei 
verschiedenen DNS-Reparaturmechanismen untersucht, zum einen aus der Nukleotid- (NER) und zum 
anderen aus der Basenexzisionsreparatur (BER). Als Beispiel für zwei völlig unterschiedliche Ansätze zur 
Schadenssuche, -erkennung und -verifizierung, habe ich das NER Protein Xeroderma pigmentosum group 
D (XPD) mit den BER Proteinen humane Thymin DNA Glykosylase (hTDG) und der humanen 8-Oxoguanin 
Glykosylase (hOgg1) verglichen. 
Im Detail habe ich Einzelmoleküluntersuchungen mittels Rasterkraftmikroskopie (engl. ‚atomic force 
microscopy‘, AFM) und unterstützenden biochemischen und biophysikalischen Techniken angewandt. Ich 
habe eine einfache und optimierte Probenaufbereitungsmethode etabliert, welche es ermöglicht 
homogene, hochreine und lange (mehrere 100 Basenpaare) DNS-Substrate herzustellen, die für AFM 
Studien mit DNS-Reparaturenzymen geeignet sind. Mit Hilfe dieser Probenherstellungs-Technik kann 
eine einzelne, gewünschte Zielstelle an einer bestimmten Position in diese DNS-Substrate eingefügt 
werden. Die Verwendung dieser speziellen DNS-Substrate erlaubt eine separate Analyse von spezifischen 
Protein-DNS-Komplexen, die an bestimmte Läsionen gebunden sind, und unspezifischen Komplexen mit 
unbeschädigter DNS. 
Der erste Teil dieser Arbeit behandelt die Rolle von XPD in der eukaryotischen NER. Der NER 
Mechanismus entfernt DNS-Schäden, welche die Helix-Struktur der DNS verzerren. Das sind zum einen 
krebserregende UV-Schäden, wie zum Beispiel Cyclobutan-Pyrimidindimere (CPDs) sowie sperrige DNS-
Addukte. Die 5‘-3‘ Helikase XPD wird als eines der Schlüsselenzyme bei der Schadens-Verifizierung 
gehandelt, was jedoch derzeit noch umstritten ist. In meinen Studien habe ich mich mit dem XPD-Protein 
aus dem archäischen Organismus Thermoplasma acidophilum (taXPD) beschäftigt. Dieses weist eine 
relativ große Sequenzhomologie mit dem humanen Protein auf und stellt daher ein gutes Modell für das 
eukaryotische XPD dar. Auf Grund von AFM Experimenten und DNS-Bindungsaffinitätsmessungen mittels 
Biolayer-Interferometrie (BLI), konnte XPD eine eindeutige Rolle in der DNS-Schadensverifizierung 
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zugesprochen werden. Meine Ergebnisse zeigten, dass die ATP-abhängige Helikase-Aktivität von XPD 
durch die Anwesenheit eines DNA-Schadens gehemmt wird, was zur Schadensverifizierung und Bildung 
von XPD-DNA-Komplexen führt, die von der Schadensstelle ‚aufgehalten‘ wurden. 
Eine erfolgreiche Schadensverifizierung führt daraufhin zu ATP-abhängigen Konformationsänderungen, 
die sich in einer Änderung des DNA-Biegewinkels von ~ 50° zu ~ 65° an der Stelle des gebunden Proteins 
äußern. Es ist bemerkenswert, dass diese Änderung des DNS-Biegewinkels sowohl mit ATP und als auch 
mit ATPγs (nicht-hydrolysierbares ATP Analog) beobachtet wurde. Dies zeigt, dass bereits die Bindung 
und anstatt der Hydrolyse von ATP ausreicht, um reparaturkompetente Konformationsänderungen durch 
XPD zu veranlassen. Darüber hinaus haben meine detaillierten Proteinbindeposition- und DNS-
Biegewinkelanalysen haben zum ersten Mal gezeigt, dass XPD sperrige Fluoreszein-Schäden vor allem auf 
dem translozierten DNS-Strang erkennt, während CPD-Schäden vor allem auf dem gegenüberliegendem 
nicht-translozierten Strang erkannt werden. Trotz dieser unterschiedlichen Erkennungsstrategien für die 
zwei Schadenstypen, nehmen die beiden Schäden die gleiche Konformation im Schadensverifizierungs-
Komplex an, was als Signal für die Rekrutierung weiterer NER Faktoren dienen könnte. 
Im zweiten Teil meiner Arbeit kombinierte ich AFM-Experimente mit einem sogenannten ‚base flipping' 
Test, der auf der Fluoreszenz von 2-Aminopurine basiert, um die Schadenssuche und -erkennung durch 
DNS-Glykosylasen im BER-Mechanismus zu untersuchen. Als Beispiel für die weitläufige Familie der 
Glykosylasen wählte ich hTDG aus. hTDG schneidet Thymin und Uracil aus mutagenen G:T und G:U 
Fehlpaarungen heraus. Die AFM Daten zeigten, dass sich hTDG für die initiale Schadenserkennung die 
intrinsische Flexibilität in G:T und G:U Paaren zu Nutze macht, während die DNA als Suchkomplex geprüft 
wird (engl. ‚search complex‘, SC, leicht gebogene DNS-Struktur). Erstaunlicherweise scheint hTDG dabei 
kontinuierlich zwischen einem Such- und Prüfkomplex umzuschalten (engl. ‚interrogation complex‘, IC, 
stärkere Biegung der DNS). Im IC werden Basen durch „flippen“ außerhalb der DNS-Helix geprüft, was 
durch die Protein induzierte DNS-Biegung und die erhöhte Flexibilität von Fehlpaarungen in der DNS 
ermöglicht wird. Die Analyse von AFM- und Fluoreszenzexperimenten brachte zum Vorschein, dass die 
‚geflippte‘ Base durch den Arginin-Finger von hTDG stabilisiert wird. Die korrekten Zielbasen passen 
exakt in die katalytische Tasche des Enzyms und werden dort perfekt stabilisiert, was zu einer längeren 
Aufenthaltsdauer führt, die wiederum die Wahrscheinlichkeit erhöht, dass die Base herausgeschnitten 
wird. Um zu testen, ob das für hTDG vorgeschlagene Schadenssuchmodel auch allgemein für andere BER 
Glykosylasen gilt, habe ich die gleichen Experimente mit einer weiteren Glykosylase (hOgg1) 
durchgeführt, ein Protein das strukturell stabilere 8-Oxoguanin-Schäden entfernt. Die Daten für hOgg1 
untermauern die Hypothese, die für die Schadenssuche von hTDG erarbeitet wurde, als eine 
gemeinsame Strategie von BER Glykosylasen.  
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2. Introduction 
DNA repair is of vital relevance to maintain the stability of the human genome. Several cellular 
mechanisms have evolved to detect and remove specific DNA damages. In this thesis, atomic force 
microscopy (AFM) imaging as well as biochemical and biophysical techniques have been used to 
investigate two DNA repair mechanisms, nucleotide excision repair (NER) and base excision repair (BER). 
The NER helicase Xeroderma pigmentosum group D (XPD) and the BER proteins thymine DNA glycosylase 
(TDG) and human 8-oxoguanine glycosylase (Ogg1) were chosen as examples to compare different 
approaches for damage search, recognition and verification. 
2.1 Atomic Force Microscopy (AFM) imaging of biomolecules 
In the major part of my studies, the technique AFM was used to investigate protein-DNA-interactions in 
DNA repair. AFM can be used for direct visualization and studies of proteins, DNA and their complexes at 
the single molecule level (Hansma and Hoh, 1994) due to its high lateral resolution of a few nanometers 
(Seo and Lee, 2008). In this technique, a sharp probe fixed at the end of a flexible cantilever is scanned 
over a sample surface. Owing to attractive and repulsive forces arising between atoms of the probe and 
surface, a topographical image can be formed without the need for staining the samples (Bustamante et 
al., 1992, Bustamante et al., 2000, Scheuring et al., 2001).  
2.1.1 Principles of AFM 
During the last two decades, biological research has remarkably advanced towards investigation of 
processes at the level of single molecules. One of the high-resolution imaging methods is AFM, which 
belongs to the group of scanning probe microscopies (SPM). The basic element in these techniques is a 
mechanical probe, which scans the topography of a sample deposited onto a smooth surface. The 
invention of the scanning tunneling microscopy (STM) in 1982 (Binnig et al., 1982) gave rise to the 
development of a couple of SPM techniques including AFM, which was established four years later by 
Binning, Quate and Gerber (Binnig et al., 1986, Santos and Castanho, 2004). As the lateral resolution in 
AFM is predominantly determined by the dimensions of the probe, AFM tips are very small and sharp, 
with a diameter of usually lower than 10 nm (Albrecht et al., 1989). The tip is fixed at the bottom end of 
a flexible cantilever, which is commonly made of silicon nitride (Si3N4) and has force constants ranging 
from 0.01 to 100 Nm-1 (Colton et al., 1997, Walters et al., 1997). 
In AFM imaging, the sample surface is screened row by row in xy plane either by moving the sample 
stage via a piezo-scanner system (piezo driver and converters implemented in the AFM controller 
electronics) or by moving the AFM tip itself. Any molecular interactions arising between atoms of the tip 
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and the sample surface are detected from the bending of the cantilever towards (for attractive forces) or 
away from the surface (for repulsive forces). The most relevant interaction forces for AFM are various 
non-covalent forces, long range electrostatic interactions, short range attractive van der Waals forces, 
and very short range Pauli repulsion (Allen et al., 1997). 
The deflection of the cantilever is commonly detected by a laser beam focused on the back of the 
cantilever and reflected onto a position sensitive photodiode. Any bending of the cantilever leads to 
displacement of the laser position on the split photodetector, which is translated into a differential 
electronic signal. This electric potential is further converted into height information for each pixel 
position. Usually, a feedback mechanism is applied for keeping a roughly constant distance between 
AFM tip and the sample stage. The sample stage is connected to a piezo scanner, which enables 
movement of the sample in direction of the z-axis. A rise or depression of the sample surface induces a 
change in the interaction force and is compensated by either approaching or removing the sample stage 
from the tip. This displacement of the sample stage (z value) is measured for each xy position of the 
sample by the feedback system and a pseudo-three-dimensional topography picture of the sample is 
produced by the computer software (Ando et al., 2013, Ando, 2013). In contrast to AFM imaging, which 
provides height information, the deflection of the cantilever is translated into information on interaction 
forces in AFM force spectroscopy. 
Three different modes are commonly used for AFM imaging: contact, intermittent contact and non-
contact mode (Figure 1). 
 
Figure 1: Imaging modes in AFM. 
For details please refer to the main text (adapted from Benzanilla et al. (1994)). 
In contact mode, the AFM tip is in continuous contact with the molecules in the sample and directly 
follows the sample topography while scanning the surface. When the AFM tip encounters either a rise or 
a depression in the structure, the cantilever is bent. The degree of bending is directly translated into 
sample height by the AFM electronics. The high lateral forces exerted on the sample during the scan are 
10 
 
a major drawback of contact mode imaging. These forces may cause severe damage to soft biological 
materials such as proteins or lead to their detachment from the surface (Binnig et al., 1986). 
Thus, intermittent contact mode (alternatively named tapping mode) has been developed for imaging of 
biological structures. Figure 2 shows the typical instrumental setup of tapping mode AFM. 
 
Figure 2: Typical setup of a tapping mode atomic force microscope. 
A biological sample (e.g. DNA molecules) deposited onto a flat surface is scanned by a sharp, oscillating AFM tip and 
a three-dimensional topographical image of the sample is produced on the computer screen (for details see main 
text) (adapted from Ando et al. (2013)). 
In general, tapping mode imaging combines high lateral resolution with minor invasiveness. In this 
imaging mode, the AFM tip is intermittently brought into contact with the sample surface by oscillating 
the flexible cantilever in z-direction at its first resonance frequency (Figure 2). To minimize lateral forces, 
the probe touches the sample surface only in vertical direction and at the minimum of its oscillation 
amplitude. The oscillating movement of the AFM stylus in a pre-defined frequency, amplitude and height 
baseline is driven by a piezoactuator, which excites the cantilever and is connected to a sine wave 
generator. Upon tapping the surface, the deflection of the cantilever is detected as a decrease in the 
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cantilever’s oscillation amplitude (amplitude cutting) leading to a phase shift relative to the excitation 
signal. Using a feedback control system, the original height of the amplitude (set point value) is restored 
by moving the sample stage in z-direction. For each x-y-position on the scanned sample surface a 
corresponding signal of the feedback controller (amplitude) is recorded, which is proportional to the 
sample height at this specific position. Similar as described above for contact mode imaging, the 
feedback controller output is used for reconstruction of a pseudo-three-dimensional image of the 
sample topography (Ando et al., 2013, Ando, 2013). Furthermore, by detection of phase changes the 
tapping mode provides an additional parameter for characterization of material features (adhesion, 
friction) of the sample (Stark et al., 2001). 
The most gentle imaging mode is non-contact imaging, which uses very small oscillation amplitudes of 
the AFM tip so that it does not even touch the surface. The detection is based on attractive tip-sample 
interactions and solely relies on measuring the amplitude increase and the change in oscillation phase. 
This occurs at the expense of a poor lateral resolution because the thus detected forces are very weak 
(Allen et al., 1997). 
2.1.2 Assets and drawbacks of AFM 
Biochemical and biophysical ensemble methods such as electrophoretic mobility shift assays (EMSA), 
surface plasmon resonance (SPR) and calorimetric assays are powerful techniques for analysis of 
thermodynamic equilibrium constants of protein–DNA interactions (Carey, 1991, Lohman and 
Bujalowski, 1991, Myszka, 2000, Oda et al., 1998, Winzor and Wills, 1995). However, they share several 
major limitations. To begin with, these methods are bulk measurements and their results represent an 
averaged sum of all molecules (Record et al., 1991), neglecting different states of individual molecules. 
Second, analysis of protein-DNA interaction often relies on indirect detection of a signal, which is 
assumed to be linearly proportional to the actual parameter of interest e.g. binding affinities measured 
as heat in isothermal titration calorimetry (ITC). Although this assumption is often true, in many cases a 
linear proportionality is not given (Lohman and Bujalowski, 1991). Third, the size of the DNA oligomers 
typically used in biochemical assays is often limited to a few dozen of base pairs (bp). 
The single molecule technique AFM allows direct visualization of individual molecules and is able to 
resolve different populations of protein-DNA complexes. In contrast to conventional methods including 
X-ray crystallography, AFM imaging allows application of long DNA substrates of hundreds to thousands 
of bp length. These DNA substrates more closely resemble naturally occurring DNA strands and are long 
enough to stabilize tertiary structures e.g. DNA loops, triple helices or G-quadruplexes. Finally, we can 
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considerably reduce the interference of DNA ends on protein binding by using long DNA fragments 
(Buechner and Tessmer, 2013). 
Besides its great advantages, AFM also holds some limitations, which are evident in comparison with the 
two major microscopic methods, electron microscopy and fluorescence microscopy (Table 1).  
Table 1: Feasibility comparison of AFM with other types of microscopes. 
Microscopy 
Conditions     
In-liquid 
specimen 
High spatial 
resolution 
High temporal 
resolution 
Low 
invasiveness 
Direct imaging 
Fluorescence microscopy ●             ●* ● ● X 
Electron microscopy ϴ             ● ϴ X ● 
Atomic force microscopy ●             ● X ϴ ● 
● Fully met; ϴ partially met or conditional; X impossible or extensive efforts required to meet. * requires 
application of computer assisted superresolution fluorescence microscopy. ‘Direct imaging’ means that the 
morphologyof an object itself is resolved (adapted from Ando (2013)). 
Most conveniently, AFM does not require staining of the samples for visualization, which allows direct 
imaging without background or artifacts introduced by labelling. Due to its high sensitivity with spatial 
resolution in the range of a few nanometers, AFM offers remarkable insights into structural and 
functional parameters of protein–DNA complexes. EM imaging affords slightly higher spatial resolution 
than AFM because it is not limited by convolution of the sample with the AFM tip. Regarding the native-
ness of the imaged particles, however, AFM is superior over EM. By means of rapid and easy sample 
preparation (see below for description), AFM imaging in liquid even enables the observation of fully 
hydrated molecules under near physiological conditions in buffer solution (Drake et al., 1989). 
Major criticism on AFM imaging often concerns the invasiveness of the AFM probe on the scanned 
sample molecules. By using tapping mode, lateral forces exerted on the samples can be largely avoided. 
The remaining effect of the tip on the sample is given as the impulsive force, which is defined as product 
of the tapping force (vertical force induced by AFM tip tapping) and the duration of the acting force. The 
maximum tapping force exerted on a typical protein (5 nm height) in a conventional AFM setup is 
estimated to be ~100 pN (Ando, 2013). However, the actual effect of the AFM probe on the sample is 
minimal because the force acting time is very short (< 100 ns). 
Although AFM imaging can provide a wealth of information about the static structure of biomolecules, 
the temporal resolution of a typical AFM setup is limited (~30 s at its highest level) (Ando, 2013). To 
resolve the dynamics of fast biological processes, high-speed AFM (HS-AFM) has been developed by 
Ando and colleagues offering subsecond to sub-100-ms temporal resolution (Katan and Dekker, 2011, 
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Ando et al., 2013, Ando, 2014, Eghiaian et al., 2014, Lyubchenko, 2014). Combining AFM imaging in liquid 
with the recently developed technology of HS-AFM may serve to resolve dynamic actions of protein and 
DNA (either the interaction of both or the two components on their own). In this newly emerged field, 
some groups have observed e.g. the formation of DNA structures (e.g. supercoiling, condensation), DNA 
folding into intricate shapes (DNA origami) and the assembly and disassembly of proteins bound and 
unbound to DNA (Yokokawa et al., 2006, Crampton et al., 2007, Endo et al., 2010, Suzuki et al., 2010, 
Shlyakhtenko et al., 2012a, Shlyakhtenko et al., 2012b). 
2.1.3 Biological applications of AFM 
AFM is a widely used approach for studying structure and function of biomolecules. For example, AFM 
imaging can be used to investigate the structure of supported membranes (for reviews see Dufrene and 
Lee (2000) and Balashev et al. (2001)) or even the surface of a whole cell or a virus (e.g. Ohnesorge et al. 
(1997) and Grandbois et al. (2000)). Moreover, AFM is an attractive approach to analyze structure and 
function of soluble proteins (e.g. muscular fibers of actin (Weisenhorn et al., 1990) myosin (Hallett et al., 
1995), ß-amyloid fibrilization, (Blackley et al., 2000, Xu et al., 2001) and membrane proteins (e.g. F1F0 
complex of ATP synthase, (Singh et al., 1996), Bacteriorhodopsin (Moller et al., 2000). In general, AFM 
studies can reveal oligomerization states, characteristic substructures of individual proteins, 
conformational changes, protein-protein interactions (including association constants) and the assembly 
of membrane proteins (e.g. (Seelert et al., 2000, Scheuring et al., 1999, Fotiadis et al., 2000, Mou et al., 
1996)). 
To demonstrate the strength of AFM to investigate conformational changes of proteins, the AFM 
experiments with the protein collybistin performed in a recent collaboration with the group of H. 
Schindelin will be described here exemplarily (see Figure 3). The brain-specific GDP/GTP exchange factor 
collybistin acts at inhibitory postsynapses as adaptor protein by linking the scaffold protein gephyrin to 
plasma membrane phosphoinositides (Papadopoulos and Soykan, 2011, Soykan et al., 2014). Collybistin 
has been proposed to switch between an open/active and closed/inactive conformation, which regulates 
the gephyrin content of inhibitory postsynapses. In this protein interaction network, conformational 
states of collybistin are regulated by the adhesion protein neuroligin-2, which stabilizes the open 
conformation by competing with an intramolecular interaction in collybistin between the SH3 and DH/PH 
domains favoring the closed conformation. AFM experiments were performed with collybistin wildtype 
(wt) and its variant E262A (AFM images in Figure 3), which is indicated to disturb the intramolecular 
interactions in collybistin and to modulate the equilibrium between the two conformational states 
towards the open/active conformation. The AFM images displayed mixtures of circular and elongated 
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shapes for both proteins. To quantify the observed elongation in the variant, the molecules were 
described by ellipses and the ratio of the minor/major axes of the protein was determined as an 
indicator for conformational changes. Statistical analyses of the individual particle shapes revealed an 
equilibrium between three major conformational states of the wt protein and the variant, which were 
classified by their axial ratios as compact (~ 1.22), intermediate (~ 1.45), and elongated states (~ 1.75). 
The intermediate (axis ratio 1.45) and the most extended form (axis ratio 1.75) were significantly 
preferred by the variant suggesting stabilization of the open/active (elongated) conformation in the 
mutant E262A. 
 
Figure 3: Conformational states of a neuro-protein visualized in AFM experiments. 
A) AFM images of CBSH3
+
 wt (left) and the E262A variant (right). Filled arrow heads (compact form), open arrow 
heads (intermediate form), and arrows (elongated form) point to different particle shapes. B) Relative frequencies 
of occurrence of CB particle shapes as classified by the different major/minor axis ratios featuring compact (red), 
intermediate (green), and elongated (blue) states for the WT and E262A samples. One representative experiment is 
shown for each protein with n representing the number of particles per experiment. C) Quantification of 
frequencies of compact, intermediate, and elongated particles confirmed that the intermediate form (axis ratio 
1.45) and the most extended form (axis ratio 1.75) are significantly preferred by the variant as calculated by 
pairwise Student's t‐test This research was originally published in Soykan et al. (2014)© EMBO, John Wiley & Sons . 
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Most interesting for the present work are of course AFM imaging experiments on protein-DNA 
interactions, which can reveal details of the molecular recognition of a specific target site in DNA by a 
protein. In general, AFM experiments in air with dried samples and AFM imaging in liquid in physiological 
buffer solutions can be distinguished. In this thesis, the well-established technique of AFM imaging in air 
was applied to characterize protein-DNA interactions in DNA repair. For more than one decade, many 
groups have performed extensive AFM studies in air with a diversity of protein-DNA systems involved in 
essential cellular processes such as transcription, replication and DNA repair (Verhoeven et al., 2001, 
Chen et al., 2002, Seong et al., 2002, Verhoeven et al., 2002, Janicijevic et al., 2003, Wang et al., 2003, 
Crampton et al., 2006, Wu et al., 2010, Jiang and Marszalek, 2011, Shlyakhtenko et al., 2011, 
Shlyakhtenko et al., 2012b, Billingsley et al., 2012).  
2.2 DNA repair as a fundamental concept for genome maintenance 
2.2.1 Sources and consequences of DNA damage 
The integrity of our genome is continuously endangered by DNA damaging factors. It has been estimated 
that a total of 105 DNA lesions are induced in one mammalian cell during one day (Swenberg et al., 2011). 
In general, the presence of a DNA lesion may affect the stability of our genome twofold (Figure 4). 
 
Figure 4: The twofold danger of DNA damages. 
For details please refer to the main text (adapted from Hoeijmakers (2009)). 
If DNA repair is not working correctly or a damaged template has been replicated, persistent changes in 
our genetic code can occur in the form of mutations or chromosomal aberrations. These may give rise to 
activation of proto-oncogenes and inactivation of tumor-suppressor genes increasing the risk of cancer 
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(Bartek et al., 2007). Alternatively, DNA lesions may block the essential cellular processes transcription 
and replication leading to cellular senescence and cell death. Such lesion-induced apoptosis is a double-
edged sword: on the one hand it is an important mechanism to fight cancer, but on the other hand it 
may contribute to accelerated aging (Schumacher et al., 2008) (as reviewed by Hoeijmakers (2009)). 
DNA damaging factors originate from two main sources. First, exogenous agents from our environment 
such as UV-irradiation, ionizing radiation and genotoxic substances contained in cigarette smoke and 
chemotherapeutics result in structural alterations of DNA. Second, the stability of DNA is threatened by 
endogenous substances from our metabolism including nitrogen species and reactive oxygen species 
(ROS) produced during respiration and lipid peroxidation. Due to these DNA damaging factors and due to 
the chemical nature of DNA in an aqueous solution, nucleic acids are highly vulnerable under 
physiological conditions. Spontaneous reactions (mostly hydrolysis and nucleophilic attack) can lead to 
formation of abasic sites and deamination of cytosine, adenine or guanine (Hoeijmakers, 2001, 
Hoeijmakers, 2009). Overall these factors may induce a plethora of DNA damages. The most common 
types are summarized in Figure 5. 
 
Figure 5: Sources and types of DNA damages.  
DNA damaging agents (top) can cause a variety of DNA lesions as displayed by some typical examples (middle). 
Different DNA repair mechanisms have evolved for removal of a specific subset of lesions (bottom) (adapted from 
Hoeijmakers (2001)). 
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Considering the battery of DNA lesion types, a single DNA repair mechanism would be completely 
overburdened. Thus, several different DNA repair mechanisms have evolved to maintain the stability of a 
cell’s genetic information. Although each of the pathways has specialized for removal of a specific subset 
of lesions, DNA repair systems are a highly interwoven network with partly overlapping specificities. 
2.2.2 DNA damage excision repair pathways 
As DNA is the genetic material in all living cells, the problem of DNA injury has existed ab initio. In 
contrast to other biomolecules, damaged DNA cannot be completely replaced by a new molecule, but 
solely relies on repair of single nucleotides to remain intact. Thus, DNA repair systems must have 
developed very early in evolution and are conserved in all three kingdoms of life, which are comprised of 
eukaryotes, prokaryotes and archaea (Woese and Fox, 1977). Remarkably, the main principles of DNA 
repair are usually similar across the prokaryotic and eukaryotic border. Among eukaryotes, the structure 
and function of most DNA repair proteins is largely conserved and in some cases even throughout 
bacteria. This high conservation is a great benefit in studying and understanding the mechanisms of DNA 
repair (as reviewed by Taylor and Lehmann (1998)). 
In eukaryotes, the most relevant DNA repair pathways include: nucleotide excision repair (NER), base 
excision repair (BER), double-strand break repair, and mismatch repair (see Figure 5). Here, I will focus 
on the two DNA lesion excision mechanisms of NER and BER. As a common feature, DNA injury in these 
two processes affects only one of the DNA strands. In general, DNA excision repair pathways operate 
through ‘cut-and-patch’ type reactions, in which the DNA damage (with or without some flanking DNA 
sequences) is excised and removed. The complementary non-damaged DNA strand is used as a template 
for the repair synthesis to restore the original DNA sequence. The most fundamental steps in the two 
pathways are DNA lesion search and recognition over the excess of nonspecific bases. These processes 
will be discussed exemplarily for eukaryotic NER and BER in this thesis. 
In NER, a short fragment of single-stranded DNA (24-32 nucleotides) surrounding the DNA lesion is 
excised and removed. Most DNA substrates for NER originate from exogenous sources (except for some 
oxidative lesions) and embrace the class of helix-distorting lesions, which may disrupt normal base-
pairing and generally obstruct normal transcription and replication. For example, bulky carcinogenic 
photoproducts induced by UV irradiation, such as cyclobutane pyrimidine dimers (CPD) as well as cis-
platin-adducts and benzopyren-adducts caused by chemotherapy and smoking can be removed by the 
NER pathway (Lindahl, 1993, Gillet and Scharer, 2006). Its extraordinarily wide range of substrate 
specificities renders NER an excellent model mechanism for the study of recognition strategies for 
different target sites in DNA repair. The high versatility of NER is based on its two-step damage 
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recognition strategy (also called ‘bipartite substrate discrimination’). The initial damage sensing step 
circumvents direct recognition of the lesion itself, but instead uses a set of common features shared by 
many different DNA damages such as helix distortion for lesion discrimination. In a second and ATP-
dependent step, the presence of a chemical modification is verified by a multi-protein damage 
recognition complex, a process also referred to as ‘kinetic proofreading’.  
The BER mechanism recognizes and removes small, non-helix-distorting chemical base lesions, which 
predominantly arise from endogenous sources. Alterations in bases can be due to oxidation, alkylation or 
deamination (Lindahl, 1993), which provide a high miscoding potential, but may not interfere with 
transcription and replication as rigidly as the NER mechanism. Thus, BER is particularly essential to 
prevent mutagenesis caused by mispairing or breaks in DNA during replication. BER involves 4-5 steps, 
with the initial step performed by DNA glycosylases. DNA glycosylases recognize a damaged or 
mismatched base within the huge excess of normal bases with high specificity by employing a base-
flipping mechanism to identify their target site in their active site pocket (Friedman and Stivers, 2010). In 
addition, these enzymes catalyze base excision by cleaving the glycosidic bond between the base and the 
DNA sugar-phosphate backbone.  
It is remarkable that DNA glycosylases do not require any metal cofactors or exogenous energy source 
for fulfilling these tasks and solely rely on DNA base pairing energies. Lesion recognition and excision in 
BER is then followed by a common multi-protein pathway usually involving an AP-endonuclease for 
processing of the abasic site, a DNA polymerase for repair synthesis and a DNA ligase for nick sealing. In 
striking contrast to NER, the broad substrate specificity in BER is based on a variety of different DNA 
glycosylases, which have specialized for a narrow subset of base alterations, instead of a multi-subunit 
damage recognition complex. Hence, glycosylases are interesting target proteins to compare the two 
different approaches for damage search and recognition strategies in the two DNA excision repair 
pathways, BER and NER. 
2.3 Nucleotide excision repair (NER) 
The general mechanism of NER is conserved in prokaryotes and eukaryotes and can be grouped into four 
common steps: a) initial damage detection b) damage verification c) damage removal and d) DNA re-
synthesis. The prokaryotic NER system mainly involves the UvrABC machinery. The DNA is initially probed 
for the presence of lesions by the sliding complex of UvrAB. Upon lesion encounter, UvrA loads UvrB 
onto DNA and then dissociates from the UvrB-DNA complex. After successful damage verification by 
UvrB, a stable pre-incision complex is formed by recruitment of UvrC, which cuts DNA 3’ and 5’ to the 
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lesion. Subsequently, the incised oligonucleotide as well as UvrB and UvrC are released by the helicase 
UvrD to allow DNA re-synthesis and ligation by DNA polymerase I and DNA ligase, respectively (Van 
Houten et al., 2005, Truglio et al., 2006). 
Accounting for the higher organization in eukaryotes, up to 30 different proteins cooperate in a 
sophisticated cascade in eukaryotic NER. Due to the complexity of NER itself and its crosstalk with other 
cellular processes such as transcription and the cell-cycle, defects in NER proteins can lead to inherited, 
severe diseases: Xeroderma Pigmentosum (XP), Cockayne Syndrome (CS) and Trichothiodystrophy (TTD). 
Patients suffering from XP show high photosensitivity and high proneness to skin cancer. XP is often 
coupled to CS, a second syndrome with high UV-light sensitivity that is accompanied by additional 
symptoms such as neurological abnormalities and short stature. TTD phenotypes are also sensitive to 
UV-irradiation and associated with neurological disorders and premature ageing (as reviewed by 
Lehmann (2001),  Gillet and Scharer (2006) and Egly and Coin (2011)). The following chapter describes 
the mechanism of eukaryotic NER in detail with special focus on the process of DNA damage verification. 
2.3.1 Mechanism of eukaryotic NER 
 Eukaryotic NER can be divided in two subpathways, which are schematically depicted in Figure 6. In 
global genomic repair (GG-NER) the whole genome is scanned for the presence of helix distortions, 
whereas transcription-coupled repair (TC-NER) removes lesions on actively transcribed genes induced by 
a blockage of RNA polymerase II (RNA Pol II) (as reviewed by Hoeijmakers (2001), Hoeijmakers (2009) 
and Marteijn et al. (2014)). 
In GG-NER, the heterotrimeric complex of XPC, the RAD23 homologue B (RAD23B) and centrin 2 (CETN2) 
continuously probes DNA for the presence of helix-distortions (step 1, upper pathway) (Masutani et al., 
1994, Sugasawa et al., 1998, Sugasawa et al., 2001, Nishi et al., 2005). Most NER lesions strongly 
destabilize the DNA duplex causing small unpaired DNA regions (bubbles). Due to its high affinity for 
junctions between single-stranded DNA (ssDNA) and double-stranded DNA (dsDNA) (Min and Pavletich, 
2007), XPC binds to the complementary strand opposite the DNA damage, recognizing lesions in an 
indirect manner. For detection of CPD lesions, which induce only minor helix destabilization (Sugasawa 
et al., 2001, Reardon and Sancar, 2003) and could not be detected by XPC on its own, XPC is assisted by 
the ultraviolet radiation DNA damage binding protein complex (UV–DDB, step 2) (Chu and Chang, 1988, 
Wakasugi et al., 2002, Scrima et al., 2008). By intercalation between the DNA strands with its ß-hairpin 
domain, XPC stabilizes the ssDNA region and was also proposed to enlarge the bubble size to allow 
binding of the large ring-like transcription factor II H (TFIIH) (Sugasawa et al., 2001, Maillard et al., 2007, 
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Min and Pavletich, 2007). Prior to recruitment of TFIIH, RAD23B dissociates from the heterotrimeric XPC 
complex (step 3). 
RNA Pol II transiently interacts with UV-stimulated scaffold protein A (UVSSA), ubiquitin-specific-
processing protease 7 (USP7) and Cockayne syndrome protein (CSB) during transcription elongation (step 
1, lower pathway). Upon damage encounter, the TC-NER pathway is activated (Hanawalt and Spivak, 
2008, Vermeulen and Fousteri, 2013) by RNA Pol II stalling at the lesion site thereby enhancing the 
affinity of CSB (step 2). To allow unhindered DNA repair, CSA is recruited to form a complex with CSB and 
RNA Pol II (Fousteri et al., 2006, Schwertman et al., 2012), which induces RNA Pol II to move backwards, 
down-stream from the damage (backtracking) (step 3). 
In the next step, the formation of the pre-incision complex, GG-NER and TC-NER merge into a common 
pathway (step 4). A central player is the ten-subunit TFIIH-complex with the Cdk-activiating kinase (CAK) 
subcomplex (three subunits) (Yokoi et al., 2000, Volker et al., 2001, Riedl et al., 2003). The TFIIH complex 
fulfils a dual role as it functions in NER as well as in transcription initiation (as reviewed by Compe and 
Egly (2012)). Upon binding of the TFIIH complex to DNA-bound XPC, the CAK sub-complex readily 
dissociates (Coin et al., 2008) from the TFIIH core complex (seven subunits). The 3’ specific endonuclease 
XPG is recruited simultaneously either in complex with TFIIH or separately (Dunand-Sauthier et al., 2005, 
Zotter et al., 2006, Ito et al., 2007). The TFIIH-complex includes the 5’-3’-helicase XPD and the ATPase 
XPB (Riedl et al., 2003). XPB has been suggested to anchor TFIIH at the site of the damage by its ATPase 
activity (Oksenych et al., 2009), which has been shown to be stimulated by XPC (Bernardes de Jesus et 
al., 2008) in the GG-NER pathway. In the pre-incision step, XPB is indicated to undergo ATP-dependent 
conformational changes to enlarge the DNA bubble size by its ATPase activity (Coin et al., 2007). XPD is 
proposed to further unwind the DNA around the damage by its helicase activity in 5’-3’ direction (Tapias 
et al., 2004, Compe and Egly, 2012). Concomitantly, the evolving undamaged ssDNA strand is stabilized 
by the single-stranded DNA binding protein replication protein A (RPA) (de Laat et al., 1998). Apart from 
this proposed role in NER, XPD has been indicated to fulfil an essential function in damage verification 
likely supported by the ATPase activity of XPB and the factor XPA, which has a proposed high affinity for 
single-stranded, chemically modified DNA (Camenisch et al., 2006, Sugasawa et al., 2009). 
After the presence of a chemical modification is verified successfully, the ‘point of no return’ is reached. 
XPA and RPA direct the 5’ specific endonuclease XPF-ERCC1 complex to the 5’ site of the lesion (step 5). 
XPF-ERCC1 cleaves at the 5’ of the damage (Fagbemi et al., 2011) and the trimeric proliferating cell 
nuclear antigen (PCNA) ring loads onto DNA. XPG cuts at the 3’ side of the lesion and an oligomer with a 
length of 24-32 nucleotides containing the lesion is excised (step 6) (Huang et al., 1992, Moggs et al., 
1996). The missing ssDNA gap is filled by the DNA re-synthesis machinery including DNA Pol δ, DNA Pol κ 
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or DNA Pol ε recruited by PCNA (step 7). Finally, DNA-Ligase I or DNA-Ligase III seals the remaining nicks 
between the newly synthesized DNA-strand and the original strand (step 8) (Moser et al., 2007, Ogi et 
al., 2010). 
 
Figure 6: Schematic of the eukaryotic NER mechanism. 
DNA lesion search and initial damage sensing (steps 1-3) can either occur through the GG-NER or the TC-NER 
pathway. After initial damage detection, GG-NER and TC-NER merge into a common pathway. Subsequent to 
damage verification (step 4), a short stretch of DNA containing the lesion is excised and removed (steps 5-6). Then, 
the original DNA sequence is restored by the DNA re-synthesis machinery using the non-damaged strand of the 
DNA duplex as template for repair synthesis (steps 7-8). For details see main text (adapted from Marteijn et al. 
(2014)). 
2.3.2 DNA damage verification in eukaryotic NER 
DNA damage verification is the most fundamental step in NER. On the one hand, cytotoxic or mutagenic 
DNA lesions have to be verified and removed as efficiently as possible and on the other hand futile repair 
of non-damaged bases has to be avoided (Dip et al., 2004). Currently, it is highly debated whether XPD is 
involved in damage verification and if this task is fulfilled solely by TFIIH or by TFIIH in cooperation with 
further NER factors such as XPA (see above, step 4 in NER pathway) (Camenisch et al., 2006, Sugasawa et 
al., 2009). 
In eukaryotes, XPD serves as structural component within the TFIIH complex by bridging the TFIIH core 
complex with the CAK complex via its interaction with p44 (structural protein in the core complex) and 
MAT1 (CAK) (Reardon et al., 1996). More importantly, XPD plays a functional role in NER, but is 
dispensable for transcription initiation (Tirode et al., 1999). In the pre-incision step, XPD is essential to 
22 
 
enlarge the repair bubble around the lesion by its helicase activity (see above, NER mechanism step 4), 
which is a prerequisite for dual incision by XPG and XPF.  
In general, DNA helicases such as XPD are motor proteins, which translocate on nucleic acids in a 
predetermined direction utilizing the free energy provided by binding and hydrolysis of nucleoside 
triphosphates to unwind double-stranded nucleic acids (Singleton et al., 2007). As a common feature, 
helicases share seven helicase motifs (walker motif I, Ia, II, III, IV, V and VI) constituted of conserved 
amino-acid sequences. XPD is an ATP-dependent 5’-3’ helicase and belongs to the superfamily II (SF2) 
helicases.  
In an early study using a yeast homolog of XPD (Rad3), it has been shown that DNA translocation of XPD 
was stalled at lesion sites in vivo (Naegeli et al., 1992) implicating XPD in damage verification. Recent 
biochemical studies with an archaeal XPD homolog from Ferroplasma acidarmanus (facXPD) confirmed 
that XPD’s helicase activity was blocked by the presence of a lesion in vitro and discovered that XPD 
formed a stable complex with DNA at the site of the damage (Mathieu et al., 2010, Mathieu et al., 2013). 
These observations argued for a role of XPD in damage recognition as well as verification. In contrast, a 
different group showed that XPD from the archaeal organism Sulfolobus acidocaldarius (saXPD) was not 
stalled by DNA lesions addressed by the NER pathway (Rudolf et al., 2010). Overall, these studies 
demonstrate that DNA damage verification by XPD is still a matter of considerable debate and will 
require further investigation. 
2.3.3 Archaeal XP homologs as a model for eukaryotic NER 
DNA repair proteins from archaeal homologs have been widely used as model systems for eukaryotic 
NER in biochemical and structural approaches (see above in 2.3.2 and Nishino et al., 2003, Roberts et al., 
2003, Fan et al., 2006, Fan et al., 2008, Liu et al., 2008, Richards et al., 2008, Wolski et al., 2008, Mathieu 
et al., 2010, Ma et al., 2011), because archaeal proteins are often thermophilic (preferred temperature 
> 45°C) and thus are more amenable to biochemical investigation than their human counterparts. As 
DNA repair mechanisms are highly conserved between the three domains of life (see 2.2.2), archaeal and 
eukaryotic NER proteins often share a high sequence homology.  
Archaea were identified as the third kingdom of life (Woese and Fox, 1977) and can be grouped into 
euryarchaea and crenarchaea based on phylogenetic analysis of their ribosomes (Cox et al., 2008). 
Considering the natural habitats of archaea in particular those of hyperthermophilic species (preferred 
temperature >80°C) e.g. living in vulcanos and hot springs, archaea have to face tremendous challenges 
in preserving their genomic stability. Obviously, the question is raised, which genome maintenance 
mechanisms are employed in archaea (Grogan, 2000, Grogan, 2004).  
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Bioinformatic homology searches for eukaryotic and prokaryotic DNA repair proteins among the wealth 
of genomic sequence information, which is available for archaea, revealed that archaeal repair proteins 
more closely resemble their eukaryotic than their prokaryotic counterparts (Grogan, 2004). Table 2 
provides an overview of selected DNA repair proteins among different sequenced archaeal organisms:  
Table 2: Distribution of selected DNA repair proteins in sequenced archaeal genomes. 
Species XPF XPB XPD FEN-1 Dpo4 Photo
-lyase 
UvrAB
C 
MutS/ 
MutL 
Temp 
(°C ) 
Aeropyrum pernix 1 1 1 1     95 
Pyrobaculum aerophilum 1 2 1 1     95 
Sulfolobus solfataricus 1 2 1 1 1 1   80 
Sulfolobus tokodaii 1 2 2 1 1 1   80 
Sulfolobus acidocaldarius 1 2 1 1 1 1   75 
Methanopyrus kandleri 1   1     100 
Pyrococcus furiosus 1 2 1 1     100 
Pyrococcus horikoshii 1 2 1 1     100 
Pyrococcus abyssi 1 2 1 1     100 
Thermococcus 
kodakarensis 
1 1 1 1     85 
Nanoarchaeum equitans 1 1 1 1     85 
Methanococcus 
jannaschii 
1  1 1     85 
Archaeoglobus fulgidus 1 1  1     85 
Methanothermobacter 
thermautotrophicus 
1   1  1 •  70 
Picrophilus torridus  1 1 1 1 1   60 
Thermoplasma 
acidophilum 
 1 1 1     60 
Thermoplasma volcanium  1 1 1     60 
Methanosarcina 
acetivorans 
1 1 1 1 1 1 • • <40 
Methanosarcina mazei 1 1 1 1 1 1 • • <40 
Haloarcula marismortui 1 2  1 1 3 • • <40 
Halobacterium NRC-1 1 2 1 1 1 2 • • <40 
Archaeal species are grouped by growth temperature. Hyperthermophilic organisms (>80°C) are marked in red, 
thermophilic in yellow (45-80°C) and mesophilic in blue (<45°C) • indicates the presence of bacterial DNA repair 
proteins in archaeal organisms (adapted from Kelman and White (2005)). 
Only a few archaeal organisms particularly the mesophilic species (temperatures < 45°C preferred, 
compare Table 2) possess the bacterial UvrABC repair system (Kelman and White, 2005) likely by lateral 
gene transfer from a bacterial donor (Grogan, 2000). In the majority of archaea, eukaryotic NER proteins 
were found such as the helicase  XPD and the ATPase XPB and the endonucleases XPF and the Flap 
structure-specific endonuclease 1 (FEN-1) (Table 2), a homolog of the eukaryotic endonuclease XPG, 
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which also functions in other DNA repair mechanisms (e.g. in the BER mechanism, see 2.4.1) and 
replication. However, not all archaeal species embrace the same set of XP-homologs and archaeal 
genomes generally lack XPC and XPA, two essential factors required for eukaryotic NER. It is evident from 
the overview provided by Table 2 that the distribution of DNA repair proteins is highly diverse among 
archaea. 
The existence of a NER-type patch repair pathway in archaea has been only shown for the archaeon 
Methanothermobacterthermautotrophicus, which contains the UvrABC machinery and exhibited a 
procaryotic-type excision pattern of NER (Ogrunc et al., 1998), but not for eukaryotic-type NER so far. 
Hence, the pure presence of homologous XP-proteins in archaeal organisms does not necessarily argue 
for their role in NER and it is likely that XP-proteins may function in other cellular mechanisms such as 
DNA replication in archaea (Kelman and White, 2005, Rouillon and White, 2011). Despite the poor 
understanding of NER in archaea, the archaeal XP homologs, however, represent attractive NER models 
due to their significant sequence similarity to the eukaryotic NER proteins (Grogan, 2000, Grogan, 2004). 
2.3.4 Objectives in lesion recognition and verification by XPD 
As described in the previous section, archaeal XP homologs can be employed as an adequate model for 
eukaryotic NER. In this thesis, the XPD homolog from the euryarchaeon Thermoplasma acidophilum 
(taXPD), whose complete genome sequence has been published (Ruepp et al., 2000), served as model to 
investigate damage verification in NER because the protein shares a high sequence identity of 39 % with 
its human counterpart (as defined by BLAST, NCBI). Compared to other archaeal species (Table 2), 
T. acidophilum contains only a few XP proteins including XPD, XPB and the XPG homolog FEN-1 and 
completely lacks prokaryotic-type UvrABC proteins or further homologous proteins from other repair 
systems. In contrast to eukaryotic XPD, which functions as part of the TFIIH complex, taXPD is a 
monomeric protein in solution and has not been shown to form stable interactions with other protein 
partners so far (Rouillon and White, 2011). Hence, XPD from T. acidophilum may provide a simplistic 
model for damage verification processes. Due to its thermophilia (growth temperature of ~ 60 °C), the 
proteins from this archaeal organism are more applicable to biochemical and structural approaches than 
their human equivalents. Importantly, detailed knowledge about the enzyme’s three-dimensional 
structure can be gained from the crystal structure of taXPD (Wolski et al., 2008). In the crystal structure 
of taXPD four domains can be distinguished (Figure 7): The two RecA-like domains, (helicase domain 1 
and 2, respectively) responsible for helicase activity, a highly conserved arch domain and an iron sulfur 
cluster domain (Wolski et al., 2008). 
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In addition, the X-ray structure of taXPD supports the molecular understanding of the point mutations 
leading to three inherited, severe diseases XP, CS combined with XP and TTD (compare 2.3) in the human 
homolog. Using mutational and biochemical studies, the implications of disease-related taXPD variants 
(corresponding to mutations in the human homologue) on the protein’s functions such as DNA binding, 
helicase and ATPase activity were investigated (Wolski et al., 2008, Kuper et al., 2012). 
 
Figure 7: Primary and crystal structure of taXPD showing mutated residues as used in this work. 
A) Schematic representing the primary structure of taXPD. The helicase motifs (I-VI), the FeS cluster and the 
molecular weight of the protein are indicated (adapted from Wolski et al. (2008)). B) The crystal structure of taXPD 
(PDB-ID: 2VSF) (adapted from Wolski et al. (2008)) is shown in ribbon presentation with the RecA-like helicase 
domains 1 and 2 in yellow and red, respectively. The FeS cluster domain is depicted in cyan and the arch domain in 
green. The FeS cluster is shown in purple. The positions of the residues Lys170 and Arg567 (depicted in space-filling 
representation) are indicated in the structure as the XPD variants K170A and R567W were used as controls in the 
AFM studies. 
Based on a recent co-crystal-structure of taXPD bound to a short fragment of ssDNA, a model of the 
possible path of DNA across the enzyme could be derived (Kuper et al., 2012). The first three domains 
(helicase domain 1, the FeS cluster domain and the arch domain) form a donut-shaped structure with a 
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pore (10 Å diameter). In the XPD-DNA model, the ssDNA is threaded in the pore. The route of the 
modeled DNA passes by a narrow pocket, which is located in the wall of the central pore directly next to 
the FeS cluster (Wolski et al., 2008). The pocket is shaped by the strictly conserved residues Arg88 and 
Tyr166 on the one side and by Tyr185 on the other side. An undamaged base, either a purine or a 
pyrimidine, would perfectly fit in this narrow hole and could be stabilized via Van-der-Waals interactions 
with the arginine and the two tyrosine residues. In contrast, a bulky DNA damage such as cis-platin- or 
benzopyren-adducts would be excluded from this pore. Due to these findings and the close proximity to 
the FeS cluster, this narrow pocket has been proposed to be involved in damage verification.  
Interestingly, a recent study by Barton and co-workers showed that [4Fe-4S] cluster containing proteins 
(e.g. XPD) may employ such clusters as a damage sensor (Sontz et al., 2012). Within perfectly matched 
unmodified DNA (Figure 8, left), DNA-mediated charge transfer (CT) (green arrow) can occur between 
two FeS cluster containing proteins of similar potential (Fe3+, dark red and violet oval), which are capable 
of performing CT.  
 
Figure 8: Model for DNA mediated charge transfer. 
For details see main text (adapted from Sontz et al. (2012)). 
In principle, stacking interactions between base pairs in the DNA double helix (∏-∏ interactions) can 
serve as a ‘molecular wire’ for rapid, one-dimensional charge separation (or DNA-mediated CT) (Eley and 
Spivey, 1962). DNA CT between two DNA-bound proteins is driven by free guanine radicals formed under 
oxidative stress, which stimulates reduction of the FeS clusters (Fe2+, light red and light violet ovals). 
Reduced proteins possess lower affinity to DNA and dissociate from DNA. In the presence of an 
intervening damage or mismatch (Figure 8, right, yellow star), DNA CT is not able to proceed (red arrow) 
and DNA-bound repair proteins remain in the oxidized state (Fe3+, dark red and violet oval). Instead of 
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dissociation from DNA, the repair proteins remain bound close to the DNA lesion and can translocate 
towards the damage for repair on a lower time scale (Romano et al., 2011). Thus, inhibition of DNA-
mediated CT by the presence of a lesion can lead to redistribution of repair proteins in the vicinity of the 
lesion, which has been shown for XPD (from the archaeon Sulfolobus acidocaldarius) and Endo III (BER 
glycosylase from E. coli) in AFM imaging experiments on long DNA fragments (>1 kb) (Romano et al., 
2011, Sontz et al., 2012). Thus, it can be envisioned that the mechanical readout of DNA bases is coupled 
to redox sensing by the iron-sulfur cluster. 
Although the crystal structures of taXPD can reveal the enzyme’s general architecture and residues 
involved in protein-DNA interactions, the understanding if and how XPD may achieve lesion recognition 
and verification still remains elusive. To gain more detailed insights into these processes from a 
mechanistic perspective, XPD-DNA interactions were investigated in single molecule AFM imaging 
experiments. In contrast to X-ray crystallography, AFM imaging allows application of long DNA substrates 
of hundreds to thousands of bp length, which more closely resemble the in vivo occurring DNA strands. 
Thus, AFM can resolve different populations of XPD at the molecular level in a single experiment. 
Furthermore, different experimental conditions e.g. the presence or absence of ATP and various DNA 
substrates can be more readily tested.  
In addition, in my studies I compared DNA interactions of two taXPD variants to the wt protein by AFM. 
Firstly, the residue Arg567, which is located near the ATP-binding site in the crystal structure (Figure 7) 
was substituted by tryptophane. The resulting taXPD variant R567W has been indicated to be deficient in 
ATP binding and hydrolysis and corresponds to R666W in the human homolog, which is related to the 
disease XP (Wolski et al., 2008). Secondly, the taXPD variant K170A was applied, which has recently been 
suggested to possess helicase hyperactivity and elevated ATPase activity compared to the wt protein 
(Kuper et al., 2012). As the mutated Lys170 residue is located in close vicinity to the FeS cluster (Figure 7), 
which is proposed to be involved in damage verification as described above, the K170A variant can be 
expected to possess a damage verification phenotype in the AFM studies. 
To account for the high substrate versatility of NER, I compared damage verification by XPD for two 
structurally different NER lesions (Figure 9). First, a CPD damage was used as representative for UV-
photoproducts, induced by UV-light-driven dimerization of adjacent thymines. In contrast to other 
photolesions such as (6-4) pyrimidine-pyrimidone photoproduct (6-4 PP), CPD causes only minor helix 
distortion (Kim and Sancar, 1995, McAteer et al., 1998, Lee et al., 2004). Second, a fluorescein damage, 
an artificial substrate often used for damage recognition studies in NER (Rudolf et al., 2010), served as 
representative of bulky DNA-adducts.  
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Figure 9: DNA substrates for lesion recognition studies with taXPD. 
The NER lesion CPD (left) is caused by UV-light-driven dimerization of adjacent thymines and is related to minor 
helix distortion. The artificial DNA substrate fluorescein (right) functions as a representative for bulky DNA-adducts. 
In the DNA substrates used for AFM, the fluorescein damage is attached to a thymine base by a short linker. 
2.4 Base excision repair (BER) 
2.4.1 Principles and mechanism of BER 
A variety of cytotoxic and mutagenic base lesions are initially detected and removed by DNA 
glycosylases, which employ a base-flipping mechanism to identify a target site within the huge excess of 
normal bases (Friedman and Stivers, 2010). Based on their catalytic mechanism of base excision, DNA 
glycosylases can be divided in two classes (Hegde et al., 2008, Schermerhorn and Delaney, 2014). 
Monofunctional glycosylases (e.g. TDG) use an activated water molecule for nucleophilic attack of the 
base-sugar (N-glycosidic) bond of the everted base creating an intact abasic site in the DNA (Figure 10, 
step 1A). Abasic sites entail a great risk for the cells: they are susceptible to ssDNA breaks and have a 
tendency to induce intrastrand crosslinks with DNA or crosslinks of DNA with proteins (Sczepanski et al., 
2010). Therefore, these cytotoxic DNA sites are protected by monofunctional glycosylases in humans, 
until a downstream AP endonuclease (APE1) arrives (step 2A) (Vidal et al., 2001). APE1 cleaves the 
phosphoribose backbone at abasic sites, inducing a nick with 3′-OH and 5′-deoxyribose phosphate (dRP) 
termini (Barzilay et al., 1995, Erzberger and Wilson, 1999). Following cleavage by APE1, DNA pol β cleans 
the remaining DNA ends by converting the 5′-dRP to a 5′-phosphate using its dRP lyase activity (step 3A) 
(Beard and Wilson, 2006, Prasad et al., 2010). 
In contrast, bifunctional glycosylases (e.g. NTH1 and OGG1) utilize the ε-NH2 of a lysine or the amino 
group of an N-terminal proline for nucleophilic attack (step 1B) and harbor an additional intrinsic AP 
lyase (DNA strand cleavage) activity for processing of the abasic site. In a concerted step, a transient 
Schiff base between the amino group of the protein and the C1′ of deoxyribose is formed both to excise 
the base lesion and to cleave the DNA backbone (McCullough et al., 1999, Dalhus et al., 2011). Via β-
elimination (step 2B), a 3′-phosphor-α,β-unsaturated aldehyde (3’PUA) and a 5′-phosphate terminus are 
generated. In the next step, 3’-PUA is converted to a 3’-OH group by APE1 (step 3B).  
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Alternatively, some bifunctional DNA glycosylases (e.g. NEIL1 and NEIL2) also utilize an N-terminal 
proline as nucleophile for removal of the deoxyribose residue yielding a 3′-phosphate terminus at the 
nicking site (βδ-elimination, step 2C) (Zharkov et al., 2003). As the product of the βδ-elimination is a poor 
substrate for APE1, the polynucleotide kinase (PNK), which is highly expressed in mammals, 
dephosphorylates the 3’phosphate by its 3′-phosphatase activity (step 3C) (Meijer et al., 2002). 
Downstream from these steps, BER can continue in two different modes, either as short-patch BER (SP-
BER, also named single nucleotide BER (SN-BER)) (Kubota et al., 1996) or as long patch BER (LP-BER) 
depending on the status of the 5’ terminal group and on other factors. For example, if the 5′-dRP group is 
modified to 5’ phosphate, the dRP lyase activity of pol β can be inhibited and the LP-BER pathway is 
preferred (Horton et al., 2000, Sung et al., 2005).  
In LP-BER, polymerase β, δ, or ε incorporates 2-8 deoxynucleotides at the gap site (step 4A) (Singhal et 
al., 1995) introducing a displaced single-stranded flap of DNA. The flap is removed by the 5′-flap 
endonuclease 1 (FEN-1) (step 5A) (Prasad et al., 2000) leaving a nick, which is sealed by DNA Ligase I 
(step 6) (Taylor et al., 2011). Pol β, δ, or ε, FEN-1 and DNA Ligase I are recruited by the sliding clamp 
PCNA (see NER mechanism in 2.2.2) (Moldovan et al., 2007), which is loaded onto duplex DNA by the 
replication factor-C (RFC) (Levin et al., 2000). 
In SP-BER, a single nucleotide is incorporated to the 3′-OH of the nick by pol β, which interacts with the 
X-ray repair cross-complementing protein 1 (XRCC1) (step 4B) (Caldecott, 2003). Finally, the nick is sealed 
by DNA Ligase IIIα (Gao et al., 2011, Simsek et al., 2011), which also requires interaction with XRCC1 
(step 5B). 
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Figure 10: Schematics of BER subpathways. 
The base lesion or mismatch is represented by a red line. Divergent pathways for base excision and strand cleavage 
(red) merge into common steps for end processing of terminal groups (‘end cleaning’, yellow). DNA repair synthesis 
(cyan) can either occur via LP-BER or SN-NER. Newly inserted ‘correct’ nucleotides are depicted as blue lines.  For 
other details please refer to the main text (adapted from Hegde et al. (2008)). 
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2.4.2 DNA lesion search and recognition by DNA glycosylases 
So far, it remained largely controversial how BER enzymes detect their target sites within the huge 
excess of undamaged bases. In general, DNA glycosylases have to compromise between the needs to 
minimize the time for lesion search and to maximize the selectivity for removal of their target base 
(Zharkov et al., 2010). Under the in vivo conditions of high DNA concentration, these DNA repair 
enzymes have developed the ability to bind nonspecific DNA with moderate affinity (Berg et al., 1981, 
Bruinsma, 2002). One-dimensional diffusion in contact with undamaged DNA (sliding) and three-
dimensional transfer among DNA segments (hopping) may then facilitate rapid lesion detection (Halford 
and Marko, 2004, Blainey et al., 2006, Hu et al., 2006). Final target identification requires contacts with 
residues in the catalytic center of the enzyme, which are achieved by flipping of the damaged base into 
an extrahelical state. Many DNA glycosylases (e.g. UDG, hOgg1, or AlkA )(Stivers and Jiang, 2003)) display 
a high density of polar phosphodiester interactions with the damaged strand and only a few contacts 
with the undamaged strand leading to DNA backbone chain distortion (bending). Such protein-induced 
DNA bending may function to introduce torsional stress on the damaged base to lower the energetic 
barrier for base eversion (Ramstein and Lavery, 1988).  
Furthermore, in computational studies damaged DNA was found to be intrinsically more flexible, 
facilitating bending and flipping at damaged sites (Fuxreiter et al., 2002, Seibert et al., 2002, Imhof and 
Zahran, 2013, Yin et al., 2014). Currently, these processes are less well understood for nonspecific DNA 
and the question whether DNA glycosylases bend and flip undamaged DNA during lesion search is still a 
matter of considerable debate (McCullough et al., 1999, Friedman and Stivers, 2010). The mechanisms 
underlying enzymatic base flipping have been studied for some glycosylases (e.g. UDG, T4-Pdg, hOgg1, 
AlkA) by different techniques such as equilibrium fluorescence, stopped-flow and quenching 
experiments and diffusion-decelerated fluorescence correlation spectroscopy combined with molecular 
dynamics simulations (Chen et al., 2002, Walker et al., 2006, Bellamy et al., 2007, Zharkov et al., 2010, 
Yin et al., 2014). A major question is whether the proteins fulfill an active (inducing base flipping) or 
passive (stabilizing the flipped state) role in nucleotide flipping. For instance, the UNG glycosylase, has 
been reported to capture transiently emerging bases (passive flipping) at non-target sites (Cao et al., 
2004, Cao et al., 2006, Parker et al., 2007, Friedman et al., 2009). The glycosylase hOgg1 and its bacterial 
homolog MutM, however, have been indicated to employ an active extra-helical base interrogation and 
flipping mechanism (Nelson et al., 2014, Qi et al., 2009). The type of exploited base eversion mechanism 
(active or passive) may hence vary for different glycosylases. Moreover, not only base extrusion but also 
the entire process of damage search in BER appears to be optimized for the individual energetic 
requirements of the particular target sites of a specific glycosylase.  
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2.4.3 Thymine DNA glycosylase (hTDG) 
In my studies, the question of DNA lesion search strategies of DNA glycosylases was addressed by atomic 
force microscopy (AFM) imaging focusing on the specific example of the human thymine DNA glycosylase 
(hTDG). The monofunctional DNA glycosylase hTDG belongs to the uracil DNA glycosylase (UDG) protein 
superfamily (Pearl, 2000) and is involved in BER as well as epigenetic gene regulation being responsible 
for active DNA demethylation (Wu et al., 2010, Nabel et al., 2012). It shows a strong repair activity for 
uracil from G:U mispairs as well as for oxidized forms of 5-methylcytosine (mC) created by Tet enzymes 
(5-formylcytosine, 5fC and 5-carboxylcytosine, 5caC) (He et al., 2011, Maiti and Drohat, 2011). In 
addition, hTDG restores CpG sites by selective removal of thymine from G:T mismatches caused by 
deamination of mC. Notably, hTDG avoids futile repair of undamaged DNA, by excising thymine, a normal 
base, with 18000 fold greater activity from G:T mispairs than from A:T pairs (Morgan et al., 2007).  
So far, several co-crystal structures of the hTDG catalytic core domain (hTDGcat) in complex with DNA 
have been solved, which provided valuable insights into the active site of the enzyme. Due to its largely 
unstructured N-terminal domain, there are no crystal structures of hTDG full length available so far. An 
early X-ray structure shows hTDG bound to the abasic site analog tetrahydrofuran (THF) simulating the 
protein in the product state (Maiti et al., 2008). Recent structures of hTDGcat captured the enzyme in the 
lesion recognition state bound to the substrate analog 2’-deoxy-2’-flouroarabinouridine (UF) (Maiti et al., 
2012) (Figure 11) or 5cac (Hashimoto et al., 2012), which was flipped into the active site but not cleaved.  
Interestingly, in two of these structures (Maiti et al., 2008, Maiti et al., 2012) the enzyme crystallized in a 
2:1 complex with DNA, with one subunit bound to the target site (to THF or G:UF, respectively) (specific 
complex) and one subunit bound to undamaged DNA (nonspecific complex) directly next to the specific 
complex. Biochemical assays and kinetic studies confirmed dimerization (of the catalytic domain as well 
as the full length protein) under conditions of high and saturating [hTDG], but showed that a monomer 
of hTDG was fully capable of DNA lesion recognition and base excision (Maiti et al., 2008, Morgan et al., 
2011). 
Both hTDGcat structures (bound to an abasic site analog and to G:U
F (Figure 11) revealed several residues 
essential for nucleotide flipping and catalysis (Maiti et al., 2008, Maiti et al., 2012). The strictly conserved 
residue Arg275 forms the tip of an arginine finger, which has been implicated in promotion and/or 
stabilization of nucleotide flipping in TDG. Based on the co-crystallographic studies and further pre-
steady-state kinetics experiments, the arginine finger has been proposed to penetrate the DNA minor 
groove and to fill the void created by base extrusion (Maiti et al., 2008, Maiti et al., 2009, Maiti et al., 
2012). Although the chemistry of base excision catalysis has not been studied thoroughly so far, 
structural and biochemical studies suggested that the strictly conserved residue Asn140 (in TDG and MUG 
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enzymes) is essential for the chemical step of this enzymatic reaction. Furthermore, it has been 
suggested that Asn140 is not involved in the steps prior to base excision and is dispensable for DNA 
substrate binding (Maiti et al., 2009). 
 
Figure 11: Primary structure and co-crystal structure of hTDG bound to a uracil analog. 
A) Schematic representing the primary structure of hTDG. Important structural motifs and residues are indicated by 
different colors as described in the figure legend (adapted from Cortazar et al. (2007)). B) The co-crystal structure 
of the catalytic core domain of hTDG bound to DNA (in stick representation) reveals a hTDG homodimer with one 
subunit bound at the specific site (non-cleavable uracil analog, 2’-deoxy-2’-flouroarabinouridine, U
F
) and the 
second subunit bound in close proximity at nonspecific DNA (PDB-ID: 3UFJ). The close-up view of the catalytic 
center shows U
F
 flipped into the active site. The side chain Asn
140
 is involved in the catalytic step of base excision. 
Arg
275
 penetrates the minor groove and fills the void from the orphaned base. (adapted from Maiti et al. (2012)). 
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2.4.4 8-oxoguanine DNA glycosylase (hOgg1) 
To investigate the generality of this lesion search mechanism among DNA glycosylases, lesion search 
strategies for hTDG, I further compared them with those of human 8-oxoguanine DNA glycosylase 
(hOgg1), which addresses target sites with completely different structural features. hTDG and hOGG1 are 
two representatives of the vast glycosylase family, which address target sites with significantly different 
structural features. While hTDG predominantly repairs an unstable G:T and G:U wobble pair, hOGG1 
mainly removes 7,8-dihydro-8-oxoguanine (8-oxoguanine, oxoG), which can form Watson-Crick like base 
pairing. OxoG is caused by ROS via spontaneous oxidation of guanine (see 2.2.1) and differs at only two 
atoms in the chemical composition from the normal base, guanine (Wallace, 2002, Evans et al., 2004). 
Due to guanine’s low redox potential, oxoG is one of the most common DNA oxidation products. In 
addition, 8oxoG is also one of the most deleterious base lesions (Steenken and Jovanovic, 1997, Burrows 
and Muller, 1998, Dedon, 2011). Besides its ability to form a Watson-Crick pair with cytosine, oxoG can 
also pair with adenine as a Hoogsteen pair during replication. A Hoogsteen base pair is an alternative 
base pairing within DNA duplexes, which can be formed by hydrogen bonds in the major groove and 
differs from the usual geometry found in Watson-Crick pairs. In this alternative DNA conformation, the 
distance between the C1’ atoms of the two nucleobases is smaller and the angle between the two 
glycosidic bonds is larger than in regular base pairs (Hoogsteen, 1963, Aishima et al., 2002, Nikolova et 
al., 2011). Misread as thymine by the replicative DNA polymerization machinery, the resulting oxoG:A 
may lead to a G/C → T/A transversion mutation after one further round of replication (Shibutani et al., 
1991, Michaels and Miller, 1992, Grollman and Moriya, 1993). 
To elucidate the impressive task of recognizing and removing oxoG, hOgg1’s lesion specificity and 
catalytic mechanism have been investigated thoroughly in structural and biochemical studies. Thus, this 
well-characterized glycosylase represents an attractive model for studying lesion detection by DNA 
glycosylases in AFM. A total of 27 different crystal structures of hOgg1 and its complexes with various 
DNA substrates have been solved so far revealing essential residues for lesion recognition and catalysis 
(e.g. Bruner et al., 2000, Bjoras et al., 2002, Norman et al., 2003, Banerjee et al., 2005, Radom et al., 
2007, Dalhus et al., 2011, Crenshaw et al., 2012).  
The bifunctional glycosylase hOgg1 belongs to the HhH-GPD superfamily, with a helix-hairpin-helix (HhH) 
motif followed by a Gly/Pro-rich loop terminating in an Asp residue as central structural feature (Thayer 
et al., 1995, Nash et al., 1996, Bruner et al., 2000, Bjoras et al., 2002). For base excision, the ε-NH2 group 
of Lys249 attacks the C1’ atom of the oxoG nucleotide. Via Schiff base formation and β-elimination, the 
DNA strand is cleaved at the 3’-side of the abasic site creating 3’-PUA and a 5’-phosphate terminus (see 
3.2.1) (Girard et al., 1997, Nash et al., 1997). The co-crystal structure of hOgg1 K249Q, a catalytically 
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inactive variant with intact substrate recognition activity, bound to oxoG:C, reveals that the DNA is 
severely kinked by 70° at the target site (Figure 12) (Bruner et al., 2000). The base lesion is extra-helically 
flipped from the DNA duplex into a dedicated lesion recognition pocket of hOgg1 enabling access to 
active site residues (Phe319, Cys253, Gly42, Gln43, Phe45 and Gln315) essential for DNA substrate recognition 
and catalysis. The X-ray structure of a covalently trapped complex of hOgg1 with an undamaged guanine 
(G-ligand) revealed that the nonspecific base (G) was completely flipped out of the DNA helix, but into an 
exo-site, which is located in close proximity (0.5 nm distance) from the active site pocket. This finding 
suggests that hOgg1 discriminates G from oxoG by extrahelical interrogation, while rejecting the 
undamaged base from the active site. From a biological perspective, this strategy is effective to prevent 
futile incision of normal bases (Banerjee et al., 2005). 
 
Figure 12: Primary structure and co-crystal structure of hOgg1 with 8oxoG flipped in the active site. 
A) Schematic representing the primary structure of hOgg1. Important structural motifs and residues are indicated 
by different colors as described in the figure legend (adapted from Hashiguchi et al. (2004)). B) hOgg1 in complex 
with a 15 bp DNA substrate containing a 8oxoG:C lesion (PDB-ID: 1EBM). The target base is completely flipped out 
of the DNA duplex into the active site of the enzyme, whereas the complementary cytosine remains in the double 
helix. hOgg1 strongly bends DNA by 70° at the plane of the oxoG:C base pair (adapted from Bruner et al. (2000)). 
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2.4.5 Objectives in BER lesion search and recognition 
Although the crystal structures of hTDG and hOgg1 provide a wealth of information about the residues 
involved in base flipping, lesion recognition and base excision, they can only present a static snapshot of 
the enzyme-DNA complex. In contrast, the dynamics of base flipping in particular for undamaged 
nonspecific bases are less well understood and it remains elusive, for instance, whether hTDG flips DNA 
bases in an active or passive manner.  
In the AFM studies, long DNA substrates (500 – 2000 bp) were applied, either non-damaged homoduplex 
DNA or DNA fragments that contain a specific lesion at a well-defined position. For hTDG, a G:U and a 
G:T mismatch in a CpG context were used as target sites for hTDG in AFM (Figure 13). 
 
Figure 13: DNA substrates used for AFM studies with hTDG. 
A) Deamination of cytosine at CpG sites causes a U:G mispair. B) Deamination of methylated cytosine (mC) 
produces a T:G mismatch in a CpG context. 
To capture the enzyme in its lesion recognition state, the catalytically inactive hTDG variant N140A was 
used, which exhibits similar DNA binding affinity as the wt enzyme but only very minor, residual base 
excision activity for G:U and no detectable activity for G:T mispairs (Maiti et al., JBC, 2009; Hardeland et 
al JBC 2000). Nucleotide flipping by TDG was investigated using mutational studies with the hTDG variant 
R275A and a fluorescence-based nucleotide flipping assay. Identical studies were performed with a 
second glycosylase, hOgg1, which recognizes structurally different 8oxoG lesions, to generalize the 
findings for hTDG in the context of DNA lesion search by DNA glycosylases.  
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3. Materials 
3.1 Equipment 
Table 3: Instruments. 
Equipment Supplier 
Autoclave Systec V-150 Systec 
Bacteria shaker ISF-1-W  Kühner 
Balances 
XS 105 Dual Range (0-1 g) 
XS 6002S Dual Range (0.5-500 g) 
Mettler Toledo 
Bio-Photometer Eppendorf 
CD Spectropolarimeter J-810 Jasco 
Cell disruptor Constant Systems 
Centrifuges 
Centrifuge 5415 D (0-2 mL) 
Centrifuge 5810 R (0-50mL) 
Avanti J-26 XP (0-1000 mL) 
 
Eppendorf 
Eppendorf 
Beckmann Coulter 
Chromatography system Äkta express GE Healthcare 
Chromatography system Äkta purifier GE Healthcare 
Columns for affinity chromatography 
Econo-Column 1,5 x 15 cm 
Econo-Column 2,5 x 20 cm 
Biorad 
Fluoromax4 fluorescence spectrometer Horiba Jobin Yvon 
Fluorescence ultra-micro cuvette (30 µL) Hellma Analytics 
Fraction collector Frac-950 GE Healthcare 
Gelelectophoresis Mini-Protean 3-cell  Biorad 
Gelfiltration HiLoad 26/60 Superdex 200 prep 
grade  
GE Healthcare 
Ice machine 94774  Ziegra Eismaschinen 
Magnetic stirrer MR 3002 Heidolph 
Molecular force probe (MFP) 3D-Bio AFM Asylum Research 
Monitor pH/C-900 (pH, conductivity temperature) 
Monitor UV900 (absorption) 
GE Healthcare 
Nanodrop ND 1000 Spectrophotometer Peqlab 
Octet RED System Forté Bio 
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PharosFX imager system Biorad 
pH electrode and -meter Schott 
Pipettes (10, 20, 200, 1000 µL) Rainin 
Pipette (2 µL) Eppendorf 
Pippetboy easypet Eppendorf 
Power supply Biorad 
Rotors 
JLA 25.50 
JA 8.1000 
Beckmann Coulter 
sample loading pump P960   GE Healthcare 
Thermomixer Eppendorf 
Table 4: Disposable Materials. 
Disposables Supplier 
Blotting paper Roth 
Column material for affinity chromatography 
Ni-NTA Agarose 
Invitrogen 
Concentrator MWCO 30,000 Vivaspin 20 Sartorius Stedim Biotech 
Filter (0.22 μm pore size) Roth 
Filter Anotop (0.02 μm pore size) Whatmen 
Greinertube 15 mL, 50 mL Greiner 
Mica Grade V  SPI Supplies 
Microcon centrifugal filters for DNA concentration 
10 kD MWCO 
50 kD MWCO 
100 kD MWCO 
Millipore 
Microscope slides (76 x 26 x 1 mm) Hartenstein 
OMCL-AC240TS noncontact/ tapping mode silicon 
probes 
Olympus 
Pipette tips 20 μL, 200 μL, 1000 μL  Rainin 
PageRuler prestained protein ladder Fermentas 
Pipette tips 2 µL Eppendorf 
Reactiontube 0.5 mL, 1.5 mL  Eppendorf 
Streptavidin tips for biolayer interferometry Forté Bio 
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Table 5: Kits. 
Kit Supplier 
NucleoSpin Extract II Macherey-Nagel, Dueren, Germany 
NucleoBond Plasmid Kit Macherey-Nagel, Dueren, Germany 
Table 6: Computer software. 
Software Author/ Reference 
Aekta Software Unicorn 5 GE Healthcare 
Adobe Photoshop Elements 8.0 Adobe Systems Incorporated 
CD-Spectroscopy, Spectra Manager Jasco 
Corel Paintshop Pro X4 Corel Corporation 
Fluoromax Software Horiba Jobin Yvon 
GIMP Spencer Kimball, Peter Mattis 
Igor Pro for MFP3D Asylum Research 
Image J Wayne Rasband, NIH, USA 
Image SXM Steve Barrett 
Nanodrop V3 Software Peqlab 
Octet RED Software Analysis 6.3  Forté Bio 
OriginPro 8.5 Origin Lab Corporation 
OriginPro 9.0 Origin Lab Corporation 
Pubmed NCBI 
Pymol DeLano 2002 
Quantity One (Molecular Imager)  Biorad 
3.2 Chemicals 
All chemicals and solutions were obtained from Carl Roth (Karlsruhe), Sigma Aldrich (Seelze), Fluka (Neu-
Ulm), Hampton Research (Laguna Hills, USA), or Applichem (Darmstadt) if not noted differently. All 
chemicals were of analytical grade or better. 
Table 7: Media for bacterial cell culture. 
Name Composition 
LB-Media 10 g/L Tryptone; 5 g/L yeast extract; 10 g/L NaCl 
LB-Agar 10 g/L Tryptone; 5 g/L yeast extract; 10 g/L NaCl; 15 g/L Agar 
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Table 8: Media additives. 
Substance Stock solution Final concentration 
Ampicillin  100 mg/mL in ddH2O 100 μg/mL 
Chloramphenicol  34 mg/mL in 70 % Ethanol 34 μg/mL 
Isopropyl—thiogalactoside (IPTG) 1 M 0.1 mM 
Table 9: Buffers and solutions. 
Cell lysis and protein purification of taXPD and variants 
Lysis buffer  
50 mM Tris pH 8 
500 mM NaCl 
5 mM Imidazole 
Elution buffer 
50 mM Tris pH 8 
500 mM NaCl 
500 mM Imidazole 
SEC and storage buffer 
50 mM Tris pH 8 
300 mM NaCl 
1 mM DTT 
Reaction buffers for taXPD 
Octet reaction buffer  
20 mM Tris pH 8 
5 mM MgCl2 
1 mM EDTA 
10 mM KCl 
5 mM DTT 
0.1 mg/mL BSA 
AFM deposition buffer 
25 mM HEPES pH 7.5 
25 mM NaAc 
10 mM MgAc 
AFM incubation buffer  
20 mM Tris pH 8 
5 mM MgCl2 
1 mM EDTA 
10 mM KCl 
5 mM DTT 
+/- 2 mM ATP 
Helicase Assay buffer  
20 mM Tris pH 8 
5 mM MgCl2 
1 mM EDTA 
10 mM KCl 
Helicase assay stop buffer 
10 mM Tris pH 8 
10 mM KCl 
10 mM EDTA 
0.5 % SDS 
50 % Glycerol 
Helicase assay running buffer 
14.4 g/L Glycine 
3 g/L Tris  
1 mM MgCl2 
 
 
Reaction buffers for hTDG 
AFM deposition  and  
incubation buffer 
25 mM HEPES pH 7.5 
25 mM NaAc 
10 mM MgAc 
2-AP base flipping assay buffer 
20 mM HEPES pH 7 
0.2 mM EDTA 
2.5 mM MgCl2 
100 mM NaCl 
 
 
Additional buffers  
2-AP base flipping assay 
buffer for hOgg1 
50 mM Tris pH 7.5 
1 mM EDTA 
50 mM KCl 
1 mM DTT 
 
 
hOgg1 storage buffer 
20 mM Tris pH 8.0 
100 mM NaCl 
40 % Glycerol 
hTDG storage buffer 
20 mM HEPES pH 7 
0.5 mM EDTA 
100 mM NaCl 
1 mM DTT 
1% Glycerol 
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1x TAE buffer for agarose gels 
40 mM Tris pH 7.6 
20 mM acetic acid 
1 mM EDTA 
Buffer for DNA ligase 
50 mM Tris pH 7.5 
50 mM KCl 
10 mM MgCl2 
5 mM DTT 
+ 1 mM ATP 
SDS staining solution 
50 % Methanol 
10 % Acetic acid 
0.1 % Coomassie brilliant blue 
SDS destaining solution 
10 % Methanol 
5 % Acetic acid 
SDS running buffer (1x) 
192 mM Glycine 
0.1 % SDS 
25 mM Tris 
SDS loading buffer 
50 mM Tris pH 6.8 
100 mM DTT 
2 % SDS 
0.1 % Bromphenol blue 
15 % Resolving Gel 
15% AA/ BAA 
375 mM Tris pH 8.8 
0.1 % SDS 
0.25 % APS 
0.05 % TEMED 
5 % Stacking Gel 
15% AA/ BAA 
125 mM Tris pH 6.8 
0.1 % SDS 
0.25 % APS 
0.15 % TEMED 
8% native Gel 
8% AA/ BAA 
0.5x Trisglycine pH 8 
0.2 % APS 
0.1 % TEMED 
All buffers were adjusted to the respective pH value by adding either 32 % (w/v) NaOH or 37 % (v/v) HCl. 
3.3 Biochemicals 
Table 10: Enzymes. 
Enzyme Source 
AccI New England Biolabs 
BglII New England Biolabs 
BspQI New England Biolabs 
Desoxyribonuclease I (DNase I) Invitrogen 
hOgg1 MyBioSource 
hTDG (wt/ variants N140A and R275A) A. Maiti (group A. Drohat, University of Maryland) 
NdeI New England Biolabs 
Nt. BstNBI New England Biolabs 
SspI New England Biolabs 
T4 DNA Ligase New England Biolabs 
T4 polynucleotide kinase New England Biolabs 
XhoI New England Biolabs 
XPD from T. acidophilum  
(2nd batch wt/ variants K170A) 
G. Michels/ S. Wolski  
(group C. Kisker, University of Wuerzburg) 
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Table 11: DNA substrates for AFM and BLI experiments with taXPD. 
 DNA substrate DNA sequence 
A Bottom strand GGT CGA CTC TAG AGG ATC AGA TCT GGT ACC TCT AGA CTC GAG GCA TGC 
B Top - / - GCA TGC CTC GAG TCT AGA GGT ACC AGA TCT GAT CCT CTA GAG TCG ACC 
C Top - / bubble (8nt) GCA TGC CTC GAG TCT AGA CTC TTT CCA TCT GAT CCT CTA GAG TCG ACC 
D Top F / bubble (8nt) GCA TGC CTC GAG TCT AGA CTC FTT CCA TCT GAT CCT CTA GAG TCG ACC 
E Top F / bubble (14nt) GCA TGC CTC GAG TCT AGT CTC GTT CCF ATA TAT CCT CTA GAG TCG ACC 
F Top F / 5’ bubble (8nt) GCA TGC CTC GTC AAA TCT GGT ACC AGA TCT GAT CCT CTA GAG TCG FCC 
G Top F / 3’ bubble (8nt) GCA TGC CFC GAG TCT AGA GGT ACC AGA TCT CTA AAG TAA GAG TCG ACC 
H Top F / - GCA TGC CTC GAG TCT AGA GGT FCC AGA TCT GAT CCT CTA GAG TCG ACC 
I Top CPD / bubble 
(8nt) 
GCA TGC CTC GAG TCT AGA CTC [CPD] TT CCA TCT GAT CCT CTA GAG TCG 
ACC 
J Top CPD / 5’ bubble 
(8nt) 
GCA TGC CTC GTC AAA TCT GGT ACC AGA TCT GAT CCT CTA GA [CPD] TCG 
ACC 
K Top CPD / 3’ bubble 
(8nt) 
GCA TGC [CPD]TC GAG TCT AGA GGT ACC AGA TCT CTA AAG TAA GAG TCG 
ACC 
L Top CPD / - GCA TGC CTC GAG TCT AGA GGT [CPD] CC AGA TCT GAT CCT CTA GAG TCG 
ACC 
M Top fork  
(helicase assay) 
AGC TAC CAT GCC TGC ACG AAT TAA GCA ATT CGT AAT CAT GGT CAT AGC 
T-Cy3 
N Bottom fork  
(helicase assay) 
AGC TAT GAC CAT GAT TAC GAA TTG CTT GGA ATC CTG ACG AAC TGT AG 
O Competitor oligo  
(helicase assay) 
GAC CAT GAT TAC GAA TTG 
The DNA sequences forming unpaired DNA regions (bubble of fork) are underlined. F = fluorescein adducted 
thymine; [CPD] = cyclobutane pyrimidine (thymine) dimerized with 3’-thymine. Cy3 = Cyanine dye for gel-based 
helicase assays. For BLI measurements, substrate A was obtained with a biotin group coupled to the 3’-end and 
annealed with substrates B, C, D, H, I and L at an equimolar ratio. For DNA substrates used in the AFM studies only 
the 48 nt insert is shown (see Methods 4.1.2) and the target site is located from 28-34% of DNA fragment length 
(916 bp). DNA substrates M and N for helicase assays (from Biomers) were annealed at equimolar ratio yielding 
forked substrates for XPD. Competitor oligonucleotide O for bottom fork N prevented re-annealing of the 
separated DNA duplex. DNA oligonucleotides containing a fluorescein (substrates D-H) were obtained from 
Integrated DNA Technlogies (IDT) and CPD-containing oligomers (I-L) were provided by Thomas Carell’s group, LMU 
Munich. Undamaged oligonucleotides were purchased from Biomers. 
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Table 12: DNA substrates for hOgg1 and hTDG. 
  DNA substrate DNA sequence 
A G:U mismatch GCA TGC CT(dU) GAG TCT AGA GGT ACC AGA TCT GAT CCT CTA GAG TCG ACC 
B G:UF mismatch GCA TGC CT(dUF) GAG TCT AGA GGT ACC AGA TCT GAT CCT CTA GAG TCG ACC 
C G:T mismatch  GCA TGC CT(T) GAG TCT AGA GGT ACC AGA TCT GAT CCT CTA GAG TCG ACC 
D 8oxoG:C GCA TGC CTC (8-oxo-G)AG TCT AGA GGT ACC AGA TCT GAT CCT CTA GAG TCG ACC 
E 2-AP G:UF ATG CAT GCC (2-AP)(dUF)G AGT CTA GAG G  
F 2-AP nonspecific AT GCA TGC C (2-AP)CG AGT CTA GAG G  
G 2-AP 8oxoG:C AT G CA T GC C (2-AP)(8oxoG)G AGT CTA GAG G 
H 2-AP Counter 1 CCT CTA GAC TCG TGG CAT GCA T 
I 2-AP Counter 2 CCT CTA GAC TCC TGG CAT GCA T 
A-D: DNA substrates for AFM  experiments. E-I: DNA substrates for fluorescence assays containing 2-Aminopurine 
(2-AP). For DNA substrates for AFM only the 48 nt insert is shown (see Methods 4.1.2) and the target site is located 
at 46% of DNA fragment length (549 bp). The bases that form a specific DNA site are in brackets. Target sites for 
hTDG are G:U, G:U
F
 (2’-deoxy-2’-flouroarabinouridine, U
F
), and G:T mismatches in a CpG context, the target site for 
hOgg1 is 8oxoG:C. Oligonucleotides E and F were annealed with oligonucleotide H at an equimolar ratio, 
respectively. Likewise, oligonucleotide G was annealed with Oligonucleotide I. Oligonucleotides B, D, E, G were 
purchased from Midland Certified Reagents and oligonucleotides H and I from Sigma Aldrich. Oligonucleotides A, F 
were obtained from Integrated DNA Technologies and oligonucleotides C from Biomers. 
Table 13: Bacterial strains. 
Name Genotype Source 
BL21-CodonPlus(DE3)-RIL E.coli B F-ompT hsdS(rB
-mB
-) dcm+ Tetr gal ʎ(DE3) 
endA Hte [argU ileY leuW Camr] 
Stratagene 
Table 14: Plasmids. 
Name Vector Resistance Tag Source 
taXPD (T3)  pET16b Ampicillin N-terminal His10 J. Truglio (group C. Kisker) 
taXPD mutants pET16b Ampicillin N-terminal His10 S. Wolski (group C. Kisker) 
pUC19N pUC19-based Ampicillin / S. Wilson, NIEHS, USA 
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4. Methods 
4.1 Atomic Force Microscopy (AFM) imaging 
Originally, AFM has been developed for visualization of atoms on solid surfaces (Binnig et al., 1986) and 
has been widely used and accepted in material sciences. However, high-resolution AFM imaging is now 
valued as highly attractive tool in life sciences as it meets several requirements necessary for studying 
biomolecules. In the present work, I use AFM as an especially appealing approach to analyze protein-
DNA interactions in DNA repair processes. 
4.1.1 Sample deposition 
For studying biological samples by AFM, molecules have to be deposited onto a substrate surface. Above 
all, AFM substrates have to be extremely smooth at the atomic level. In addition, the substrate has to 
bind the particles strong enough to prevent dragging by the tip while preserving the native structure of 
the sample as far as possible. Adsorption is mainly mediated by physical interactions such as 
electrostatic, polar or Van der Waals forces, which can be adjusted e.g. by pH, ionic strength and the 
solution composition (Keller and Bustamante, 1993, Muller et al., 1997). 
The AFM substrate most commonly used for biological samples is Mucsovite (mica). Mica is constituted 
by layers of (Si,Al)2O5 ionically bound to a central layer of Al2(OH)2 and has a typical surface roughness of 
0.05 nm root mean square (RMS) (Fronczek et al., 2011). Conveniently, mica can be easily prepared (and 
reused) for sample deposition by cleaving a layer with simple scotch tape. However, other materials used 
as AFM substrates e.g. glass or gold have to be carefully cleaned before sample deposition (Hegner et al., 
1993, Keller and Bustamante, 1993, Muller et al., 1997). 
DNA was one of the first biological subjects used for AFM imaging. Initial difficulties in deposition and 
imaging of DNA molecules were overcome by the work of Bustamante and colleagues in 1992 
(Bustamante et al., 1992). The deposition of DNA was optimized based on their studies. 
For AFM imaging in air, DNA can be deposited onto untreated mica in a suitable buffer solution 
containing divalent cations (e.g. Mg2+, Ni2+). In air, the negative net charge of mica is compensated by 
potassium ions, while in an aqueous solution, K+ ions will dissociate and the negative net charge of mica 
is neutralized by protons (Herder et al., 1987, Claesson et al., 1986). Thus, for deposition of DNA, mica is 
rinsed with ultrapure water, which depletes the solution surrounding DNA of free cations and allows 
stable chelation of the negatively charged DNA molecules to the mica surface by Mg2+ in the buffer 
solution (Lyubchenko and Shlyakhtenko, 2009).  
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For the AFM imaging experiments described here, all DNA substrates used for AFM were heated at 65° C 
for 10 min prior to the experiments and slowly cooled down to room temperature to remove possible 
salt microcrystals formed upon storage on DNA. All DNA and protein samples for AFM imaging were 
deposited in AFM deposition buffer (see Table 9). 
In the following section, incubation conditions for taXPD will be discussed. In incubations with specific 
916 bp DNA substrates, 350 nM taXPD (wt, K170A and R567W) were mixed with 15 nM DNA substrates 
(Table 11, substrates C-L) and incubated for 30 min at 37°C in XPD incubation buffer (see Table 9) ± 2 mM 
ATP or ATPγs.  For sample deposition, protein-DNA samples were diluted 8-fold in AFM deposition buffer 
to a final volume of 20 μL and immediately pipetted onto freshly cleaved mica (Grade V; SPI Supplies). 
Depositions were then immediately rinsed with ultra-pure deionized water to remove all buffer 
components (Lyubchenko and Shlyakhtenko, 2009) and carefully dried in a gentle stream of nitrogen. 
Likewise, taXPD wt was incubated with 9 nM 1813 bp nonspecific linear DNA fragments or 5 nM plasmid 
DNA pUC19N (2729 bp) for determination of DNA binding densities in the presence and in the absence of 
2 mM ATP.  
This section describes experimental conditions for AFM experiments with DNA glycosylases. For analysis 
of hTDG interactions with lesion specific 549 bp DNA substrates for AFM (Table 12, substrates A-C), 
50 nM hTDG (variants N140A and R275A) were mixed with 2.5 nM DNA substrates (G:U, G:UF, G:T 
mismatch in a CpG context). The samples were incubated for 20 min at room temperature and a final 
volume of 20 µL was deposited onto freshly cleaved mica as described above for taXPD. 50 nM hTDG (wt 
and variant R275A) were mixed with 1.5 nM undamaged DNA fragments (1813 bp) and 50 nM hTDG 
N140A were mixed with 2.5 nM undamaged DNA fragments (549 bp) in AFM deposition buffer to analyze 
nonspecific hTDG-DNA complexes. The samples were incubated and deposited as in incubations with 
specific DNA substrates. hOgg1 wt (150 nM) was incubated with undamaged DNA fragments (2 nM for 
1813 bp DNA and 5 nM for 549 bp DNA) in AFM deposition buffer for 10 min at room temperature. The 
solution was deposited for 1 min onto freshly cleaved mica and subsequently rinsed and dried as 
described above for the other protein systems. 
To determine intrinsic DNA bend angles from reference images, DNA substrates were imaged in the 
absence of protein at a deposition concentration of 2.5 nM for 549 bp DNA fragments, 2.0 nM for 916 bp 
DNA fragments and 1.5 nM for 1813 bp DNA fragments.  
Control images for protein in the absence of DNA were collected at a deposition concentration of 25 nM 
for taXPD, hTDG and hOgg1. 
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4.1.2 AFM image collection and processing 
All AFM images were collected in air with a molecular force probe (MFP) 3D-Bio AFM (Asylum Research, 
Santa Barbara, CA) in tapping mode using OMCL-AC240TS (Olympus) noncontact/ tapping mode silicon 
probes with spring constants of ~2 N/m and resonance frequencies of ~75 kHz. AFM micrographs were 
captured at a scan speed of 2.5 μm/s with image sizes of 1 µm x 1 µm, 2 μm x 2 μm, 4 μm x 4 μm or 
8 μm x 8 μm and pixel resolution of ~2 nm. Utilizing Asylum Research software on Igor Pro, AFM images 
were processed by 3rd order plane-fitting and flattening. 
4.1.3 AFM data analysis 
This section gives an overview of different analytical approaches to extract quantitative information from 
AFM images of dried protein-DNA samples. Statistical analysis of protein-DNA complexes can offer 
valuable clues to protein binding affinities on DNA from the number of bound protein molecules. 
Moreover, determination of protein binding positions on DNA substrates containing a single DNA lesion 
at a defined position enables the investigation of molecular DNA damage recognition and can reveal 
information about binding specificities of a protein for its target site in DNA. Finally, conformational 
properties of protein-DNA complexes and information on oligomeric states of proteins bound and 
unbound to DNA can be gained from analysis of the bend angles induced into DNA at the site of the 
bound protein and AFM volumes. 
Initially, protein-DNA complexes were manually identified from the AFM images neglecting protein-
complexes on DNA aggregates and on DNA fragments that were cut off by the image margins. To 
quantify DNA coverage with protein, all DNA fragments (bound with protein and unbound) and all 
protein-DNA complexes were counted. DNA binding densities per base pair (bp) were calculated as: 
𝑏𝑖𝑛𝑑𝑖𝑛𝑔 𝑑𝑒𝑛𝑠𝑖𝑡𝑦 =
# 𝑝𝑟𝑜𝑡𝑒𝑖𝑛 𝑝𝑒𝑎𝑘𝑠
(#𝐷𝑁𝐴 𝑓𝑟𝑎𝑔𝑚𝑒𝑛𝑡𝑠∗#𝑏𝑎𝑠𝑒𝑝𝑎𝑖𝑟𝑠)
 (Equation 1) 
AFM experiments for determination of binding densities (Figure 23B) were performed at least in 
triplicates for each substrate and condition (± ATP or ATPγs), with n = 340 – 876 DNA-bound protein 
peaks for each substrate type.  
Substrate binding specificities S of a protein for its target site were quantified from Gaussian fits to 
position distributions of protein complexes on DNA as recently described (Tessmer et al., 2008, Buechner 
et al., 2014). In short, complex positions were determined as the distance of protein peaks to the closer 
DNA fragment end normed to the full length of the DNA substrate by placing a contour along the DNA 
backbone using the NIH software Image J. Only DNA fragments with lengths within two standard 
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deviations from the center of a Gaussian fit to the DNA length distributions were included in the 
analyses. Positions were plotted as histograms using the software Origin Pro 8.5. 
For quantitative analysis of binding specificities, DNA end-bound protein complexes in the histograms 
were excluded, starting at 5 % of DNA length. A fixed bin size of 4 % was applied for all individual 
experiments. Lesion specificity for a target site results in a Gaussian shaped peak at the position of the 
specific site, which can be fitted with a single Gaussian curve (Figure 14).  
 
Figure 14: Illustration of the position distribution of protein binding to a single target site in DNA. 
The DNA fragment contains a single specific target site (orange star) in the middle. The areas under the position 
distribution of protein-DNA complexes, Ansp (grey) and Aspec (orange), and the height of the background in the 
Gaussian fit (y0)  are indicated. The parameters derived from the Gaussian distribution can be used for calculation 
of the lesion specificity of a protein for a specific target site in DNA (Equation 6) (adapted from Yang et al. (2005)). 
Integration of the Gaussian peak area (Aspec) provides the fraction of specific complexes over the fraction 
of nonspecific complexes, which is represented by the area of the nonspecific background (Ansp) and is 
calculated as the product of considered DNA length (5 - 50 % of DNA fragment length, excluding DNA 
ends) and the height of the background in the Gaussian fit (y0) (Yang et al., 2005). Lesion specificity S is 
defined as: 
𝑆 = 𝑁 ∗
𝐴𝑠𝑝𝑒𝑐
𝐴𝑛𝑠𝑝
+ 1 (Equation 2) 
With N being the number of available binding sites on DNA (N = 824 for XPD and N = 494 for hTDG 
excluding 2 x 5 % of DNA fragment length). Gaussian widths were all fixed to the width of the Gaussian fit 
to the DNA substrate with highest specificity (2.6 % for taXPD and fluorescein/bubble with ATP and 3.2 % 
for hTDG R275A and G:UF) to facilitate direct comparison of binding specificities for different DNA 
substrates and conditions. Specificities were calculated as average values from at least three individual 
experiments with standard deviations (SD) derived from the variations between single experiments. All 
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position distributions shown in this work represent pooled data from at least three individual 
depositions. 
Based on the protein position distributions, complexes bound at positions within two standard 
deviations (based on Gaussian widths) from the center of the fit were classified into specific complexes 
and nonspecific complexes bound elsewhere on DNA. For further analysis (DNA bend angle and AFM 
volume analysis) specific and nonspecific protein-DNA complexes were treated separately. 
DNA bend angles β were defined as the deviation from a straight line through the DNA backbone: 
𝛽 = 180° − 𝛼 (Equation 3) 
α was determined by placing two lines along the DNA backbone on each side of a protein complex by 
manual tangent overlay using Image J. All DNA bend angle distributions in the presence of protein shown 
in this work represent pooled data from at least three individual AFM experiments. Bend angle values for 
protein-DNA complexes were derived as the maxima of single, double or triple Gaussian fits to pooled 
bend angle distributions from at least three individual experiments with errors estimated from the half-
width of the Gaussian peak (σ). To determine percentage areas of different bend angle populations, we 
fixed widths of the Gaussian fits in such a way yielding highest possible R2 values. The resulting peak 
areas were integrated using Origin Pro. 
To determine intrinsic DNA bending of specific DNA substrates at the site of the damage, a mask 
comparable to the size of the protein was moved to the position of the target site (to 30% of DNA 
fragment length for taXPD and to 46 % for hTDG) DNA bending was measured at this position as 
described above for protein induced DNA bend angles. To exclude any influence of intrinsic DNA bending 
behavior due to sequence context at the position itself, intrinsic bending was determined for 549 bp 
undamaged DNA substrates at this position (46 % of fragment length). 
Furthermore, intrinsic DNA bending of nonspecific (undamaged) DNA fragments was measured by 
moving the mask at regular intervals of 50 nm along DNA. All individual intrinsic DNA bend angle 
distributions for the different DNA substrates in the absence of protein represent pooled data from two 
individual AFM experiments. 
To gain further information on conformational and oligomeric states of protein molecules, we 
determined AFM volumes of free (non-DNA-bound) proteins and protein-DNA complexes from the AFM 
images using the software ImageSXM. The AFM volumes V of proteins can be translated into molecular 
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weight (MW) (Ratcliff and Erie, 2001) using the empirically derived calibration for the employed AFM set-
up (Roth et al., 2012): 
𝑀𝑊 = (𝑉 + 5.9)/1.2 (Equation 4) 
These different approaches described above, point out a number of merits in AFM imaging experiments 
on analysis of protein-DNA interactions.  
4.2 Molecular biology 
4.2.1 Transformation and plasmid isolation 
For transformation, 100 µL of chemocompetent Escherichia coli (E.coli) BL21-CodonPlus (DE3)-RIL cells 
(carrying the resistance for chloramphenicol) (Stratagene) were incubated with 1 μL of plasmid DNA 
(~100 ng/μL) (pET16b or pUC19N, both carrying the resistance for ampicillin) for 30 min on ice. The cells 
were subsequently heat shocked at 42°C for 1.5 min and cooled down on ice for 2 min. Prior to 
incubation, 1 mL sterile Luria Broth (LB) medium were added to the cell suspension. Afterwards, the cells 
were shaken and incubated at 37°C for 1h (600 rpm; Eppendorf Thermomixer), spread on a LB-agar plate 
with the appropriate antibiotics (ampicillin (Amp) and chloramphenicol (Cam) at concentrations of 
100 μg/mL and 34 μg/mL, respectively) and grown overnight at 37°C. For protein expression, a single 
colony was picked from the agar plate to inoculate a pre-culture.  
To amplify plasmid DNA (pUC19N) for DNA substrate preparation for AFM (see 4.1.2), 200 mL LBAmp Cam 
medium were inoculated with a single colony from the LB-agar plate of a fresh transformation. After 
shaking and incubation overnight at 37°C and 200 rpm, the bacterial cells were pelleted by centrifugation 
at 4000 rpm for 10 min at 4°C (centrifuge 5810R, Eppendorf). Cell lysis and DNA isolation was performed 
using the NucleoBond Plasmid Kit (Macherey Nagel) according to the manufacturer’s instructions. 
4.2.2 DNA substrate preparation for AFM 
DNA repair proteins possess a high binding preference for specific types of DNA lesions. To study 
molecular recognition of their target sites by AFM imaging experiments, a single DNA damage can be 
introduced into long DNA substrates at a known position. The next section describes the preparation 
procedure for production of such DNA substrates for AFM, which has been established and optimized in 
our laboratory (Buechner and Tessmer, 2013). 
The DNA substrate preparation is based on the modified pUC19 based DNA plasmid pUC19N (1, Figure 
15) (Hou et al., 2007). pUC19N (2729 base pairs, a kind gift from Samuel Wilson’s laboratory NIEHS, USA) 
contains 6 restriction sites for the nicking endonuclease Nt.BstNBI (GAGTC). Three of these restriction 
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sites are in close vicinity (positions 422, 440 and 470) and serve to produce a ssDNA gap of 48 nt, which 
can then be replaced by an specific oligonucleotide of choice (Buechner and Tessmer, 2013). 
After incubation with Nt.BstNBI for 2h at 55°C (2, nicking, Figure 15), a short ssDNA fragment (48 nt) 
between the two incision sites was removed by repeated heating at 68°C in the presence of an at least 
10-fold excess of complementary oligonucleotide (substrate A, Table 11) (3, gapping, Figure 15). The 
annealed 48 bp oligomers and the excess of 48 nt ssDNA counter oligonucleotides were filtered out by 
centrifugation through a molecular weight cut-off filter (125 nt cut-off; Amicon Ultra, Millipore). The 
resulting ssDNA gap was replaced by incubation with a 20-fold excess of a specific 5’-phosphorylated 
target site containing DNA insert (DNA sequences listed in Table 11 and Table 12) for 4h at 45 °C (4, 
annealing, Figure 15). The remaining nicks between the insert DNA and the original strand were ligated 
by overnight incubation with T4 DNA Ligase I at room temperature (5, nick sealing, Figure 15). 
Damage containing plasmids with target sites for taXPD were digested with the restriction enzymes SspI 
and BspQI yielding linear specific 916 bp DNA fragments and linear nonspecific 1813 bp DNA fragments, 
which were used as undamaged control substrates for damage search studies (6, linearization, Figure 
15). Depending on the position of the bubble (5’ or 3’ to the damage), target sites for taXPD (fluorescein/ 
CPD) were located at 28-34 % of DNA fragment length. Incubation conditions for the digestion reactions 
were based on the enclosed product information provided with the restriction enzymes. To ensure 
complete digestion of DNA, the reactions were performed using twice as high incubation concentrations 
of the enzymes and reaction times as recommended in the manufacturer’s instructions. 
To produce target site containing DNA substrates for glycosylases, lesion specific pUC19N was cut by 
NdeI and BspQI yielding 549 bp specific DNA fragments (containing target sites for DNA glycosylases) and 
2180 bp nonspecific fragments similar as described in the previous section. The target sites for hTDG 
(G:T, G:U or G:UF mismatch) or hOgg1 (8oxoG:C) were located at 46 % of DNA fragment length. 
Nonspecific DNA fragments of 549 bp length were generated by digestion of undamaged pUC19N with 
NdeI and BspQI.  
After restriction enzyme digestion, all DNA substrates (specific and nonspecific) used for AFM imaging 
were purified by extraction of the corresponding band from agarose gel electrophoresis following the 
instructions of the NucleoSpin Extract II Kits (Macherey-Nagel, Dueren, Germany) (6, gel purification, 
Figure 15). The UV-irradiation used for visualization of the stained DNA bands in the agarose gels can 
induce additional UV lesions in DNA, which can interfere with the correct interpretation of the AFM 
experiments on protein-DNA interactions (Buechner and Tessmer, 2013). To avoid UV light exposure of 
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the DNA substrates, agarose gels were cut between lane 1 and the remaining lanes and only lane 1 was 
exposed to UV-irradiation. Upon re-combining the two gel parts, the correct excised DNA band then 
functions as a marker for the position of the specific DNA substrate in the rest of the gel. 
 
Figure 15: Schematics of DNA substrate preparation for AFM imaging experiments. 
1) AFM image of the nonspecific undamaged plasmid pUC19N (2729 bp). The scalebar corresponds to 200 nm. 
2) pUC19N, which contains two nicking sites in close vicinity, was incubated with a nickase to generate ssDNA cuts. 
3) Gapped DNA was produced by repeated heating and filtration steps in the presence of an excess of a 
complementary oligonucleotide. 4) An excess of a target site containing oligonucleotide (red) was inserted into the 
ssDNA gap of the plasmid. 5) The remaining nicks between the insert and the original strand of the vector were 
sealed by a DNA ligase. 6) Plasmids were cut into linear fragments containing the specific target site at a defined 
distance from the closer DNA fragment end by digestion with appropriate restriction enzymes and purified by 
agarose gel extraction. 7) AFM image of linear DNA fragments (916 bp) after gel purification containing a single 
fluorescein modification within the context of a DNA bubble at 30 % of DNA fragment length. DNA length 
measurements of the purified DNA fragments (n=358) resulted in a distribution with a distinct Gaussian peak with 
maximum at 298 nm (corresponding to 876 bp DNA). The small deviation from the theoretical DNA length (311 nm 
with 0.34 nm/bp) of 4% is typical for DNA length measurements from AFM images (Campbell et al., 2008). The 
insert shows the digestion products of pUC19N upon incubation with the restriction enzymes SspI and BspQI. The 
red arrow points to the specific target site containing DNA fragment (916 bp). Both AFM images in 1) and 7) are 
1 µm x 1 µm. For details see main text (adapted from Buechner and Tessmer (2013)). 
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Linear, lesion-specific DNA fragments suitable for AFM studies (7, Figure 15) are the end product of the 
DNA substrate preparation. A successful DNA substrate preparation typically yielded homogenous and 
pure linear DNA fragments containing a target at a defined position. In the specific example in Figure 15, 
the DNA fragments were 916 bp long and contained a fluorescein adduct in the context of an 8 nt bubble 
at 30 % of the DNA fragment length.  
The concentration (cDNA) of the purified DNA substrates could be determined from the maximum 
absorption at 260 nm (A260) using a nanodrop UV/Vis spectrophotometer (Peqlab). The DNA 
concentration is given by Lambert-Beer’s law (Pfeiffer and Liebhafsky, 1951): 
𝑐𝐷𝑁𝐴 =
𝐴260
(𝜀𝐷𝑁𝐴)∗𝑑
 (Equation 5) 
with d being the thickness of the cuvette (d = 1 cm) and εDNA being the extinction coefficient for DNA 
determined by the nearest neighbor method (Cantor et al., 1970, Fasman, 1975). In the nearest neighbor 
model, interactions between adjacent bases are considered and measured empirically. Using these 
nearest neighbor parameters, accurate values for εDNA can be calculated (Table 15) (Warshaw and 
Tinoco, 1966): 
Table 15: Nearest neighbor values for ε260 of dNTPs. 
5’ → 3’ dA dC dG dT 
dA 27,400 21,200 25,000 22,800 
dC 21,200 14,600 18,000 15,200 
dG 25,200 17,600 21,600 20,000 
dT 23,400 16,200 19,000 16,800 
Values are provided in (L/mol)*cm (Warshaw and Tinoco, 1966). 
Then, the following equation is applied to calculate the molar extinction coefficient for DNA (Cantor et 
al., 1970, Cavaluzzi and Borer, 2004): 
𝜀260 = ∑ 𝜀𝑛𝑒𝑎𝑟𝑒𝑠𝑡 𝑛𝑒𝑖𝑔ℎ𝑏𝑜𝑟
𝑁−1
1 − ∑ 𝜀𝑖𝑛𝑑𝑖𝑣𝑖𝑑𝑢𝑎𝑙 𝑏𝑎𝑠𝑒𝑠
𝑁−1
2 + ∑ 𝜀𝑚𝑜𝑑𝑖𝑓𝑖𝑐𝑎𝑡𝑖𝑜𝑛𝑠
𝑁
1  (Equation 6) 
Each step of the sample preparation (nicking, gapping and annealing) was controlled by electrophoretic 
mobility shift assays using agarose gel electrophoresis as previously reported (Buechner and Tessmer, 
2013, Buechner et al., 2014). The introduction of nicking sites into pUC19N during the first preparation 
step is tested by a nicking assay (Figure 16A). A successful nicking procedure leads to relaxation of 
superstructures in the plasmid DNA. The nicked plasmid possesses a different electrophoretic mobility in 
agarose gels (Figure 16A, lane 1) compared to untreated, supercoiled pUC19N (Figure 16A, lane 2). 
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Complete removal of the ssDNA fragment (48 nt) between the nicks in close vicinity (gapping assay, e.g. 
Figure 16B) and correct insertion of the target site specific oligomer into the ssDNA gap can be tested by 
incubation with the restriction enzymes XhoI (for XPD substrates A plus C, D, E, H, I, and L, Table 11), AccI 
(for XPD substrate G, Table 11) and BglII (for XPD substrates F, J, and K, Table 11 and for hTDG and hOgg1 
substrates A-D, Table 12). Gapped DNA lacks intact restriction sites and could not be digested by the 
restriction enzymes (in Figure 16B), whereas successfully replaced DNA substrates could be incised 
resulting in higher electrophoretic mobility in agarose gels.  
 
Figure 16: Assaying DNA substrate preparation. 
Agarose gel-based electrophoretic mobility shift assays to control successful A) nicking and B) replacement of the 
ssDNA gap with a target site specific oligonucleotide insert. DNA bands were stained with Midori Green. A) In the 
nickase assay, a shift in the electrophoretic mobility is observed between the untreated, supercoiled plasmid (lane 
1) and the incised (nicked), relaxed plasmid (lane 2). B) Correct removal of the ssDNA fragment between the nicks 
and replacement with a specific insert can be tested via restriction enzyme digestion e.g. by XhoI. Nicked DNA 
(lanes 1 and 2) and plasmids replaced with specific oligonucleotides (lanes 5 and 6) still contain the restriction site 
in the gapped DNA area and were incised upon addition of the enzyme (lanes 2 and 6). The white arrowhead points 
to the running position of the linearized plasmid, which indicates successful digestion by XhoI. Gapped DNA (lanes 3 
and 4) could not be digested by the enzyme due to missing restriction sites. The bold arrowheads in A) and B) 
indicates the same DNA marker position (3000 bp) (adapted from Buechner and Tessmer (2013)). 
Using this simple DNA substrate preparation described above, a single specific target site can be 
introduced into long DNA substrates (500-3000 bp) at a known position. The homogeneous and pure 
DNA substrates are suitable for AFM as well as other single molecule techniques such as optical or 
magnetic tweezers and may represent better mimics of the naturally occurring DNA substrates than the 
short oligonucleotides typically used in biochemical ensemble methods (Buechner and Tessmer, 2013, 
Buechner et al., 2014).  
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4.3 Expression and purification of taXPD 
4.3.1 Protein expression and cell lysis 
Expression and purification of taXPD proteins is based on an established protocol (Wolski et al., 2008, 
Kuper et al., 2012). Briefly, bacterial cells from Escherichia coli (E.coli) BL21-CodonPlus (DE3)-RIL cells 
were transformed with pET16b vectors carrying the genes encoding XPD wt or the variant R567W from 
T. acidophilum (the constructs were kindly provided by Caroline Kisker’s laboratory) as described above 
(see 4.1.1). A single colony was picked from the LB-Agar plate to inoculate 200 ml LBAmp/Cam medium. The 
pre-culture was incubated overnight at 37 °C and 200 rpm and 20 mL cells were transferred into 2 L 
LBAmp/Cam. For expression, 2 L bacterial cell cultures were grown at 37 °C and 200 rpm to an optical 
density (OD) of 0.5 to 0.6. To obtain sufficient protein amount, a total volume of 8 – 16 L cell culture was 
applied for large scale expressions of taXPD and variants. Prior to induction (OD ~ 0.3 to 0.4), the 
temperature was reduced to 14°C to prevent formation of inclusion bodies during expression. 0.1 mM 
isopropyl--thiogalactoside (IPTG) was added to induce protein expression. After incubation for 18 h at 
14 °C and 200 rpm, bacterial cells were harvested by centrifugation (Rotor JLA 8.1000, 4 °C, 5,000 xg, 
20 min; Beckmann Coulter Avanti Centrifuge J-26 XP).  
The cell pellet was re-suspended in lysis buffer (50 mM Tris-HCl pH 8.0, 500 mM NaCl, 5 mM imidazole). 
After addition of DNase I in a final concentration of 2 units per 50 mL suspension, the cell suspension was 
lysed using a cell disrupter system at a pressure setting of 1.8 kbar. For separation of soluble proteins 
from insoluble proteins and cell debris, the cell lysate was centrifuged for 1 h at 4 °C and 30,000 xg 
(Rotor JA 25.50, Beckmann Coulter Avanti Centrifuge J-26 XP). The supernatant contained soluble 
overexpressed taXPD, which was purified by two-step column chromatography: first by metal affinity 
chromatography followed by size exclusion chromatography. 
4.3.2 Metal affinity chromatography 
In the first purification step, the cell lysate was added to the matrix of a Ni2+-column consisting of Ni-NTA 
agarose after equilibration of the column with 25 mL Lysis buffer (5 column volumes). The overexpressed 
protein in the supernatant contains an N-terminal polyhistidine-tag (His 10-tag), which binds with high 
affinity to Ni2+-ions of the column material. Unbound protein was removed from the column in a washing 
step with 50 mL lysis buffer. taXPD was then eluted with 500 mM imidazole, which is chemically and 
structurally similar to histidine residues and strongly competes with protein molecules bound to the 
column. After affinity chromatography, representative fractions (lysate, wash and elution fractions) were 
analyzed on a 15 % SDS gel (Laemmli, 1970). Subsequently, all elution fractions containing taXPD were 
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pooled and concentrated to a final volume of 5 mL with Vivaspin 20 concentrators 
(MWCO 30,000 g/mol). 
4.3.3 Size exclusion chromatography 
The concentrated protein solution was further purified by size exclusion chromatography (SEC), which 
separates proteins according to their molecular weight and shape. In SEC, differently formed proteins 
show different retention times on the column material. Small, roundish particles are able to enter the 
pores of the column resulting in longer diffusion ways and longer elution times, whereas larger particles 
being excluded from the pores elute at earlier time points. 
Specifically, I used a Superdex 200XK 26/60 column on an ÄKTA-Purifier-Chromatography-System for 
purification of taXPD proteins. The Superdex column (~320 mL column volume) is able to separate 
proteins between 10 kDa and 600 kDa and its column material consists of dextran covalently attached to 
agarose. After equilibration of the Superdex with SEC buffer (Table 9), the protein solution was injected 
via a sample loop or the sample loading pump P960. During the flow (1 mL/min for 1.2 CV), the pH-value, 
the conductivity, and the temperature were detected by a monitor pH/C-900. Via a UV900 monitor, 
three wavelengths could be detected simultaneously in the size exclusion chromatogram: 260 nm 
(absorption of nucleic acids), 280 nm (protein absorption) and 410 nm (absorption of the iron sulfur 
cluster of XPD). The elution fractions were automatically collected by the fraction collector Frac-950 and 
were checked on a 15 % SDS-Gel as described further down. 
4.4 Protein characterization 
4.4.1 SDS-PAGE analysis 
To identify the elution fractions containing taXPD and to test for the purity of the protein, I performed 
sodium dodecyl sulfate (SDS) polyacrylamid gel electrophoresis (SDS-PAGE). In SDS-PAGE, proteins can 
be separated according to their electrophoretic mobility in an electric field under denaturing conditions. 
For gel analysis, 10 µL of the protein fraction were mixed with 3 μL 5x protein sample buffer containing 
SDS. The anionic detergent SDS is applied to normalize the intrinsic charge of proteins as it binds with 
high affinity to proteins. Thus, the charge of SDS-protein complexes is proportional to the molecular 
weight of the protein. Furthermore, the protein sample buffer contained a reducing agent (dithiothreitol, 
DTT) to destroy intra- and intermolecular disulfide bonds. Before loading onto the gel, samples were 
heated for 5 min at 95 °C to linearize the proteins by disruption of secondary and tertiary structures. As a 
ruler for molecular weight, the PageRuler prestained protein ladder (bands between 10 and 170 kDa) 
was applied in the first lane of the gel. The SDS gel was run for 45 min at 200 V and afterwards stained 
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with Coomassie staining solution for 20 min at room temperature. Finally, the unbound dye could be 
washed out with destaining solution (Laemmli, 1970). 
4.4.2 Determination of protein concentration by UV-spectrophotometry 
Protein absorption was measured with a nanodrop UV/Vis spectrophotometer using the spectrum mode 
from 175 nm to 875 nm. The protein concentration (cprotein) could be calculated from the maximum 
absorption (A280 nm) by Lambert-Beer’s law (Pfeiffer and Liebhafsky, 1951) as described above for DNA 
absorption (see 4.1.2): 
𝑐𝑝𝑟𝑜𝑡𝑒𝑖𝑛 =
𝐴280 𝑛𝑚
𝜀𝑝𝑟𝑜𝑡𝑒𝑖𝑛∗𝑑
 (Equation 7) 
with ε being the extinction coefficient of the protein at 280 nm and d = 1 cm the thickness of the cuvette. 
The molar extinction coefficient for taXPD (molecular weight of 72 kDa including his-Tag) at 280 nm 
considers the number of fluorescent residues n in the monomeric protein (2 tryptophanes, 36 tyrosines 
and 8 cysteines,) and is expressed by the equation: 
𝜀280 = (𝑛 ∗ 𝑇𝑟𝑝 ∗ 5690 + 𝑛 ∗ 𝑇𝑦𝑟 ∗ 1280 + 𝑛 ∗ 𝐶𝑦𝑠 ∗ 120) (Equation 8) 
For XPD from T. acidophilum the extinction coefficient is 65,140 M-1cm-1. 
4.4.3 Circular dichroism (CD) 
Chiral molecules in solution such as protein and DNA are able to absorb circular polarized light. The 
difference in absorbance of right- and left-circularly polarized light is measured by circular dichroism (CD) 
spectroscopy and can be quantified as ellipticity (in degrees). Protein and nucleic acids contain secondary 
structure elements that lead to characteristic CD-spectra. Thus, the technique enables us to gain 
structural information e.g. about the content of α-helices, β-strands and unfolded regions in a protein 
(Kelly et al., 2005) as well as conformational properties in DNA including B-form, A-form, Z-form, guanine 
quadruplexes, triplexes etc. (Kypr et al., 2009).  
Here, CD spectroscopy was applied to analyze and compare folding of taXPD wt and the variant R567W 
using a J-810 CD spectropolarimeter. CD spectra were recorded from 260 nm to 190 nm at 20°C in 0.1 cm 
quartz cuvettes. The proteins were diluted in 200 μL in 50 mM potassium-phosphate buffer (Sörensen 
buffer) pH 8.0 to a final concentration of 1.25 µM. For optimization of the signal to noise ratio, spectra 
were accumulated 10 times at a scan speed of 50 nm/min and at a response time of 1 s. 
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4.5 Analysis of protein-DNA interactions 
4.5.1 Gel-based helicase assay 
DNA unwinding activity of taXPD wt was investigated by a gel shift assay using forked Cy3 labeled dsDNA 
substrates (for DNA sequence see Table 11, substrates M and N) (Figure 22). taXPD (0.1, 0.25, 0.5, 0.75, 1 
µM) was mixed with 50 nM DNA substrate and 1 μM competitor oligonucleotides (Table 11, substrate O) 
in helicase reaction buffer (see Table 9) in a reaction volume of 50 µL. Upon addition of 2 mM ATP, the 
helicase reaction was started and samples were incubated for 20 min at 37 °C.  After incubation, 50 µL 
stop buffer containing EDTA and SDS (see Table 9) were added to stop the reaction by denaturation of 
the enzyme, and samples were put on ice. As controls, the DNA substrate without protein (double 
stranded control), a reaction without ATP (negative control) and boiled DNA substrate (10 min at 95 °C, 
single stranded control) were pipetted and incubated as described above. Finally, 15 µL of each sample 
were loaded on a 8 % native polyacrylamide gel and then the gel was run at 100 V for at least 1 h. 
Fluorescently labeled DNA substrates were directly visualized by the PharosFXTM imager system. 
4.5.2 Bio-Layer Interferometry (BLI) DNA binding assay 
DNA binding affinities of taXPD and hTDG were determined by the label-free biosensor technology Bio-
Layer Interferometry (BLI) using an Octet RED system (Fortebio, Menlo Park, CA). The Octet instrument 
emits white light down the sensor and detects the light reflected back from the sensor surface, which is 
called interference of light (Figure 17). The interference pattern is recorded by the Octet system as a 
unique spectral signature and is indicated as a relative intensity unit in nm. As the interference depends 
on the thickness of the biological layer coated on the sensor surface, it can serve as a direct measure for 
any change in the thickness of the molecular layer induced by binding. 
 
Figure 17: Principle of Biolayer Interferometry. 
BLI measures the interference of incident white light emitted from the instrument and reflected from the sensor 
surface (reflected beams, in blue and red). The optical layer consists of molecules (e.g. biotinylated DNA, black 
lines) immobilized to the streptavidin coated sensor surface and proteins bound to DNA (red spheres). Unbound 
proteins (blue spheres) have no effect on the detected shift in the interference pattern induced by protein-DNA 
interactions (adapted from ‘Octet RED’ brochure, ForteBio, Menlo Park, CA). 
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For BLI experiments, biotinylated DNA substrates (ligand) were immobilized on streptavidin coated fiber 
optic sensors (capture molecules) using a ‘Dip and ReadTM’ workflow (Figure 18). In the association step, 
DNA coated sensors were dipped in the protein solution to detect DNA binding activity of the protein 
(analyte). Upon immersion into ligand-free buffer solution, the protein molecules dissociate from the 
sensor. Association rate constants (kobs) and dissociation (kdiss) were derived from fits to association and 
dissociation curves using a 1:1 binding model from the Octet Data Analysis software. KD values were 
determined as the ratio of dissociation and association rate constants for the applied protein 
concentration c: 
𝐾𝐷 =
𝑘𝑑𝑖𝑠𝑠
𝑘𝑎𝑠𝑠
=
𝑘𝑑𝑖𝑠𝑠
𝑘𝑜𝑏𝑠∗(𝑐−1)
 (Equation 9) 
 
Figure 18: BLI binding assay. 
The BLI binding assay consists of five distinct steps using a ‘Dip and Read
TM
’ workflow. Prior to immobilization of the 
ligand, the baseline of the buffer is recorded. In the loading step, the ligand (biotinylated DNA) is bound to the 
capture molecules (streptavidin sensors). Subsequently, a second baseline is recorded after loading of the ligand. In 
the association step, binding of the analyte (protein) to the immobilized ligand molecules is detected. Finally, 
dissociation of the analyte from the ligand is determined by dipping of the sensor into ligand-free buffer solution 
(adapted from Octet RED brochure, Menlo Park, CA). 
For better comparison, the DNA substrates for Octet were of the same DNA sequence as the 48 nt 
inserts used for AFM (Table 11). The bottom strand (Table 11, A) was purchased with a biotin group 
attached to the 3’ end and mixed at a ratio of 1:1 with the corresponding top strands (Table 11, 
substrates B, C, D, H, I and L) for annealing. 
To investigate XPD-DNA interactions, 50 nM DNA and 100 – 300 nM XPD were applied for the DNA 
substrates containing ssDNA-regions, and 100 nM DNA and 400 – 500 nM XPD for fully dsDNA 
substrates. The binding reactions were performed at room temperature in XPD octet buffer (Table 9). BLI 
experiments for XPD were carried out at least in triplicates and with three different protein batches. 
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4.5.3 2-Aminopurine fluorescence based flipping assay 
Nucleotide flipping activity of hTDG and hOgg1 was monitored using a 2-Aminopurine (2-AP) 
fluorescence based base flipping assay (Figure 19). 2-AP is a fluorescent base analog of adenine and can 
be incorporated into oligonucleotides as a sensitive probe for local conformational changes in the DNA 
structure (Millar, 1996). Due to its capability to form a Watson-Crick base pair with thymine, 2-AP 
maintains the overall topology of the DNA double helix (Sowers et al., 1986). The fluorescence intensity 
of 2-AP is highly sensitive to the surrounding environment (Ward et al., 1969) and is significantly 
quenched upon hybridization with a complementary DNA strand (Raney et al., 1994) (Figure 19, green 
star) and by stacking interactions with neighboring bases (Guest et al., 1991, Xu et al., 1994). Moreover, 
the fluorescence excitation and emission maxima of this nucleoside analog can be separated from those 
of tryptophane and tyrosine and ‘normal’ DNA bases. Thus, 2-AP is an ideal reporter for enzyme-induced 
conformational changes in the DNA duplex and has been used to study several different protein-DNA 
systems (Holz et al., 1998, Nakano et al., 2005, Bellamy et al., 2007). Upon destacking of the DNA duplex 
structure by protein-induced destabilization such as base flipping, the 2-AP fluorescence is expected to 
increase (Figure 19, red star). 
 
Figure 19: 2-AP fluorescence base flipping assay. 
For details see main text.  
2-AP was incorporated in short DNA substrates (22 bp) either within homoduplex DNA ( 
, F/H) to follow flipping of nonspecific bases, or neighboring hTDG or hOGG1 target sites (G:UF in a CpG 
context or 8oxoG:C,  
 E/H and G/I, respectively) to detect substrate specific base flipping. Due to the weak fluorescence signal 
of 2-AP, a DNA concentration of at least 170 nM was needed to reach sufficient fluorescence intensities 
as determined in concentration series prior to the experiments. To separate 2-AP fluorescence from 
intrinsic protein (tryptophan and tyrosine) and DNA fluorescence, an excitation wavelength of ʎex = 320 
nm was chosen for the fluorescence assays. Steady-state fluorescence emission spectra (340-400 nm) 
were acquired with a Fluoromax-4 fluorescence spectrometer (Horiba Jobin Yvon) at excitation and 
emission bandwidths of 4 and 6 nm, respectively. Fluorescence measurements were carried out at room 
temperature (25 °C) in hTDG or hOgg1 optimized 2-AP base flipping assay buffer. Increasing amounts of 
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concentrated protein were titrated to DNA substrate (final concentration of 170 nM) to reach final 
protein concentrations of 3 and 5 µM in the reactions. The samples were rapidly mixed and incubated 
for at least 5 min at room temperature to ensure binding was at equilibrium. Reference spectra were 
recorded for the hOgg1 and hTDG binding buffers in the absence of DNA and protein to correct the 
emission spectra for the fluorescence background of the buffers, respectively. Furthermore, control 
spectra were determined for the protein solutions (3 and 5 µM for hTDG and 5 µM for hOgg1) in the 
absence of DNA (in the same buffer solutions) that were subtracted from the emission spectra in the 
presence of 2-AP DNA and protein to account for contributions to the fluorescence spectra from the 
proteins. All experiments (except for the control spectra of the protein solutions in the absence of DNA) 
were performed in duplicates of individual titrations. 
For quantification of the protein induced 2-AP fluorescence intensity change (ΔI2-AP), the maxima of the 
2-AP fluorescence intensity at a wavelength of ʎem = 373 nm were determined for 2-AP DNA in the 
absence (I2-AP,DNA) and in the presence of the maximum applied protein concentration (I2-AP,DNA+protein) for 
hTDG and hOGG1. Hence, the relative 2-AP fluorescence change ΔI2-AP induced by base flipping or 
destabilization is given by: 
ΔI2-AP = I2-AP,DNA+protein - I2-AP,DNA (Equation 10) 
Fluorescence intensities were determined as averages from two different titration experiments with 
standard deviations derived from the variation between experiments. The consistently higher 2-AP 
fluorescence intensity changes observed for hOgg1 compared to hTDG may in part be due to the 
different chemical environments for the two proteins; hOGG1 contains 10 tryptophans while hTDG only 
has two.  
61 
 
5. Results and discussion 
The two DNA excision repair pathways, NER and BER, differ significantly in their strategies employed for 
DNA lesion search and recognition. The broad DNA substrate versatility of NER is based on the bipartite 
substrate discrimination including an initial damage sensing step and an ATP-dependent damage 
verification step. In eukaryotic NER, these processes involve a coordinated cascade of different proteins 
and a multi-subunit damage verification complex. Contrarily, damage recognition and removal in BER is 
fulfilled by a variety of different DNA glycosylases– each of them highly specialized for a narrow subset of 
base lesions. Notably, DNA glycosylases neither require further protein factors nor the energy from ATP 
hydrolysis to accomplish these tasks. Specifically, I focus on the NER helicase XPD and on two 
representatives from the vast glycosylase family, hTDG and hOgg1, to compare those different 
approaches for damage search and recognition. 
5.1 Substrate versatility of the NER helicase XPD in damage verification DNA 
Efficient and correct damage verification is of vital importance for the cell. One the one hand, the GG-
NER system has to be highly specific for damaged bases to avoid futile incisions of undamaged bases. On 
the other hand, the detection machinery has to be versatile enough to recognize a variety of structurally 
different lesions. In the proposed bipartite damage recognition model (see 2.3.2), a helix-distortion 
induced by a ‘base-pairing disruption’ is initially detected by XPC followed by damage verification by the 
TFIIH complex, which ensures the presence of a chemical modification (Naegeli et al., 1992, Hess et al., 
1997, Sugasawa, 2010). The TFIIH complex is comprised of two sub-complexes, the core-complex 
(7 subunits) and the CAK-complex (3 subunits), which is dispensable for NER. The two key players of the 
TFIIH are the ATPase XPB, which has been proposed to enlarge the repair bubble by its ATPase activity 
(Coin et al., 2007) and the 5’-3’ helicase XPD, which is implicated in unwinding the DNA around the 
damage by its helicase activity (Tapias et al., 2004, Compe and Egly, 2012). Apart from this well 
established function in NER, XPD has been suggested to be involved in damage verification and DNA 
translocation of XPD has been shown to be stalled at lesion sites (Naegeli et al., 1992, Hess et al., 1997, 
Sugasawa, 2010). Sugasawa and co-workers provided evidence that the orientation in which the TFIIH 
complex is loaded on DNA is essential for correct damage verification and processing (Sugasawa et al., 
2009). Currently, the exact processes of ‘kinetic proofreading’, however, are not completely understood 
and it is still a matter of debate, which TFIIH proteins are involved in this process. Although XPD appears 
to be the most obvious candidate, damage verification may also depend on other TFIIH subunits such as 
XPB or even on TFIIH non-members such as XPA, which is indicated to possess a binding preference for 
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single-stranded, chemically modified DNA (Camenisch et al., 2006, Sugasawa et al., 2009). To focus solely 
on the function of XPD, I reconstituted a simplistic in vitro model for damage verification in NER using 
archaeal XPD from T. acidophilum, which requires only a few NER factors including XPB and the XPG 
homolog, FEN-1 (Rouillon and White, 2011). Due to the high sequence similarity to its human 
counterpart, the archaeal XPD homolog can be employed as an adequate model for eukaryotic NER as 
described above (2.3.3). In these studies, I compared interactions of taXPD with DNA substrates 
containing two structurally different NER lesions, a bulky fluorescein-adduct and a CPD damage, which 
causes only minor helix-distortions compared to other UV-photoproducts (Figure 9). 
5.1.1 Purification of taXPD proteins 
To obtain sufficient amounts of active taXPD protein for my studies, the protein was overexpressed in 
E.coli cells and purified in 2 steps by metal affinity and size exclusion chromatography based on an 
established protocol (Wolski et al., 2008, Kuper et al., 2012) (see 4.3). 
At an absorption wavelength of 280 nm, the size exclusion chromatogram of taXPD wt (Figure 20A) 
shows five different peaks at elution volumes of ~115 mL (peak 1), ~120 mL (peak 2), ~215 mL (peak 3), 
~245 mL (peak 4) and ~270 mL (peak 5). Subsequently, the fractions corresponding to these peaks were 
analyzed by SDS-PAGE (Figure 20B). The predominant peak 3 (at ~215 mL elution volume) contains taXPD 
as indicated by bands on the SDS gel corresponding to the molecular weight of the overexpressed 
protein (72 kDa) (red arrow). Moreover, the absorption of the FeS cluster at 410 nm overlaps with the 
major protein absorption peak at 280 nm (peak 3) in the chromatogram. Fractions running at an elution 
volume of 205-235 mL were pooled for further concentration and re-checked on a SDS-gel (Figure 20E).  
The size exclusion chromatogram of the taXPD variant R567W (Figure 20C) shows three distinct peaks at 
an absorption wavelength of 280 nm. The predominant peak in protein absorption at an elution volume 
of ~86 mL corresponds to XPD as visible from the SDS gel (Figure 20D, red arrow) showing pooled 
fractions (elution volume 82-95 mL) of the purified protein R567W. The purity of the purified proteins 
was estimated from the intensities of the bands on the SDS gel. The purity of the variant R567W (~80 %) 
was lower compared to the purity of the wt (~95 %) (compare Figure 20D and E, red arrows). Impurities 
at a running position of ~25 kDa, most likely protein degradation products, were more pronounced for 
the mutant than the wt protein (compare Figure 20D and E, blue arrows). 
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Figure 20: Purification of XPD wt from. T.acidophilum. 
A) Size exclusion chromatogram of taXPD wt. During SEC, absorption was recorded at three different wavelengths 
as indicated. B) SDS-PAGE of taXPD wt samples showing the elution fractions, which correspond to the five peaks in 
the elution profile in (A). C) Size exclusion chromatogram of taXPD R567W. For the variant, only protein absorption 
at a wavelength of 280 nm was detected. D) SDS-PAGE of pooled and concentrated samples of taXPD R567W (8.0 
ng) and two different dilutions (0.9 ng and 0.2 ng). E) SDS-PAGE of pooled and concentrated samples of taXPD wt 
(4.9 ng). The running position of taXPD (~70 kDa) is indicated by red arrows in the SDS gel. Green and blue arrows 
point to impurities running at either 10-15 kDa or at 25-30 kDa.  
In order to confirm proper folding of the taXPD wt and the variant R567W CD spectroscopy was applied. 
The spectra for XPD wt and the protein variant are similar (Figure 21), with minima observed at 208 nm 
and 222 nm, which are characteristic for correct protein folding in α-helices and β-sheets. The transition 
from negative to positive ellipticity values at a wavelength of approximately 200 nm indicates the 
absence of disordered regions in the protein structures.  
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Figure 21: CD spectra of taXPD wt and variants. 
The wt protein (black) and the protein variant R567W (cyan) showed similar CD profiles. The comparable spectra 
for both proteins indicate correct protein folding in α-helices and β-sheets and the absence of disordered regions in 
the protein structures. 
Finally, DNA helicase activity of the purified taXPD wt protein was tested. The unwinding assay is based 
on different electrophoretic mobilities of dsDNA and ssDNA resulting in gel shifts. The applied DNA 
substrate (‘open fork’, see schematic in Figure 22) allowed loading of taXPD in 5’-3’ direction. With rising 
concentration of XPD, the intensity of the bands corresponding to ssDNA slightly increased (Figure 22), 
which indicated weak 5’-3’ helicase activity of taXPD. Although no dsDNA separation was expected in the 
negative control without ATP and in the negative dsDNA control without protein, we observed faint 
bands corresponding to ssDNA most likely due to incomplete annealing of the duplex. 
 
Figure 22: Gel-based helicase assay of taXPD. 
The gel shows different samples of DNA and/or taXPD in the presence or absence of ATP as indicated. With rising 
taXPD concentration (0.1, 0.25, 0.5, 0.75 and 1 µM), the helicase activity (separation of dsDNA is visible as a shift in 
electrophoretic mobility) increases. The structure of the applied DNA substrate is schematically depicted (Cy3 label 
= yellow star) with the running positions of dsDNA and ssDNA indicated by blue arrows. 
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After validation by SDS-PAGE analysis, CD spectroscopy and a gel-based helicase assay (for the wt 
protein), DNA interactions of the purified taXPD proteins were investigated in BLI and AFM experiments. 
5.1.2 taXPD preferentially loads on unpaired regions within dsDNA 
The current model of NER (Figure 6) suggests that the physiological target of XPD contains a small 
unpaired DNA region (bubble), which is introduced by the concerted action of XPC and XPB in vivo 
(Lindahl and Wood, 1999, Hoeijmakers, 2001, Friedberg, 2001, Friedberg, 2003, Oksenych et al., 2009). 
Consistent with that, XPD has been shown to possess a binding preference for ssDNA and ss/dsDNA 
junctions in several in vitro studies (Mathieu et al., 2010, Rudolf et al., 2010, Kuper et al., 2012). 
To test for the proposed binding preference, DNA binding affinities of taXPD were determined for 
different DNA substrates using the label-free biosensor technique BLI. The DNA substrates tested 
included ssDNA, DNA bubble (8 nt) substrates and fully matched DNA duplexes either in the absence or 
in the presence of a fluorescein or CPD damage (Table 16). In order to concentrate exclusively on DNA 
binding effects, the binding experiments were carried out in the absence of ATP to prevent ATP-
dependent DNA duplex unwinding and translocation on DNA. 
Table 16: DNA binding affinities of taXPD for different DNA substrates. 
DNA substrate K
D
 [nM] n P 
ssDNA 
 
155 ± 61 13 - 
dsDNA nsp 
 
541 ± 234 12 6.4 x 10-6 
- / bubble (8nt) 
 
155 ± 75 16 0.48 
F / bubble (8nt) 
 
163 ± 69 14 0.36 
F / - 
 
499 ± 210 12 7.9 x 10-6 
CPD / bubble (8nt)* 
 
138 ± 52 8 0.28 
CPD / - 
 
340 ± 94 11 5.5 x 10-6 
Equilibrium binding constants (KD) for different DNA substrates (as depicted schematically) were determined by BLI. 
Binding affinities were obtained as means ± SD from n different experiments. Binding experiments were performed 
with three (or *two) different protein purification batches. Binding affinities of taXPD for ssDNA and dsDNA 
substrates containing single stranded DNA regions (-/bubble, F/bubble, CPD/bubble) are similar (P > 0.28) 
(highlighted in blue). The difference in binding affinity between ssDNA and fully matched dsDNA substrates (dsDNA 
nsp, F/-, CPD/-) is highly significant (P < 10
-5
). One of the dsDNA substrates (CPD/-) is bound by taXPD with 
significantly higher affinity compared to completely matched nsp dsDNA (P = 0.0095). Statistical analysis of 
significances was performed with a two-tailed student t-test. All P-values given in the table were derived in 
comparison with the ssDNA substrate. DNA sequences of DNA substrates for BLI are indicated in Table 11. This 
research was originally published in Buechner et al. (2014) © the American Society for Biochemistry and Molecular 
Biology. 
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In the BLI experiments, taXPD bound to ssDNA and to dsDNA containing single stranded DNA regions 
with moderately higher affinity (~ 150 nM, Table 16, blue) compared to completely matched dsDNA 
substrates (~ 500 nM, Table 16, white). The observed binding preference for ssDNA and DNA bubble 
substrates over fully matched DNA duplexes suggests that taXPD may preferentially load onto DNA on 
ssDNA regions and is consistent with the proposed binding preference of XPD for ssDNA and ss/dsDNA 
junctions in previous studies (see above). The finding that, taXPD bound to ssDNA (155 ± 61 nM) and to 
DNA substrates containing an 8 nt bubble (155 ± 75 nM) with similar affinity further indicated that the 
size of the bubble (8 nt) is sufficient to allow loading of taXPD.  
Furthermore, the KD values obtained for DNA substrates containing either a CPD (138 ± 52 nM) or 
fluorescein damage (163 ± 69 nM) in a bubble context were comparable to those of damage-free bubble 
substrates (155 ± 75 nM). This implies that the DNA binding affinity of taXPD is rather dominated by the 
preference for the ssDNA region than by preference for the damage. Interestingly, the DNA binding 
affinity of XPD for the DNA substrate containing a CPD within fully matched DNA (340 ± 94 nM) was 
significantly higher compared to completely matched nsp dsDNA (541 ± 234 nM, P = 0.0095) and 
compared to dsDNA substrates containing fluorescein within completely matched DNA (499 ± 210 nM). 
In contrast to fluorescein, which is connected extra-helically to a thymine base with a short linker, the 
CPD damage is an intra-strand crosslink between two adjacent thymines and mildly destabilizes the DNA 
helix (Sugasawa et al., 2001, Reardon and Sancar, 2003). Thus, the CPD damage may represent a small 
access site for XPD and allow slightly enhanced loading of XPD to the site of the damage compared to 
fluorescein or nsp homoduplex DNA. 
In accordance with BLI measurements, which revealed a moderate binding affinity of taXPD for 
nonspecific homoduplex DNA compared to ssDNA and DNA substrates containing unpaired DNA regions 
(Table 16), complex formation of taXPD with nonspecific dsDNA was also discovered in AFM 
experiments. Exemplarily, Figure 23A shows an AFM image of taXPD bound to circular non-damaged 
pUC19N DNA. This observed complex formation with nonspecific dsDNA represents a novel finding, 
which has not been proven experimentally before. To quantify DNA coverage with XPD in AFM 
experiments, AFM binding densities (number of peaks/bp, see Equation 1 in 4.1.3) were further 
determined in the absence and in the presence of ATP for different DNA substrates including circular 
plasmid DNA, linear undamaged DNA fragments and DNA substrates containing a loading site for XPD 
(8 nt bubble) either in the absence or in the presence of fluorescein (Figure 23B).  
Consistent with the BLI experiments, ATP was generally not required for association of nonspecific 
taXPD-DNA complexes (grey bars in Figure 23B). Interestingly, however, the binding affinity for circular 
nonspecific DNA was significantly reduced compared to linear nonspecific DNA in the absence of ATP 
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(compare grey bars for circular and linear nsp DNA in Figure 23B, P = 0.011, mildly significant). This 
indicates that taXPD also may be capable of loading on DNA termini, which represent destabilized DNA 
structures and are a preferred binding site for many other DNA repair proteins (Yang et al., 2005, 
Tessmer et al., 2008, Wagner et al., 2009, Tessmer et al., 2012). 
 
Figure 23: DNA binding of taXPD in AFM experiments. 
A) AFM image of taXPD incubated with non-damaged plasmid pUC19N (2729 bp) in the presence of ATP. White 
arrows point to taXPD complexes bound to nonspecific circular DNA. The scalebar corresponds to 200 nm. B) AFM 
binding densities of taXPD on different DNA substrate in the presence (black) and absence of ATP (grey). For 
calculation of binding densities, the protein coverage is normalized to the number of DNA fragments (counted from 
the AFM images) and the number of bp (number of peaks/bp). DNA substrates: circular = pUC19N plasmid; linear: 
nsp = linearized full length pUC19N (2729 bp) and 1813 bp fragment, bubble = 916 bp fragment containing a 8 nt 
DNA bubble, F/bubble = 916 bp fragment containing a fluorescein (F) within the context of a DNA bubble. This 
research was originally published in Buechner et al. (2014) © the American Society for Biochemistry and Molecular 
Biology. 
Upon addition of ATP, the binding density for linear undamaged DNA was significantly lowered 
compared to the absence of ATP (compare black and grey bars for linear nsp DNA in Figure 23B, 
P = 0.00073, highly significantly different) and only slightly lowered for circular DNA (compare black and 
grey bars for circular nsp DNA in Figure 23B, P = 0.023, mildly significantly different). As XPD is an ATP-
dependent DNA translocase, this finding suggests that taXPD may translocate on nonspecific dsDNA in an 
ATP-dependent manner and slide off the DNA fragment ends.  
To investigate whether the presence of a DNA damage may prevent that taXPD slides off or dissociates 
from the DNA fragments, a fluorescein adduct, which is known to be removed by the NER system 
(Hoeijmakers, 2009, Rudolf et al., 2010), was introduced into the DNA substrates for AFM (see 4.2.2) 
within the context of a small bubble (8 nt). As expected, the binding density of taXPD on DNA substrates 
containing a fluorescein damage within a bubble was significantly higher than for undamaged DNA 
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bubble substrates, when adding ATP (compare black bars for linear bubble and F/bubble DNA in Figure 
23B, P = 0.014, mildly significant), which suggests that the ATP-dependent DNA translocation of XPD may 
be constrained by the presence of a lesion. However, in the absence of ATP and hence in the absence of 
ATP-dependent translocation on DNA, the number of XPD-DNA peaks was similar for both DNA 
substrates (compare grey bars for linear bubble and F/bubble DNA in Figure 23B, P = 0.164, not 
significant). Consistent with these findings, an NER lesion may serve as a mechanical road block for XPD 
translocation on DNA. 
5.1.3 Lesion recognition and stalling at lesion sites requires ATP hydrolysis 
Figure 24 shows a representative AFM image of taXPD incubated with DNA substrates containing a 
fluorescein lesion within a bubble context at ~ 30 % of DNA fragment length in the presence of ATP.  
 
Figure 24: Lesion binding of taXPD in AFM. 
Representative AFM image of taXPD incubated with lesion specific DNA substrates (916 bp) containing a fluorescein 
in the context of a 8 nt bubble (at ~ 30 % of DNA fragment length) in the presence of ATP. To distinguish between 
specific (lesion-bound) and nonspecific XPD complexes, protein positions on DNA were determined. Yellow arrows 
point to XPD complexes specifically bound at the lesion site, white and red arrows point to nonspecific XPD-DNA 
complexes bound to undamaged dsDNA and DNA ends, respectively. The scale bar corresponds to 200 nm. This 
research was originally published in Buechner et al. (2014) © the American Society for Biochemistry and Molecular 
Biology. 
Based on the finding that XPD showed enhanced binding density on DNA substrates containing a 
fluorescein damage in a bubble context compared to undamaged DNA bubble substrates in the presence 
of ATP (see above in 5.1.1 and Figure 23B), binding stability of XPD is assumed to be increased at an NER 
target lesion. To quantify this proposed enhancement, binding positions of XPD-DNA complexes were 
determined with respect to the closer DNA terminus (see Methods 4.1.3). As the position of the DNA 
target site on the DNA substrates is known (~ 30 % from the closer DNA terminus), specific XPD-
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complexes at the damage (Figure 24, yellow arrows) and nonspecific protein complexes bound at DNA 
fragment ends (red arrows) or bound elsewhere on undamaged DNA (white arrows) can be 
distinguished. Using the ratio of areas under the Gaussian peak at the specific site and of the nonspecific 
background from the resulting position distribution histograms, the localization specificity (or binding 
specificity S) of XPD to a specific target site was calculated (for exact values see Table 17). 
Table 17: AFM binding specifities of taXPD for different DNA substrates and under various conditions. 
DNA substrate + ATP + ATPys - ATP 
- / bubble (8 nt) 1 
 
131 ± 51 
 
n.d. 213 ± 21 
F / bubble (8 nt) 2 
 
851 ± 280 
655 ± 9 
231 ± 67 
 
169 ± 168 
112 
F / bubble (14 nt) 2b 
 
468 ± 157 n.d n.d. 
F / 5’ bubble (8 nt) 3 
 
445 ± 167 102 ± 60 
101 ± 53 
n.d. 
F / 3’ bubble (8 nt) 4 
 
95 ± 24 n.d. 
 
n.d 
F / - 5 
 
113 ± 89 
 
n.d n.d. 
CPD / bubble  
(8 nt) 
6 
 
522 ± 112 374 ± 105 
 
66 ± 51 
51 
CPD / 5’ bubble  
(8 nt) 
7 
 
117 ± 39 
109 ± 11 
96 ± 48 n.d. 
CPD / 3’ bubble   
(8 nt) 
8 
 
283 ± 99 
452 ± 3 
82 ± 70 n.d. 
CPD / - 9 
 
137 ± 105   
AFM binding specificities were determined from position distribution histograms (e.g. from Figure 25) and reflect 
average values from 2-4 individual experiments with standard deviations (SD) derived from the variations between 
single experiments. In grey below, results obtained with a second protein batch for some of the DNA substrates 
indicate good reproducibility (F = fluorescein). This research was originally published in Buechner et al. (2014) © 
the American Society for Biochemistry and Molecular Biology. 
In the presence of ATP, taXPD showed a high localization preference (S = 851 ± 280) to a bulky 
fluorescein damage within a central bubble (DNA substrate fluorescein/bubble) (Figure 25A, black bars 
and Table 17) over an excess of nonspecific dsDNA. Interestingly, in the absence of ATP, the binding 
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specificity for fluorescein in a bubble context was significantly (P = 0.027) reduced (Figure 25A, grey bars, 
S = 169 ± 168). The residual specificity for the target site in the absence of ATP is likely due to XPD’s 
binding preference for the unpaired ssDNA region, consistent with the higher affinity of XPD for the 
fluorescein/bubble DNA substrate and the -/bubble DNA substrate (KD = 163 ± 69 nM and 
KD = 155 ± 75 nM vs. KD = 541 ± 234 nM for nonspecific dsDNA) as determined in BLI binding 
experiments. To identify, whether the high localization specificity of XPD in AFM to the DNA substrate 
containing a fluorescein located within a DNA bubble was due to its preference for loading onto DNA 
bubble structures or due to its specificity for the target site, two control experiments were performed in 
AFM. The interaction of taXPD with DNA substrates containing an unpaired DNA region without a lesion 
(-/bubble) was compared with those containing a fluorescein damage within perfectly matched DNA 
(fluorescein/-). 
 
Figure 25: Specificity of taXPD for different DNA target sites. 
XPD binding position distributions on three different DNA substrates as schematically indicated. The target sites are 
located at ~ 30 % to the DNA fragment end. Fractional occupancies are plotted for ~ 33 bp long sections of 916 bp 
DNA from DNA fragment ends (0 %) to 50 % DNA length (at the DNA center). A) Complex position distribution on 
the fluorescein/bubble substrate showing high specificity for the target site in the presence of ATP (black, n = 231, 
S = 851 ± 280) and considerably reduced binding specificity in the absence of ATP (grey, n = 398, S = 169 ± 168). This 
finding indicates the relevance of ATP-dependent transitions for lesion recognition of XPD. B) The complex position 
distribution on a bubble substrate without a lesion site (bubble/-) (n = 515, S = 131 ± 51) demonstrates a low 
binding specificity of taXPD for this target site in DNA most likely due to unhindered, ATP-dependent DNA 
translocation of XPD. C) For DNA substrates containing a fluorescein damage within perfectly matched DNA 
(fluorescein/-) (n = 280, S = 113 ± 89), the observed low binding specificity is consistent with the lower binding 
affinity in BLI. All distributions represent pooled data from at least three individual AFM experiments. This research 
was originally published in Buechner et al. (2014) © the American Society for Biochemistry and Molecular Biology. 
Firstly, the localization specificity to undamaged bubble sites over nonspecific DNA was poor 
(S = 131 ± 51, Figure 25B) compared to the fluorescein/bubble target structure (S ~ 850), despite XPD’s 
high binding affinity for unpaired DNA. Thus, the high specificity of taXPD for fluorescein in the bubble 
context can be clearly ascribed to its high specificity for the fluorescein lesion. The residual lesion 
specificity for the target site -/bubble in the presence of ATP is used to define the ‘background level’ of 
the localization specificity of taXPD in the AFM experiments. 
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Secondly, for the DNA substrate fluorescein/- (Figure 25C), a significantly reduced binding specificity of 
S = 113 ± 89 was found in AFM compared to a fluorescein in the context of an 8 nt DNA bubble 
(P = 0.00028), which is consistent with the lower binding affinity for this DNA substrate in BLI 
(KD = 499 ± 210 nM) compared to ssDNA. These data indicate that loading of XPD onto DNA may be 
impaired in the absence of a ssDNA-region. Importantly, the lesion specificity of taXPD for fluorescein 
was not increased by enlarging the bubble size (S = 468 ± 157 for fluorescein/bubble 14 nt compared to 
S = 851 ± 280 for fluorescein/bubble 8 nt and Table 17), which suggests that an 8 nt bubble is sufficiently 
large to allow loading of XPD onto DNA. 
To separate the effects of loading on a bubble from damage detection, we produced DNA substrates 
containing an 8 nt bubble in 27 bp distance 5’ from the fluorescein damage (5’ fluorescein/bubble). This 
distance between the entry site for loading of XPD onto DNA (bubble) and the target site is small enough 
to be overcome by XPD’s 5’-3’ helicase activity as has been previously shown (Mathieu et al., 2010). 
Although a distance of 27 bp (9 nm with 0.34 nm/bp) is too small to spatially resolve XPD complexes 
bound at the bubble or XPD complexes bound at the fluorescein damage in the AFM images, the 
resulting position distributions of XPD on these DNA substrates can reveal important information on the 
implications of separating loading and target recognition sites. 
Indeed, I discovered that XPD could localize to the target site fluorescein (Table 17 and Figure 28A) with 
relatively high specificity of S = 445 ± 167, when loaded at the bubble 5’ to the damage in the presence 
of ATP. This finding suggests that the helicase XPD translocates on DNA in 5’-3’ direction in an ATP-
dependent manner and that its movement is stalled upon recognition of a fluorescein damage on the 
translocated DNA strand. In contrast, XPD hardly recognized the fluorescein damage, when located on 
the complementary, non-translocated strand (fluorescein/ 3’ bubble S = 95 ± 24, Figure 28B). Note that, 
XPD binding specificity for fluorescein on the translocated strand (S = 445 ± 167, Table 17 and Figure 
28B) was approximately 50% of that observed for fluorescein within the context of a central bubble 
(S = 851 ± 280), consistent with approximately half of XPD translocating along DNA in 5’ to 3’ direction on 
either DNA strand. In the presence of the non- or only slowly-hydrolysable ATP analog ATPγS, localization 
specificity of XPD to fluorescein was decreased to background levels (defined for the DNA substrate 
bubble/- in the presence of ATP), when loaded at a bubble 5’ of the damage (S = 102 ± 60, Table 17), 
which suggests that the 5’-3’ translocation on DNA is coupled to ATP hydrolysis. 
The finding that the processes leading to damage verification are ATP-dependent were confirmed by the 
effects of the taXPD variant R567W in AFM experiments. The variant R567W corresponds to R666W in 
the human protein and causes the disease XP, when mutated in XP patients (Wolski et al., 2008). As the 
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mutated residue Arg567 is located near the ATP-binding site in the crystal structure (Figure 7, between 
helicase domains 1 and 2, red and yellow), it has been proposed that the variant is deficient in ATP 
binding and hydrolysis (Wolski et al., 2008). In line with that, the localization specificity of R567W to the 
target site fluorescein/bubble in the presence of ATP (S = 216 ± 33, Figure 26) was reduced 4-fold 
compared to XPD wt under the same conditions (S = 851 ± 280, Table 17) and resembled the value 
obtained for the wt protein in the absence of ATP (S = 169 ± 168, Table 17). In addition, DNA binding 
affinities of the variant R567W were determined for different DNA substrates by BLI in the absence of 
ATP (Figure 26). In the BLI experiments, taXPD R567W bound to ssDNA and to dsDNA containing single 
stranded DNA regions (F/bubble, -/bubble) with significantly lower affinity (P < 1.9*10-4, ~ 350 nM, Figure 
26) compared to the wt enzyme (~ 150 nM, Figure 26 and Table 16, blue). The binding affinity of R567W 
determined for the nsp dsDNA substrate, however, was comparable to those measured for taXPD wt and 
dsDNA (624 ± 30 nM) and 541 ± 234 nM, respectively, P = 0.26, not significantly different, Figure 26). 
Thus, the reduced localization specificity of the taXPD variant to the target site fluorescein/bubble in 
AFM is consistent with this DNA binding phenotype observed for the variant R567W in the binding 
experiments (reduced binding affinity for ssDNA and DNA substrates containing ssDNA regions; similar 
binding affinity for dsDNA compared to wt). 
 
Figure 26: Localization specificity and binding affinities of taXPD R567W for different DNA substrates. 
A) The complex position distribution of taXPD R567W on the fluorescein/bubble substrate shows low specificity 
(S = 216 ± 33) for the target site in the presence of ATP (n = 493), which suggests that this variant is impaired in 
lesion recognition. The distribution represents pooled data from five individual AFM experiments. B) Equilibrium 
binding constants (KD) of taXPD wt (blank bars) and taXPD R567W (hatched bars) for different DNA substrates (as 
depicted schematically) were determined by BLI in the absence of ATP. Binding affinities were obtained as means 
± SD from at least three different experiments. Differences in binding affinities between taXPD R567W for ssDNA 
and DNA substrates -/bubble and F/bubble were highly significant to those observed for the wt enzyme and the 
respective DNA substrates (P < 1.9*10
-4
). Statistical analysis of significances was performed with a two-tailed 
student t-test. All P-values given in the figure were derived in comparison between taXPD wt and the variant 
R567W for each DNA substrate. DNA sequences of DNA substrates for BLI are indicated in Table 11.  
73 
 
To further characterize the significance of proper lesion verification by XPD, AFM experiments were 
performed with a second mutant, taXPD K170A. It is likely that Arg170 is involved in lesion recognition as 
the mutated residue is located in close vicinity to the FeS cluster (compare Figure 7), which has been 
implicated in damage verification (see 2.3.4).  
In contrast to the variant R567W, which has been indicated to be impaired in ATP binding and hydrolysis, 
the variant K170A has recently been described to show helicase hyperactivity and elevated ATPase 
activity compared to the wt protein (Kuper et al., 2012). In the AFM experiments, taXPD K170A showed 
very low lesion specificity for a fluorescein damage located at a distance 3’ of a bubble (DNA substrate 
fluorescein/5’ bubble, S = 67 ± 14, Figure 27). The finding that DNA translocation of this helicase mutant 
was not stalled by fluorescein is consistent with taXPD K170A ‘overreading’ the lesion sites due to its 
elevated helicase activity. Altogether, the data on the XPD variants R567W and K170A suggest that 
damage verification requires a) the ability to bind and hydrolyze ATP and b) ‘normal’ helicase activity and 
helicase stalling at lesion sites, respectively. 
 
Figure 27: Specificity of taXPD K170A for the DNA substrate fluorescein/5' bubble. 
The complex position distribution on the fluorescein/5’ bubble substrate shows only a residual specificity 
(S=74 ± 20 corresponding to background levels) for the target site in the presence of ATP (n=562) demonstrating 
that this variant is clearly impaired in lesion recognition. This research was originally published in Buechner et al. 
(2014) © the American Society for Biochemistry and Molecular Biology. 
5.1.4 taXPD utilizes different mechanisms for verification of CPD and fluorescein lesions 
The NER pathway recognizes and removes a variety of structurally diverse DNA targets embracing the 
class of helix-distorting lesions, which may disrupt normal base pairing. The fluorescein adduct, which 
has been used in these studies with taXPD so far, is an artificial substrate removed by the NER system 
and serves as representative for bulky DNA damages. In identical studies, the results for taXPD 
interactions with fluorescein will be compared with those for the less invasive UV-photoproduct CPD. 
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For a CPD damage located within the context of a central bubble (CPD/bubble), the lesion specificity 
(S = 522 ± 112) was found to be comparable (or even slightly lower) to those for the fluorescein/bubble 
target structure (S = 851 ± 280) (P = 0.13). Interestingly, however, for a DNA substrate with a bubble 
located 5’ of a CPD damage (CPD/ 5’ bubble), binding specificity was lowered to background levels (S = 
117 ± 39, Figure 28C) similar as observed for the DNA substrate -/bubble. This suggests that XPD is not 
able to detect the CPD lesion, when localized at a distance 3’ from the loading site (bubble). This is in 
contrast to the observation for the fluorescein lesion, which was recognized with high specificity on the 
translocated strand, i.e. when loaded at a bubble 5’ to the lesion (fluorescein/5’ bubble substrate). 
However, XPD binding specificity for CPD on the non-translocated strand i.e. when loaded at a bubble 3’ 
to the lesion (CPD/3’bubble, S = 283 ± 99, Figure 28D) was significantly higher than for CPD placed on the 
translocated strand (CPD/5’bubble, S = 117 ± 39, Figure 28C). Similar as observed for fluorescein, 
localization specificity to the target site CPD/3’ bubble was approximately half of that to CPD within a 
bubble context (compare S = 283 ± 99 and S = 522 ± 112, respectively). AFM binding specificities of taXPD 
wt and variants K170A and R567W for different DNA substrates are summarized in Figure 28E. 
 
Figure 28: Different strand selectivity of taXPD for bulky fluorescein and CPD damages. 
A) XPD displays a high specificity for the position of a fluorescein damage when loaded at bubble 5’ to the damage 
(fluorescein/5’ bubble substrate, n = 537 complexes, S = 445 ± 167). B) When loaded on a bubble 3’ to the damage, 
XPD poorly recognizes fluorescein (fluorescein/3’ bubble substrate, n = 272 complexes, S = 95 ± 24). C) XPD shows a 
low lesion preference for CPD, when loaded on a bubble 5’ from the damage (CPD/5’ bubble substrate, n=555 
complexes, S=117 ± 39). D) In contrast, XPD binding specificity for CPD is significantly enhanced, when XPD is 
loaded on a bubble 3’ from the damage (CPD/3’ bubble substrate, n = 353 complexes, S = 283 ± 99). All 
distributions represent pooled data from at least three individual AFM experiments. E) Quantification of lesion 
specificities of taXPD wt and variants in AFM under different conditions. Lesion binding specificities were derived 
from the position distribution histograms shown here and in Figure 25, Figure 26 and Figure 27 . Statistical analysis 
of significances was performed with one-tailed t-test relative to the bubble substrate (* < 0.05, ** < 0.01, *** < 
0.005). This research was originally published in Buechner et al. (2014) © the American Society for Biochemistry 
and Molecular Biology. 
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The observed difference in strand selectivity is most likely due to different structural prerequisites 
necessary for recognition of these structurally diverse lesions. It has been shown earlier that DNA repair 
efficiencies strongly depend on the degree of DNA helix destabilization by different lesions resulting in 
differences in NER mechanistic details for different types of lesions (Mu et al., 1996, Jain et al., 2013). 
Under the conditions of the AFM experiments (pH 8), fluorescein occurs in the anionic and dianionic 
form (protolytic constant = pKa= 6.4) (Sjöback et al., 1995). Due to its negative charge, fluorescein may 
not induce major DNA destabilization by intercalation into the negatively charged DNA. To load on DNA 
substrates containing a fluorescein lesion, XPD may hence require initial bubble opening, which is 
proposed to be performed by the concerted action of XPC and XPB in vivo (Lindahl and Wood, 1999, 
Hoeijmakers, 2001, Friedberg, 2001, Friedberg, 2003, Oksenych et al., 2009). taXPD’s requirement for 
initial bubble opening is indicated by the only residual localization specificity to a fluorescein lesion 
within the context of perfectly matched DNA (S = 113 ± 89 for the DNA substrate fluorescein/-) 
compared to the high specificity for fluorescein within a bubble context (S = 851 ± 280 for the DNA 
substrate fluorescein/bubble). When loaded onto DNA at a bubble 5’ from the fluorescein lesion, taXPDs 
movement on DNA in 5’-3’ direction may be blocked mechanically by the protruding structure of the 
fluorescein damage placed on the translocated DNA strand that XPD ‘holds on to’. 
In case of CPD, the situation is more complex. Similar as fluorescein a CPD damage does not cause major 
DNA helix distortions compared to other UV-photolesions such as 6,4-photoproducts (Kim and Sancar, 
1995, McAteer et al., 1998, Lee et al., 2004, Marteijn et al., 2014). To characterize the two DNA lesions 
by AFM, intrinsic DNA bend angles were measured at the target site positions for fluorescein and CPD 
(30 % from DNA fragment end, Figure 29B and C). In principle, AFM-based measurements of intrinsic 
DNA bend angles in the absence of protein can provide information on the degree of DNA destabilization 
induced by the presence of lesions at these target sites. As a reference for intrinsic DNA bending at 
specific DNA sites, innate bending of nonspecific (undamaged) DNA sites (Figure 29A) was measured at 
regular intervals of 50 nm by moving a mask comparable to the size of the protein along DNA. The 
resulting distributions of DNA bend angles for lesion sites and undamaged sites were similar and can be 
fitted with a semi-Gaussian curve ~ 0°, which is consistent with intrinsic bending of nonspecific DNA 
determined in previous studies (Wang et al., 2003). This suggests that neither fluorescein nor CPD exhibit 
innate DNA bending and hence may not induce major destabilization of the DNA helix. 
76 
 
 
Figure 29: Intrinsic DNA bending of nonspecific and specific DNA substrates in AFM. 
DNA bend angle measurements in the absence of protein on three different DNA substrates as schematically 
indicated. (A) Intrinsic bending of the nonspecific DNA substrate was determined by moving a mask comparable to 
the size of the protein at regular intervals of 50 nm along DNA (n = 297). (B) Fluorescein in the context of a DNA 
bubble (n = 270) (C) CPD in the context of a DNA bubble (n = 335). All distributions were fitted by a semi-Gaussian 
~ 0° with fit qualities R
2
 > 0.91 and with widths of 10‐15°. The histograms represent pooled data from two 
individual experiments. This research was originally published in Buechner et al. (2014) © the American Society for 
Biochemistry and Molecular Biology. 
However, compared to fluorescein, a CPD damage is not bulky and may not present a major mechanical 
barrier for translocation of XPD because CPD does not significantly stall movement of XPD, when loaded 
on a bubble 5’ from the damage in the AFM studies (i.e. CPD on the translocated strand) (Figure 28). In 
contrast, when loaded on a bubble 3’ from the damage (CPD on the displaced, non-translocated strand), 
CPD is recognized by XPD. Thus, for recognition of CPD, XPD may employ a different, so far unidentified 
damage verification mechanism. Based on the three-dimensional XPD-DNA model (see crystal structure 
in Figure 30), CPD is assumed to be in close vicinity to the FeS cluster, when placed on the 
complementary, non-translocated strand that XPD does not directly bind to. This observation would 
support a possible role of the FeS cluster in electrochemical sensing of CPD damages as described above 
(see 2.3.4 and Figure 8). Unfortunately, the exact location of the CPD damage on the displaced strand 
cannot be known with certainty as the path of the non-translocated DNA strand has not yet been 
resolved in the crystal structure of XPD (Kuper et al., 2012) and will require further investigation in 
crystallographic studies. 
It is tempting to speculate that XPD may simultaneously use both detection strategies (mechanical 
detection of bulky damages and electrochemical sensing of CPD damages) during damage search. 
Depending on the type of lesion, the equilibrium may then be shifted towards one of the pathways.  
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Figure 30: Model of the XPD-DNA complex. 
The co-crystal structure of taXPD and a short stretch of ssDNA (experimentally resolved DNA in orange) (Kuper et 
al., 2012) was used to build a model of the path of ssDNA (modelled DNA in blue) through the enzyme. Color coding 
of the domains is similar to Figure 7 with the helicase domains 1 and 2 depicted in yellow and red, the FeS domain 
in cyan and the arch domain in green. The first three domains (helicase domain 1, FeS cluster and the arch domain) 
form a pore through which the ssDNA is threaded. The position of Lys170 (blue ball) mutated in the taXPD variant 
K170A and the FeS cluster (Fe atoms in red and S atoms in yellow) were depicted in a space-filling representation. 
Adapted from Buechner et al. (2014) © the American Society for Biochemistry and Molecular Biology. 
Interestingly, however, the different strand selectivity observed for XPD from T. acidophilum is in 
contrast with a recent study performed by H.P. Naegeli’s group with archaeal XPD from Ferroplasma 
acidarmanus (facXPD) (Mathieu et al., 2010). Based on electrophoretic competition analyses, facXPD 
recognized CPD both on the translocated and on the non-translocated DNA strand. Furthermore, facXPD 
protected a CPD lesion on the translocated strand from incision by the glycosylase T4 Endo V suggesting 
stable complex formation of XPD with CPD. Differences between the two archaeal species and the 
different experimental approaches (including the use of long DNA substrates in my AFM studies) may 
contribute to the different strand selectivity observed in the present study and the work of Naegeli 
(Mathieu et al., 2010, Mathieu et al., 2013). Although my data demonstrated that XPD preferentially 
recognizes CPD on the non-translocated strand, they do not exclude complex formation with CPD on the 
translocated strand. 
5.1.5 Stable complex formation at the lesion involves ATP binding 
AFM-based measurements of DNA bend angles induced at the site of the bound protein can reveal 
information on conformational properties of protein-DNA complexes. To characterize potentially 
different XPD-DNA conformations upon damage verification, DNA bend angles of nonspecific XPD 
complexes with undamaged DNA and specific complexes at the DNA target sites were analyzed 
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separately under different conditions and with different DNA substrates (Figure 31 and Table 18). Based 
on the position distributions, XPD-DNA complexes can be distinguished into specific complexes (bound at 
positions within two standard deviations from the center of the Gaussian fit) and nonspecific complexes 
(bound elsewhere on DNA). In addition to those measurements of protein-induced bend angles, intrinsic 
DNA bend angles were determined for nonspecific and specific DNA sites (at the fluorescein and at the 
CPD damage within the context of a bubble structure) as described above (see 5.1.4 and Figure 29). The 
DNA bend angle distributions in the absence of protein displayed narrow half Gaussian distributions 
(maximum at ~ 0°) for both nonspecific and specific sites, which suggests that neither the presence of a 
bubble nor the presence of a damage induces innate DNA bending into the DNA substrates used for 
AFM. 
In the absence of ATP, XPD showed a DNA bend angle of ~ 50° for both nonspecific and specific 
complexes at the fluorescein damage in the context of a bubble (Figure 31A, grey and black bars and 
Table 18, 2). However, in the presence of ATP, XPD showed a DNA bend angle of ~ 50° for nonspecific 
complexes (Figure 31B, grey bars and Table 18,2) and a bend angle of ~ 65° for specific complexes (Figure 
31B, black bars and Table 18, 2). The observed transition in DNA bend angles from ~ 50° to ~ 65° at the 
site of the bound protein is highly significant (P = 1.6*10-12) and suggests that XPD may undergo ATP-
dependent conformational changes at the target site. To identify whether the observed shift in DNA 
bend angles was due to ATP binding or ATP hydrolysis, XPD was incubated with the non-hydrolysable (or 
only very slowly hydrolysable) ATP-analog ATPƴs. Notably, the same bend angle change of ~ 15° between 
nonspecific and specific complexes could also be observed in the presence of ATPƴs (Figure 31C and 
Table 18, 2), indicating that ATP binding, not ATP hydrolysis, is sufficient to induce to the shift in DNA 
bend angles.  
The conditions leading to the potential conformational changes visible as a transition in DNA bend angles 
were further characterized by DNA bend angle analysis of XPD-DNA complexes on two DNA control 
substrates, fluorescein/- (Figure 31E and Table 18, 5) and -/bubble (Figure 31D and Table 18, 1). For both 
DNA substrates, the bend angle distributions for specific target sites (binding at the bubble position or at 
the damage) and nonspecific sites (binding at homoduplex DNA sites) were similar (~ 50°). The lack of the 
bend angle shift at the target sites is consistent with the protein position analysis on the same two DNA 
substrates (see 5.1.2 and Figure 25), which revealed a low localization specificity of taXPD to both target 
sites fluorescein/- and -/bubble compared to fluorescein/bubble. By excluding that the bend angle shift 
occurs in the two controls, the data indicate that XPD requires the combination of a bubble to support 
loading on DNA and the presence of a damage for stimulation of damage-specific conformational 
changes visible as a transition in bend angles. 
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Interestingly, a bend angle shift of 15° was noticed for stalled XPD-DNA complexes at the target site 
CPD/bubble (Figure 31F and Table 18, 6) similar as observed for the fluorescein/bubble target structure. 
This finding suggests a common verification mechanism for both lesions: Once a lesion has been 
recognized, the subsequent conformational changes are comparable, irrespective of the lesion type and 
the employed lesion detection strategy. The structural rearrangements might be a signal for the 
recruitment of further NER proteins including the endonucleases XPG and XPF. 
 
Figure 31: DNA bend angle distributions of taXPD with various DNA substrates. 
A) In the absence of ATP, DNA bend angle distributions of XPD-DNA complexes are similar at nonspecific DNA sites 
(grey bars, n = 174) and specific DNA sites (black bars, n = 113). A Gaussian fit to the data centers at ~ 50° for both 
distributions. B) In the presence of ATP, XPD shows a DNA bend angle of ~ 50° for nonspecific complexes (n = 166) 
and a bend angle of ~ 65° for the specific complexes (n = 119) C) In the presence of the ATP-analog ATPƴs, bend 
angle distributions are different for nonspecific (n = 242) and specific complexes (n = 224). D)-F) AFM experiments 
with different DNA substrates in the presence of ATP. D) DNA bending for XPD complexes on DNA substrates 
containing a bubble without a lesion (-/bubble, Table 16, 1). Both distributions for specific (n = 123 complexes) and 
nonspecific sites (n = 164 complexes) are similar (~ 50°). E) DNA bending for XPD complexes on DNA substrates 
containing fluorescein within homoduplex DNA (fluorescein/-). Both distributions for specific (n = 188 complexes) 
and nonspecific sites (n = 296 complexes) are similar (~ 50°). F) A CPD damage within a bubble (Table 16, 6, (n = 156 
for nsp sites and n = 195 for spec sites)) induced the same bend angle shift as observed for the fluorescein/bubble 
substrate. This research was originally published in Buechner et al. (2014) © the American Society for Biochemistry 
and Molecular Biology. 
 
 
80 
 
Table 18: DNA bend angle analysis of taXPD-DNA complexes under different conditions in AFM. 
Bend angle (degrees)   + ATP + ATPƴs      - ATP 
DNA substrate nsp spec P-value nsp spec nsp spec 
- / bubble 
(8nt) 
1 
 
44 ± 25 
n = 164 
51 ± 22 
n = 123 
n.d. n.d. n.d. 47 ± 19 
n = 246 
48 ± 22 
n = 196 
F / bubble 
(8nt) 
2 
 
52 ± 14 
n = 94 
27 ± 13 (27 %) 
65 ± 13 (73 %) 
n = 137 
1.6 x 10-12 49 ± 19 
n = 242 
28 ± 13 (26 %) 
65 ± 13 (72 %) 
n = 224 
49 ± 21 
n = 174 
51 ± 23 
n = 113 
F / bubble 
(14nt) 
2b 
 
50 ± 13 
n = 212 
40 ± 9 (36 %) 
66 ± 9 (64 %) 
n = 223 
4.3 x 10-51 n.d. n.d. n.d. n.d. 
F / 5’ bubble 
(8nt) 
3 
 
53 ± 17 
n = 184 
33 ± 10 (37 %) 
63 ± 10 (66 %) 
n = 188 
9.8 x 10-12 51 ± 17 
n = 201 
 
27 ± 12 (35 %) 
63 ± 12 (65 %) 
n = 166 
n.d. n.d. 
F / 3’ bubble 
(8nt) 
4 
 
47 ± 19 
n = 253 
32 ± 13 (38 %) 
68 ± 13 (62 %) 
n = 118 
4.3 x 10-31 n.d. n.d. n.d. n.d. 
F / - 5 
 
48 ± 23 
n = 296 
52 ± 24 
n = 188 
n.d. n.d. n.d. n.d. n.d. 
CPD / 
bubble (8nt) 
6 
 
52 ± 18 
n = 156 
 
36 ± 12 (31 %) 
66 ± 12 (69 %) 
n = 195 
7.4 x 10-18 48 ± 19 
n = 103 
30 ± 12 (27 %) 
65 ± 12 (73 %) 
n = 103 
49 ± 20 
n = 195 
 
44 ± 22 
n = 97 
 
CPD / 5’ 
bubble (8nt) 
7 
 
52 ± 23 
n = 313 
 
26 ± 10 (34 %) 
60 ± 10 (66 %) 
n = 212 
7.4 x 10-8 n.d. n.d. n.d. n.d. 
CPD / 3’ 
bubble (8nt) 
8 
 
49 ± 18 
n = 184 
 
32 ± 11 (27 %) 
66 ± 11 (73 %) 
n = 150 
1.4 x 10-23 n.d. n.d. n.d. n.d. 
DNA bend angles of XPD-DNA were measured at lesion-specific (spec) and nonspecific, undamaged DNA sites (nsp) 
for different DNA substrates (as schematically indicated) either in the presence or absence of ATP or ATPys. The 
values given in the table represent the maxima of single or double Gaussian fits to pooled bend angle distributions 
from at least 2 experiments.  Sigma, the half-width of the Gaussian peak is given as the error. The total number of 
data points is indicated as n. The ratio between the bend angle states is given in brackets as % of total area derived 
from integration of the Gaussian peaks using the software Origin Pro. The significances of the shift in average bend 
angle between nonspecific and specific complexes (in the presence of ATP) were calculated by on-tailed student t-
test. Significances of shifts in bend angles between the absence and presence of ATP (or ATPγs) for specific 
complexes were P = 2.2 x 10
-8
 (4.8 x 10
-9
) and 9.5 x 10
-20
 (5.3 x 10
-16
) for DNA substrates 2 (F = fluorescein) and 6 
(CPD), respectively. This research was originally published in Buechner et al. (2014) © the American Society for 
Biochemistry and Molecular Biology. 
In addition to the DNA bend angle conformation with a maximum value of ~ 65°, a second DNA bend 
angle state of ~ 30° was discovered in all distributions of complexes at specific sites in the presence of 
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ATP and ATPƴs, when the distributions were fitted with a double Gaussian curve. Integration of the 
relative surface areas of the double Gaussians revealed that the predominant conformation is the larger 
bend angle state of ~ 65° (~ 70 % of all complexes), while the smaller bend angle of ~ 30° is populated to 
a lower degree (~ 30 % of all complexes). This slightly bent state may also be present in the broad 
distributions at nonspecific sites but may not be resolved by a double Gaussian fit because the centers of 
the Gaussians (~ 30° and ~ 50°) are too close to each other. A population of the ~ 30° bend angle is not 
detected in the distributions determined from intrinsic bend angles on nonspecific and specific DNA 
substrates in the absence of protein (Figure 29), which suggests that this state is not related to a pre-
bent innate DNA structure XPD binds to. It could be envisioned that this state with a bend angle of ~ 30° 
is protein-induced and may reflect a conformation of XPD, which probes DNA upon initial encounter on 
its way to a specific damage verification complex. However, the transition in bend angles from ~ 50° to 
~ 65° between nonspecific and specific is still considered as the relevant step for the lesion-dependent 
conformational changes.  
DNA bend angle measurements of taXPD-K170A complexes at undamaged DNA and at lesion sites (for 
fluorescein and CPD, respectively) resulted in similar distributions for nonspecific and specific complexes 
(Figure 32, A and B) without the DNA bend angle shift of ~ 15° observed for the wt protein. The lack of 
lesion-dependent conformational changes confirms that this taXPD variant is incapable of damage 
recognition, which is consistent with the position distribution of K170A showing only residual localization 
specificity to a fluorescein lesion (Figure 27). The deficiency in damage recognition by taXPD K170A is 
most likely due to its elevated helicase activity, which confirms that stalling of the helicase activity is 
implicated in damage verification. In addition, the AFM data on K170A support the hypothesis that the 
FeS cluster may be involved in damage sensing using DNA-mediated CT (Figure 8) as the mutated Lysine 
residue is located in close proximity of the FeS cluster (Figure 30). 
Consistent with the finding that the structural changes leading to damage verification by XPD wt require 
ATP-binding (Figure 31B and C), the taXPD variant R567W showed comparable bend angle distributions 
for nonspecific and fluorescein/bubble target sites without any bend angle shift (Figure 33) similar as 
observed for taXPD wt in the absence of ATP (Figure 31A). The absence of repair-competent 
conformational changes for R567W is in accordance with the position analysis data in Figure 26A, which 
indicate that this mutant is incapable of performing damage verification. This phenotype can be 
explained by a deficiency in ATP binding as it has been proposed here and in previous structural studies 
(Wolski et al., 2008), thus supporting the relevance of ATP binding for lesion-dependent conformational 
changes.  
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Figure 32: AFM experiments with taXPD variant K170A. 
DNA bend angle measurements of taXPD-K170A complexes on both A) the DNA substrate fluorescein/ 5’ bubble 
(nspec = 161 nnsp = 284) and B) on the DNA substrates CPD/ 3’ bubble (nspec = 110 nnsp = 218) resulted in similar 
distributions for nonspecific complexes bound to non-damaged DNA sites (grey bars) and specific complexes bound 
to lesion sites (black bars). The missing DNA bend angle shift of ~ 15° observed for the wt protein suggests that 
K170A is deficient in lesion verification. All distributions represent pooled data n from three individual experiments. 
This research was originally published in Buechner et al. (2014) © the American Society for Biochemistry and 
Molecular Biology. 
 
Figure 33: DNA bend angle distribution of the taXPD variant R567W. 
Bend angle distributions for R567W in the presence of ATP are similar for nonspecific (n = 227) and specific 
complexes (n = 176) and are comparable to the bend angle distribution at nonspecific DNA sites for the wt protein. 
The distribution represents pooled data from five individual AFM experiments. 
In principle, the requirement of ATP binding for the conformational changes closely resembles the 
prokaryotic NER pathway. Here, initial conformational changes of the prokaryotic XPD homolog UvrB via 
ATP hydrolysis lead to recruitment of UvrB to the lesion site. After successful damage verification, UvrB is 
converted to a pre-incision complex by ATP re-binding (Verhoeven et al., 2001) and prepared for the 
arrival of the endonuclease UvrC (Verhoeven et al., 2002). This similarity between the eukaryotic and the 
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prokaryotic NER mechanism supports the high level of conservation of NER across different species (Petit 
and Sancar, 1999, Batty and Wood, 2000, Kuper and Kisker, 2012). 
5.1.6 Model of damage verification by taXPD 
The model of XPD damage verification is based on the results of AFM and BLI experiments. XPD can load 
at bubble structures as a nonspecific complex (green circles, DNA bend angle of ~ 50°) to translocate on 
DNA in 5’-3’ direction (Figure 34). Upon damage verification, the nonspecific XPD-DNA complex is 
converted to a specific complex (red circles, DNA bend angle of ~ 65°). Depending on the type of DNA 
lesion, fluorescein or CPD, two different scenarios can be distinguished. I) Movement of nonspecific XPD 
on DNA (green circle) is stalled when a bulky fluorescein damage (red ball) is located on the translocated 
DNA strand (5’-3’) (5’ bubble). The bulky damage may hence serve as a mechanical road block 
obstructing the pore for passage of ssDNA visualized in the crystal structure in Figure 30. XPD 
translocation is not blocked when fluorescein is located on the non-translocated DNA strand (3’ bubble). 
II) In contrast, an intrastrand DNA crosslink (CPD damage, blue rectangle) is not recognized on the 
translocated DNA strand, but on the non-translocated DNA strand. It can be envisioned that taXPD 
employs a different mechanism for detecting CPD possibly involving the FeS cluster domain. Depending 
on the lesion type XPD may simultaneously use the two damage sensing mechanisms during damage 
search. However, once taXPD has verified a damage, either CPD or fluorescein, DNA bend angle analyses 
from AFM measurements indicate that the protein undergoes the same structural rearrangements, 
which may lead to recruitment of further NER factors (Buechner et al., 2014). 
 
Figure 34: Model for lesion recognition by taXPD. 
The green circle indicates taXPD moving along DNA. A bulky fluorescein damage (red ball) is preferentially 
recognized on the translocated strand, whereas a CPD damage (blue rectangle) is preferentially detected on the 
non-translocated strand. For details see main text. This research was originally published in Buechner et al. (2014) 
© the American Society for Biochemistry and Molecular Biology. 
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5.2 Lesion recognition strategies of DNA glycosylases in base excision repair 
The ability of DNA glycosylases to detect and remove base lesions rapidly and efficiently from the 
genome is essential in base excision repair (BER). How can DNA glycosylases go about finding the rare 
target sites among the huge excess of undamaged bases? Here, this key question in BER was addressed 
by using single molecule AFM imaging supported by a 2-aminopurine fluorescence base flipping assay to 
study damage search and recognition by hTDG, which initiates BER of mutagenic and cytotoxic G:T and 
G:U wobble pairs. The findings for hTDG are summarized as a model in the context of general 
implications for DNA lesion search by DNA glycosylases (5.2.6). Similar studies were performed with 
hOgg1, a second representative of the glycosylase family targeting structurally different 8oxoG:C pairs, 
to test the generalizability of the proposed model. 
5.2.1 hTDG recognizes G:U and G:T mismatch sites with moderate specificity 
For the AFM studies, a single target site for hTDG, either a G:T or a G:U base mismatch in a CpG context, 
was introduced into long DNA fragments (549 bp) at 46% of DNA fragment length. Notably, the long DNA 
fragments used for the AFM experiments represent better mimics of the naturally occurring DNA 
substrates than the short oligonucleotides typically used in biochemical ensemble methods (Buechner 
and Tessmer, 2013, Buechner et al., 2014). To study specific DNA interactions of hTDG in its lesion 
recognition state, my AFM studies focused on the catalytically inactive hTDG variant N140A, which has 
been shown to possess similar DNA binding affinity as the wt enzyme, but hardly detectable base 
excision activity (Hardeland et al., 2000, Maiti et al., 2009). Figure 35A shows a representative AFM 
image of the hTDG variant N140A incubated with DNA substrates containing a single G:U mismatch 
(compare  
 for DNA sequence). Position analyses of specific hTDG complexes at mismatches (Figure 35B and D, 
black bars) can be fitted with a Gaussian curve (grey line) with maximum at ~ 45 % of DNA full length 
consistent with the position of the mismatch. Enhanced binding at the mismatch position hence 
indicates a preference of TDG for this target site binding over binding to nonspecific homoduplex DNA. 
From the Gaussian fits, moderate specificities S = 163 ± 47 of hTDG-N140A for the G:U and S = 305 ± 95 
for the G:T mismatch were calculated (see Table 19 and Methods 4.6.1).  
Due to local helix destabilization at DNA fragment ends, hTDG also displays a strong DNA end binding 
preference (compare bar at 0 %, with ~ 0.18 fraction of counts with bar at 45 %, with ~ 0.13 fraction of 
counts in Figure 35B) as has previously been observed for many other DNA repair proteins (Tessmer et 
al., 2008, Wagner et al., 2009, Tessmer et al., 2012, Buechner et al., 2014). 
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Figure 35: Lesion specificity of hTDG N140A at G:U and G:T mismatches 
A,C. AFM images of hTDG N140A binding to DNA substrates (549 bp) containing a A) G:U mismatch and a C) G:T 
mismatch in a CpG context at 46 % of DNA fragment length. Arrows point to nonspecific (white) and specific hTDG 
N140A-DNA complexes bound to the target site (yellow). B,D. hTDG N140A binding position distribution on the 
DNA demonstrates a moderate binding preference for B) the G:U and D) the G:T mismatch (enhanced occupancy at 
~ 46 % DNA length) over nonspecific DNA. Fractional occupancies are plotted for ~ 22 bp long sections of 549 bp 
DNA from DNA fragment ends (0 %) to DNA center (50 %). Results were pooled from three individual experiments 
(n = total data points). 
Table 19: AFM binding specifities of hTDG variants to different DNA substrates. 
Protein DNA substrate AFM binding specificity n 
hTDG N140A dsDNA G:U 163 ± 47  371 
hTDG N140A dsDNA G:T 305 ± 95  364 
hTDG R275A dsDNA G:UF 358 ± 101  375 
AFM binding specificities of hTDG wt and variants for different DNA substrates were determined as means ± SD 
from three position distribution histograms derived from three individual experiments. The number of datapoints n 
is indicated. 
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The moderate localization specificity of TDG to its target sites observed from the AFM experiments 
(S ~ 150-300, see Table 19) is likely due to nonspecific background binding at the applied protein 
concentration (50 nM). In addition to the specific target site located within hundreds of nonspecific 
bases, the DNA substrates used for AFM also contain several additional CpG sites (14 % of total bases) 
spread over the entire DNA sequence. hTDG has been reported to bind to CpG sites in DNA with only 4-
fold lower affinity and to random homoduplex DNA sequences with only 16-fold reduced affinity 
compared to its G:T target sites (Morgan et al., 2011). Importantly, however, the AFM data show a 
distinct preference of TDG for its target lesions (G:T, G:U) over an excess of undamaged DNA. 
5.2.2 DNA bending and base flipping by hTDG upon lesion encounter 
Specific and nonspecific hTDG-DNA complexes can be distinguished based on their position on the DNA 
substrates (specific site at 46 % of the DNA length) and were treated separately for further DNA bend 
angle analyses (see 4.1.3).  
Measurements of DNA bend angles for hTDG N140A bound to G:U (lesion encounter complexes, Figure 
36A and Table 20) resulted in a distribution with two distinct populations. A double Gaussian fit to the 
distribution centered at (29 ± 10)° and (68 ± 10)° (R2 = 0.88). Integration of the peak areas revealed that 
33 % of the complexes are in the less bent state and 67 % are in the stronger bent state.  
Interestingly, the less bent state with bend angle of ~ 30°  is also clearly found at the mismatch site in the 
absence of protein (36 % of complexes) in addition to the straight conformation (semi-Gaussian peak at 
~ 0°) (Figure 36B), which is typically observed at homoduplex sites (Wang et al., 2003). This finding 
suggests that the G:U mismatch induces an intrinsic bend of ~ 30° in the DNA backbone (under the 
conditions of these AFM studies), which also prevails in part of the specific, mismatch-bound complexes 
in equilibrium with the stronger bent state (bend angle of ~ 70°).  
The distributions of DNA bend angles induced by hTDG-N140A at G:T sites (Figure 36C) also shows the 
two populations of ~ 30°  and ~ 70° as observed for hTDG-N140A and G:U and were fitted by a double 
Gaussian. Although the two bend angle states induced by hTDG at G:T sites (Figure 36C) appear to be not 
as distinct as those observed for hTDG at G:U sites (Figure 36A), the ratios between the smaller and the 
larger bend angle are comparable ((26 ± 15)° (42 %) and (65 ± 15)° (58 %) for hTDG on G:T sites vs. 
(29 ± 10)° (33 %) and (68 ± 10)° (67 %) for hTDG on G:U sites, P = 0.14, not significantly different). 
Measurements of intrinsic DNA bend angles at the specific site in the absence of protein revealed 
intrinsic bending of the DNA at the site of the G:T mismatch by (31 ± 9)° (32 %) similar as observed for 
the G:U mismatch (in addition to the straight conformation with bend angle of ~ 0° (68 %). 
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Figure 36: DNA bending by hTDG N140A at G:U and G:T mismatches 
A) The distributions of DNA bend angles induced by hTDG-N140A at G:U sites shows two distinct populations. A 
double Gaussian fit (R
2
 = 0.88) to the data centers at (29 ± 10)° (33 %) and (68 ± 10)° (67 %). B) Measurements of 
intrinsic DNA bend angles at the site of the G:U mismatch in the absence of protein reveal a similar less bent state 
with bend angle of ~ 30° (36 %) as observed in A) in the presence of protein. However, the predominant state 
(64 %) is the straight conformation (semi-Gaussian peak at ~ 0°. C) Distribution of DNA bend angles induced by 
hTDG-N140A at G:T sites. A double Gaussian fit (R
2
 = 0.87) centered at (26 ± 15)° (42 %) and (65 ± 15)° (58 %). 
Distribution of intrinsic DNA bend angles at the G:T mismatch in the absence of protein revealed similar DNA 
bending by (31 ± 9)° (32 %) as in (B) in addition to a predominant straight DNA state (0 ± 9)° (68 %). The ratio 
between the two states was derived from the areas of the Gaussian peaks. The bend angle distributions in A) and C) 
were pooled from three individual experiments and those in B) and D) from two individual AFM experiments. The 
total number of data points is indicated as n. 
Furthermore, DNA binding and bending was studied by the hTDG variant R275A (Figure 37). Crystal 
structures of DNA-bound hTDG (to the abasic site analog THF and to the non-cleavable G:U analogue 
G:UF) revealed that the strictly conserved residue Arg275 is located at the tip of an arginine finger (Maiti 
et al., 2008, Maiti et al., 2012). Based on these structural findings and further pre-steady-state kinetics 
experiments, the arginine finger had been implicated in promotion and/or stabilization of nucleotide 
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flipping in TDG by penetrating the DNA minor groove and filling the void created by base extrusion (Maiti 
et al., 2009). Complex position analysis from the AFM images revealed a lesion specificity of hTDG-R275A 
for G:UF comparable to (or even slightly higher than) the specificity of the catalytically inactive hTDG 
variant N140A for G:U (S = 358 ± 101 and S = 163 ± 47, respectively, Figure 37B and Figure 35B, Table 19). 
 
Figure 37: Lesion specificity of hTDG R275A at G:U
F
 mismatches. 
A) AFM image showing hTDG-R275A incubated with DNA substrates (549 bp) containing a non-cleavable G:U
F
 
mismatch in a CpG context at 46 % of DNA fragment length. Yellow arrows point to complexes specifically bound at 
the target site, white arrows indicate nonspecific hTDG-DNA complexes bound to non-damaged DNA sites including 
DNA ends. B) hTDG R275A binding position distributions on G:U
F
 containing DNA substrates revealed a lesion 
specificity comparable to the specificity of hTDG N140A for G:U. The position distribution in B) is pooled from three 
individual experiments. The total number of data points is indicated as n. 
AFM experiments in the absence of protein showed intrinsic bending of the DNA at the site of the G:UF 
mismatch by (33 ± 12)° (Figure 38B), similar as observed for the G:U mismatch (see above and Table 20). 
Gaussian fits to the DNA bend angle distribution from AFM images of hTDG-R275A lesion encounter 
complexes bound to the G:UF target site (Figure 38A, Table 20) showed an equilibrium between three 
states. In striking contrast to N140A, the percentage of kinked protein complexes (with a bend angle of 
~ 70°) was significantly reduced for R275A (67 % for N140A at G:U versus 15 % for R275A at G:UF, 
respectively, P = 0.0005, Figure 38A and Figure 36A and Table 20). 
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Figure 38: DNA bending of hTDG R275A at G:U
F
 mismatches 
A) In contrast to N140A bound to G:U, the distribution of DNA bend angles induced by hTDG-R275A at G:U
F
 sites 
showed an equilibrium between three states. A triple Gaussian fit (R
2
 = 0.89) to the data centered at (0 ± 12)° 
(45 %), (37 ± 12)° (40 %) and (66 ± 12)° (15 %). B) Measurements of intrinsic DNA bend angles at the specific site in 
the absence of protein revealed intrinsic bending of the DNA at the site of the G:U
F
 mismatch by (33 ± 12)° (37 %) 
similar as observed for the G:U mismatch in Figure 36A. However, the predominant population (63 %) is the 
straight conformation with bend angle of ~ 0°. The bend angle distributions in A) were pooled from three individual 
experiments and those in B) from two different experiments. The total number of data points is indicated as n. The 
ratios between the different states were derived from the areas of the Gaussian peaks. 
In addition, 2-Aminopurine (2-AP) was placed as a fluorescent probe next to G:UF to investigate specific 
DNA target site interactions of hTDG in a fluorescence based base flipping assay. As described above 
(4.5.3) and in previous studies (Stivers, 1998, Bellamy and Baldwin, 2001, Bellamy et al., 2007), the 
fluorescence signal of 2-AP can be also used to monitor flipping of the uracil nucleotide from the DNA, 
when located next to 2-AP. The 2-AP fluorescence is highly quenched within the DNA duplex structure 
and is expected to increase upon destacking of the DNA helix by protein-induced destabilization or base 
flipping. In titrations with hTDG wt, the 2-AP fluorescence intensity increased with increasing [TDG], 
consistent with the expectation that uracil flips out of the duplex and into the TDG active site (Figure 39A 
and C). At the highest TDG concentration examined, we measured a significant increase in 2-AP 
fluorescence compared to the free DNA (P = 0.032). In contrast, binding of R275A-TDG to G:UF DNA does 
not result in a substantial increase in 2-AP fluorescence (P = 0.373, Figure 39B) and induced significantly 
lower fluorescence than for the wt protein (P = 0.047, Figure 39A and C and Table 21). This result is in 
accordance with the decreased population of strongly bent R275A complexes observed in the AFM data. 
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Figure 39: 2-AP fluorescence based base flipping assay of hTDG at G:U
F
 mismatches. 
Increasing concentrations of A) hTDG wt and B) hTDG R275A were titrated to 170 nM 2-AP DNA substrates. Steady-
state fluorescence emission spectra (340 – 400 nm) were recorded at an excitation wavelength of ʎex = 320 nm. The 
inset in A) shows a schematic of the 2-AP (cyan) DNA substrate containing G:U
F
 (yellow). Fluorescence spectra were 
corrected for the fluorescence background of the reaction buffer and/or the protein C) Quantification of the 2-AP 
fluorescence intensity change for 5 µM of hTDG wt (grey bar) and R275A (cyan bar). Results were derived from two 
individual titrations. The error bars indicate the standard deviation between the different experiments. 
Significances are calculated with a one-tailed student’s t-test and are classed as * P < 0.05. 
5.2.3 Nonspecific complexes of hTDG on homoduplex DNA 
After characterizing specific TDG complexes bound at target sites of the glycosylase, hTDG was incubated 
with undamaged DNA fragments to analyze nonspecific, lesion search complexes of the DNA repair 
protein (Figure 40A-C and Table 20). The catalytically inactive hTDG variant N140A mutant showed 
comparable DNA bending behavior as the wt ((31 ± 12) (39 %) and (65 ± 12)° (61 %) for hTDG N140A and 
(33 ± 11)° (46 %) and (68 ± 11)° (54 %) for hTDG wt, P = 0.478 using a one tailed student t-test, Figure 
40A and B). The DNA bend angle distributions of these nonspecific complexes of hTDG-N140A (Figure 
40A) revealed the same bend angle states as observed for hTDG-N140A bound specifically at a G:U 
mismatch (Figure 36A) with a Gaussian fit to the bend angle distribution centered at ~ 30° and ~ 70°. 
DNA bend angle measurements for hTDG-R275A on nonspecific (non-damaged) DNA displayed a tri-
phasic distribution as described above for specific, lesion-bound R275A, with a predominant peak at ~ 0°, 
a large population at ~ 30°, and an almost negligible population at ~ 70° (Figure 40C and Table 20). 
Interestingly, the percentage of complexes with an average bend angle of ~ 30° (36 % of complexes) was 
similar to that of hTDG-R275A lesion encounter complexes bound at a G:U mismatch (40 % with bend 
angle ~30°, Table 20), although the non-damaged DNA itself showed no intrinsic bending in control 
experiments in the absence of protein (Figure 40D and Figure 41, see 4.1.3). 
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Figure 40: DNA bending of hTDG at nonspecific DNA sites. 
A) The distributions of DNA bend angles induced by hTDG wt at nonspecific sites on 1813 bp DNA fragments shows 
two distinct populations. A double Gaussian fit (R
2
 = 0.96) to the data centers at (33 ± 11)° (46 %) and (68 ± 11)° 
(54 %), B) DNA bend angle measurements from AFM experiments of hTDG N140A bound to nonspecific DNA 
fragments (549 bp) result in two distinct states. A double Gaussian fit (R
2
 = 0.94) to the data centers at (31 ± 12)° 
(39 %) and (65 ± 12)° (61 %). C) DNA bend angle measurements from AFM experiments of hTDG R275A complexes 
bound to nonspecific DNA fragments (1813 bp) result in three different states. A triple Gaussian fit (R
2
 = 0.95) to 
the data centers at (-2 ± 13)° (57 %), (34 ± 13)° (36 %) and (65 ± 13)° (7 %). D) Intrinsic DNA bend angles 
measurements were pooled for two nonspecific DNA substrates (549 bp and 1813 bp). A semi-Gaussian fit to the 
data centers at (0 ± 21)°. The single distributions for the two DNA substrates (shown in Figure 41) are very 
comparable. All distributions represent pooled data from at least three individual experiments. The total number of 
data points is indicated as n. 
Intrinsic bending was also measured for 549 bp undamaged DNA fragments (Figure 41B) at the same 
position as the target site mismatch (46 % from DNA fragment end, within identical sequence context) 
resulting in a similar distribution as observed for the longer (1813 bp) non-damaged DNA fragment 
(Figure 41D). 
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Figure 41: intrinsic bending of two nonspecific DNA substrates (549 bp and 1818 bp) in the absence of protein. 
A, B) Using the same DNA substrate as in experiments with lesion containing DNA (549 bp), but without any base 
mismatches or lesions (nonspecific substrate), intrinsic bending was measured at 46 % of the DNA fragment length 
(target site position in the specific DNA substrates) in the absence of protein to exclude any influence of DNA 
sequence context on intrinsic DNA bending behavior. A semi-Gaussian fit centered at (0 ± 18)° (R
2
 = 0.895). 
C,D) Intrinsic bending within a 1813 bp DNA fragment (that did not contain any base mismatches or lesions) was 
determined by moving a mask comparable to the size of TDG at regular intervals of 50 nm along the DNA. A semi-
Gaussian fit centered at (0 ± 23)° (R
2
 = 0.963). Results were pooled from two individual experiments. The total 
number of data points is indicated as n.Both AFM images A) of the 549 bp fragments and C) of the 1813 bp 
fragments are 1 µm x 1 µm. 
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Table 20: DNA bend angle analysis for hTDG-DNA complexes and free DNA substrates. 
protein DNA substrate straight slightly  bent strongly bent n 
protein induced bending (in degrees) 
    
hTDG wt Nsp DNA (1813 bp) NA 33 ± 11 (46 %) 68 ± 11 (54 %) 442 
hTDG N140A G:U NA 29 ± 10 (33 %) 68 ± 10 (67 %) 128 
G:T NA 26 ± 15 (42 %) 65 ± 15 (58 %) 155 
Nsp DNA (549 bp) NA 31 ± 12 (39 %) 65 ± 12 (61 %) 247 
hTDG R275A Nsp DNA (1813 bp) -2 ± 13 (57 %) 34 ± 13 (36 %) 65 ± 13 (7 %) 424 
G:UF 0 ± 12 (45 %) 37 ± 12 (40 %) 66 ± 12 (15 %) 215 
intrinsic DNA bending (in degrees) 
none Nsp DNA (549 bp) 0 ± 18 NA NA 209 
none Nsp DNA (1813 bp) 0 ± 23 NA NA 260 
none 
Nsp DNA (549 bp and 
1813 bp pooled) 
0 ± 21 NA NA 469 
none G:U mismatch 0 ± 8 (64 %) 30 ± 8 (36 %) NA 241 
none G:UF mismatch -2 ± 12 (63 %) 33 ± 12 (37 %) NA 198 
none G:T mismatch 0 ± 9 (68 %) 31 ± 9 (32 %) NA 228 
Depending on DNA bending, (~ 0°, ~ 30° and ~ 70°), complexes are classed as ‘straight’, ‘slightly bent’ or ‘strongly 
bent’. The given values represent the maxima of single, double or triple Gaussian fits to pooled bend angle 
distributions. The population of the different bend angle states is given in brackets as % of total area from 
integration of the Gaussian peaks. The total number of data points is indicated as n. NA = not applicable. 
Results from 2-AP base flipping assays revealed a significant fluorescence shift for nonspecific 2-AP 
containing DNA in the presence of increasing concentrations of hTDG wt compared to the DNA control in 
the absence of protein (P = 0.0002, Figure 42A). This degree of base flipping activity of hTDG correlates 
extremely well with the percentage of strongly bent (~ 70°) complexes in the AFM experiments (Figure 
40A and B); the ratios of fluorescence enhancement in the 2-AP base flipping assay and percentages of 
complexes in the stronger bent state in AFM are both approximately 3:2 between hTDG complexes 
bound at G:U sites and nonspecific hTDG complexes during damage search (at non-damaged sites). In 
contrast, and consistent with our AFM results, hTDG-R275A (Figure 42B and C) induced no significant 
increase in 2-AP fluorescence compared to DNA in the absence of protein (P = 0.356) and showed 
significantly reduced activity compared to the wt protein (P = 0.003, Figure 42C and Table 21). 
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Figure 42: 2-AP fluorescence based base flipping assay of hTDG at nonspecific DNA. 
Increasing concentrations of A) hTDG wt and B) hTDG-R275A were titrated to 170 nM 2-AP DNA substrates. Steady-
state fluorescence emission spectra (340 – 400 nm) were recorded at an excitation wavelength of ʎex = 320 nm. The 
inset in A) shows a schematic of the nonspecific DNA substrate used containing a 2-AP (cyan) neighboring a 
Watson-Crick G:C base pair (yellow). C) Quantification of the 2-AP fluorescence intensity change in A) and B) for 
protein concentrations of 5 µM compared to buffer control. Results were derived from two individual titrations. 
The error bars indicate the standard deviation.  Significances are calculated with one-tailed student’s t-test and are 
classed as *** P < 0.005. 
Table 21: Quantification of 2-AP fluorescence based base flipping assay for hTDG proteins. 
Protein DNA substrate rel. intensity change P 
hTDG wt dsDNA 2-AP G:UF 131555 ± 56391 0.047 
hTDG R275A dsDNA 2-AP G:UF 9370 ± 7085 / 
hTDG wt dsDNA 2-AP nsp 77297 ± 7239 0.003 
hTDG R275A dsDNA 2-AP nsp 37045 ± 3514 / 
2-AP fluorescence intensity changes for the indicated hTDG proteins (5 µM) and DNA substrates. Values represent 
means ± SD derived from at least two individual experiments. Significances are calculated with a one-tailed 
student’s t-test for the differences between hTDG variant R275A versus wt protein for lesion containing and 
nonspecific DNA substrate. 
5.2.4 AFM volume analysis reveals the stoichiometry of free and DNA-bound hTDG 
In two co-crystallographic studies, hTDG has been reported to form a dimer in complex with DNA (Maiti 
et al., 2008, Maiti et al., 2012) (see 2.4.3). In the X-ray structures, one hTDG subunit was bound at the 
specific site (abasic or uracil analog) and one subunit was bound to nonspecific DNA in direct proximity. 
However, the size of the hTDG dimer interface was small, which suggests only weak dimer interactions in 
the absence of DNA. Consistent with that, the free protein has been found to be monomeric in 
sedimentation velocity analysis even at high concentrations (Maiti et al., 2008). Although biochemical 
studies showed that hTDG, indeed, is able to bind different DNA substrates (unmodified and lesion-
containing DNA) as a 2:1 complex at high protein concentrations (KD(dimerization) < 1.3 µM), an hTDG 
95 
 
monomer has been indicated to be fully capable of repairing G:U and G:U mismatches (Maiti et al., 2008, 
Morgan et al., 2011).  
To characterize the stoichiometry of hTDG in the absence and in the presence of DNA, AFM volumes of 
free (non-DNA-bound, Figure 43) and DNA-bound hTDG molecules (Figure 44) were determined. In 
principle, AFM volumes of proteins can be directly translated into molecular weight (see 4.1.3), thus 
providing information on their conformational and oligomeric properties. 
Figure 43A shows an AFM image of hTDG in the absence of DNA. AFM volume analysis of free protein 
molecules resulted in a single Gaussian peak centered at (48 ± 20) nm3 (Figure 43B) corresponding to a 
molecular weight of ~ 45 kDa. This value is consistent with the size of an hTDG monomer (theoretical 
weight 46 kDa) and is in agreement with the previous studies (Maiti et al., 2008, Morgan et al., 2011). 
 
Figure 43: Stoichiometry of hTDG in AFM experiments. 
A) AFM image of hTDG in the absence of DNA. B) AFM volume measurements of hTDG resulted in a distribution 
with a distinct peak. A Gaussian fit to the distribution centered at (48 ± 20) nm
3
. This value corresponds to a 
molecular weight of ~ 45 kDa and is consistent with the size of a monomer. The distribution represents pooled data 
from three individual depositions. The number of datapoints is indicated. 
To investigate conformational and/ or oligomeric states of hTDG on DNA, hTDG was incubated with 
specific DNA substrates containing a G:T mismatch. Incubations were performed at high protein 
concentrations (2.5 µM > KD(dimerization)) (Figure 44) to allow potential dimer formation. For the volume 
analysis, specific hTDG complexes (bound at the mismatch, black bars) and nonspecific hTDG complexes 
with unmodified homoduplex DNA (grey bars) were treated separately.  
For nonspecific hTDG complexes, two different volume states (56 ± 12) nm3 (67 %) and (82 ± 12) nm3 
(33 %) can be observed from the resulting volume distribution, which correspond to molecular weights 
of ~ 52 kDa and ~ 73 kDa, respectively. As these values reflect the size of the protein-DNA complexes 
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(the contribution of the DNA volume is estimated to be 5 - 10 nm3), these molecular weights are 
comparable with the size of an hTDG monomer (theoretical weight 46 kDa) and likely represent two 
different conformational states of hTDG formed on nonspecific DNA.  
At lesion sites, three different populations of hTDG-DNA AFM volumes were discovered. A triple 
Gaussian fit to the data centers at (54 ± 13) nm3 (35 %), (83 ± 13) nm3 (44 %) and (116 ± 13) nm3 (21 %), 
which correspond to molecular weights of ~ 50 kDa, ~ 74 kDa and ~ 102 kDa, respectively. The two major 
states with AFM volumes of ~ 55 nm3 and ~ 80 nm3 likely represent two monomeric conformations 
similar as observed for nonspecific hTDG-DNA complexes. However, the equilibrium between these two 
conformational states is shifted towards the smaller volume state of ~ 55 nm3 for nonspecific complexes 
(compare 67 % for nsp complexes and 35 % for spec complexes) and towards the bigger volume state for 
specific complexes at the mismatch (compare 44 % for spec complexes and 33 % for nsp complexes). 
Only a minor population (21 %) of the largest volume (~ 115 nm3, corresponding to a molecular weight of 
~102 kDa) has been found to consistent with the size of a dimer (92 kDa).  
 
Figure 44: AFM volume analysis of hTDG-DNA complexes. 
AFM volumes were determined at high hTDG concentration (2.5 µM) for nonspecific (grey bars) and specific hTDG-
DNA complexes bound to G:T mismatches (black bars) separately. For nonspecific hTDG complexes (n = 307), two 
different states of AFM volumes were visible. A double Gaussian fit (R
2
 = 0.94) centers at (56 ± 12) nm
3
 (67 %) and 
(82 ± 12) nm
3
 (33 %), corresponding to molecular weights of ~ 52 kDa and ~ 73 kDa. AFM volume measurements of 
specific hTDG-DNA complexes (n = 288) resulted in a triphasic distribution, with peaks at (54 ± 13) nm
3
 (35 %), 
(83 ± 13) nm
3
 (44 %) and (116 ± 13) nm
3
 (21 %), which correspond to molecular weights of ~ 50 kDa, ~ 74 kDa and ~ 
102 kDa, respectively. Only the largest AFM volume (~ 115 nm
3
 corresponding to ~ 100 kDa) found at specific G:T 
sites is consistent with a dimeric form of hTDG. The distributions represent pooled data from three individual 
experiments. 
5.2.5 hTDG complex size correlates with DNA bending 
Based on the AFM volume analysis (Figure 44), hTDG-DNA complexes of smaller (35 - 70 nm3) and larger 
size (70 - 110 nm3), which likely include two different monomeric conformations, were separated for 
further DNA bend angle analysis. DNA bend angle measurements for smaller complexes (Figure 45A, 
cyan bars) resulted in a biphasic distribution with maxima at (36 ± 12)° (56 %) and at (68 ± 12)° (44 %) 
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respectively. For larger complexes, the distribution was also biphasic and a double Gaussian fit to the 
data centers at (28 ± 13)° (32 %) and at (62 ± 13)° (68 %) (Figure 45B, magenta bars). The two 
populations observed for both smaller and larger hTDG-DNA complexes with bend angles of (28 – 36)° 
and (62 – 68)° (Figure 45) closely resemble to the bend angle states of ~ 30° and ~ 70° measured for 
hTDG complexes, when nonspecific and specific DNA sites were separated (compare Figure 36 and Figure 
40).  
Notably, when separating the bend angles values according to their AFM volumes, the equilibrium 
between these two states with bend angles of (28 – 36)° and (62 – 68)° is shifted towards the smaller 
bend angle state for small complexes and towards the larger bend angle state for large complexes 
(P = 0.006, the difference between the relative areas of small and large complexes for the population 
with a bend angle of ~ 65° is highly significant). Hence, the stronger bent complexes seem to correlate 
with a larger complex size. Assuming that protein complexes in a flipped state appear larger in AFM 
(leading to larger AFM-volumes), the observed correlation between larger bend angles and larger AFM 
volumes may confirm a role of strong DNA bending (resulting in higher DNA flexibility) in facilitating 
nucleotide flipping. This finding is consistent with the AFM data on the hTDG variants N140A and R275A 
as described above (see 5.2.2 and 5.2.3) suggesting that hTDG may exploit the higher DNA flexibility at 
G:T and G:U mismatches to induce DNA kinking and extra-helical base interrogation (see model in Figure 
46). 
 
Figure 45: Correlation between DNA bending and AFM volume of hTDG-DNA complexes. 
DNA bend angle measurements of hTDG-DNA complexes (at specific G:T sites and nonspecific DNA sites) were 
separated for A) smaller (35 – 70 nm
3
) and B) larger forms (70 – 110 nm
3
). A) For small complexes, two distinct 
populations of AFM volumes were apparent in a double Gaussian fit (R
2
 = 0.97) with maxima at (36 ± 12)° (56 %) 
and at (68 ± 12)° (44 %). B) For large complexes, two bend angle populations were visible. A double Gaussian fit 
(R
2
 = 0.88) to the data centers at (28 ± 13)° (32 %) and at (62 ± 13)° (68 %). The relative area (in %) of the second 
population with a DNA bend angle of ~ 65° is significantly increased for the larger complexes (**, P = 0.006). The 
significance was calculated by one-tailed student’s t-test. The distributions represent pooled data from three 
individual experiments. The number of data points is indicated as n. 
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5.2.6 hTDG damage search and recognition model 
TDG target sites in DNA (G:T, G:U, and its analog G:UF) were characterized using AFM-based DNA bend 
angle analyses. In the absence of protein, the DNA was intrinsically bent by ~ 30° at these base mismatch 
sites (Figure 36B,D and Figure 38B). It is worth noting that in the AFM experiments, intrinsic bending at 
different, specific DNA sites may be somewhat promoted by the surface deposition process. However, 
DNA bending at mismatch sites in the AFM experiments still reflects the degree of destabilization at 
these sites because intrinsic bending is not observed for nonspecific DNA (Figure 41). In addition, the 
findings observed in AFM are in accordance with computational simulations, which show that G:T and 
G:U wobble pairs are kinetically less stable than canonical base pairs and are more prone to spontaneous 
base pair breathing, inducing minor DNA distortions (Fuxreiter et al., 2002, Seibert et al., 2002, Imhof 
and Zahran, 2013, Yin et al., 2014). 
Glycosylases may hence have adapted to exploit these open (flipped) base configurations, stabilizing 
them to achieve a specific conformation required for lesion detection and removal. This scenario will be 
referred to as passive bending (model in Figure 46). Due to its higher flexibility, damaged DNA is also 
more prone to protein-induced DNA distortion or bending (active bending, Figure 46), which has been 
shown to reduce the energetic barrier for enzymatic base flipping (Sharma et al., 2013). 
The same slightly bent state observed at DNA mismatches in the absence of protein (bend angle of ~ 30°) 
is also observed in the protein complexes bound at DNA mismatch sites (Figure 36A,C). My data hence 
suggest that this bend angle state represents a complex of TDG adapted to the naturally pre-bent (or 
more flexible) DNA structure. Interestingly, a high fraction of these slightly bent hTDG search complexes 
(with a bend angle of ~ 30°) is also present during damage search on nonspecific DNA (Figure 40A-C), 
which (in contrast to the mismatch sites) shows no intrinsic DNA bending (Figure 40D and Figure 41B,D). 
hTDG binding may hence impose this degree of DNA bending on undamaged DNA as part of its initial 
lesion sensing mechanism. This conformation (bend angle of ~ 30°) will be termed as the lesion search 
complex (SC, green circles in model Figure 46) prior to damage recognition. Bending of nonspecific DNA 
would induce strain on the nucleotides, energetically facilitating their extrusion from the DNA double 
helix for interrogation by the glycosylase (active bending, Figure 46). 
In contrast, at its target sites, hTDG would simply stabilize the pre-bent structure of the mispairs and the 
net energy consumption for bending would be zero (passive bending, Figure 46). The energetic cost of 
DNA bending may serve as an initial target site sensing mechanism by hTDG. My findings hence suggest 
the search conformation to be dictated by the intrinsic structure of the target substrate. The degree of 
bending observed for the SC of hTDG in the AFM experiments correlates well with the degree of DNA 
bending measured from crystal structures. The structures of hTDG bound to an abasic site analog 
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(product complex, (Maiti et al., 2008)) and of hTDG bound to G:UF (lesion recognition complex, (Maiti et 
al., 2012)) contain a second subunit of hTDG that is bound to undamaged DNA and interacts with the 
specific complex via a weak dimer interface. The DNA bound by this nonspecific complex is bent by ~ 25° 
in the structures, consistent with the degree of bending observed in my AFM studies and with the idea 
that the bending exerted on nonspecific DNA substrates is dictated by a preformed DNA binding surface 
of hTDG.  
 
Figure 46: Model for lesion search and recognition by hTDG. 
DNA lesion search and recognition by glycosylases involves three different types of TDG-DNA complexes: search 
complex (SC), interrogation complex (IC), and excision complex (EC). The glycosylase scans the DNA for intrinsically 
flexible sites as a SC, continuously converting to an IC state with the target base flipped out of the DNA double helix 
for better accessibility. While homoduplex DNA is actively bent by the glycosylase during the search process, G:T or 
G:U wobble base pairs (red star) display enhanced flexibility or intrinsic pre-bending that matches its conformation 
in the SC complex (passive bending). The energetic cost for DNA bending may hence serve as an initial damage 
sensing mechanism. Correct target bases are stabilized in the extrahelical state within the catalytic pocket of the 
glycosylase in the EC conformation, supported by interactions of protein residues with the DNA (for TDG e.g. R
275
, 
which corresponds to the ‘arginine finger’) and catalysis of base excision can occur. 
The strictly conserved residues Arg275 und Asn140 of hTDG have been previously proposed to be involved 
in nucleotide flipping and base excision, respectively (Maiti et al., 2009). In the AFM experiments, both 
hTDG variants N140A and R275A are able to recognize a G:U or G:T mismatch (Figure 35, Figure 37, Table 
19) indicating that neither Asn140 nor Arg275 are absolutely required for initial damage recognition by 
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hTDG. During lesion search on nonspecific DNA, the population of the slightly bent DNA state (~30° bend 
angle) in both variants is also completely comparable to that in the wt protein. The data hence suggest a 
model (Figure 46), which includes an initial damage sensing step for TDG prior to base flipping and 
excision (represented by the slightly bent TDG-DNA structures), based on recognition of intrinsic 
structural properties of the target sites.  
Final target identification by hTDG as well as base excision require extrahelical base flipping as visualized 
by crystal structures of the lesion recognition complex (Maiti et al., 2012, Hashimoto et al., 2013). In the 
structures, the target base is brought in close contact with catalytic residues of the active site by 
complete flipping out of the DNA duplex. The damaged base is thereby perfectly stabilized by active site 
residues, leading to an enhanced residence time of the correct (target) DNA substrate in the catalytic 
pocket, which results in a higher probability for base excision.  
In my AFM analyses, a strongly bent DNA population (with a DNA bend angle of ~70°) was observed in 
addition to the slightly bent one (~ 30°) as discussed above (Figure 36A,C and Figure 40A,B). The strongly 
bent DNA conformation is induced by hTDG because it was not displayed by negative controls of DNA 
(with or without a specific mismatch site) in the absence of protein. Thus, this more strongly bent state is 
interpreted as the conformation, in which a base is flipped into the active site pocket of TDG for 
interrogation and this confirmation will be referred to as the lesion interrogation complex (IC, yellow 
circles Figure 46). Interestingly, the relative population of the strongly bent complex conformation in the 
experiments was slightly lower for hTDG bound to G:T versus G:U mismatch sites (58 % for G:T, 67% for 
G:U), consistent with previous findings that flipping of T is hindered relative to U flipping (Maiti et al., 
2012). 
Significantly reduced populations of the ~ 70° state observed in the AFM experiments (Figure 38A and 
Figure 40C) as well as a significant reduction of base destabilization activity in the fluorescence base 
flipping assays for the hTDG-R275A variant (Figure 39 and Figure 42) support this interpretation and are 
consistent with the proposed essential role of Arg275 in base flipping and stabilization of the “phosphate 
pinch” from crystal structures  (Maiti et al., 2008, Maiti et al., 2009). It is worth noting that the DNA 
bending phenotype of hTDG-R275A in the AFM studies and its lack of base flipping activity observed in 
the 2-AP fluorescence assays is not due to impaired DNA substrate binding activity of the Arg variant as 
DNA binding affinities were found to be only slightly (≤ 3-fold) reduced for hTDG-R275A versus hTDG wt 
(Maiti et al., 2009, Morgan et al., 2011). 
Importantly, in my AFM studies, the strongly bent state (~ 70° bend angle) was clearly present and 
similarly populated in nonspecific complexes of TDG with homoduplex DNA as in the specific TDG-lesion 
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complexes. Significant increase in 2-AP fluorescence in the base flipping assays further supports 
destabilization of nonspecific DNA bases by TDG during lesion search, likely by (partial or complete) base 
flipping into the protein’s active site pocket (Figure 42). The finding that both SC and IC are present both 
at nonspecific and at specific DNA sites strongly suggests an active, constant DNA interrogation process 
by TDG involving base flipping as the protein scans the DNA in search of a target site.  
5.2.7 Generalizability of hTDG lesion search and detection in comparison with hOgg1 
To test whether the proposed damage search and recognition strategies for hTDG can be transferred to a 
general model for BER, the AFM and fluorescence analyses established for hTDG were extended to 
investigate hOgg1 (Figure 47), a different and also well-characterized DNA glycosylase (see 2.4.4). The 
two enzymes detect damaged bases with significantly different base pairing energies. hTDG targets 
intrinsically flexible G:U and G:T wobble pairs (Imhof and Zahran, 2013) that result in slightly bent 
structures in the AFM images (Figure 36B,D). In contrast, hOgg1 addresses oxoG, which forms stable 
Watson-Crick like base pairs with cytosine (Crenshaw et al., 2011) that lack intrinsic DNA bending and 
show straight conformations in AFM images in the absence of protein (Figure 47C and Table 22).  
To investigate hOgg1 lesion search processes, the protein was incubated with long undamaged DNA 
fragments in the AFM experiments (see representative AFM image in Figure 47A). AFM-based DNA bend 
angle analysis of nonspecific hOgg1-DNA complexes reveals three different states of (0 ± 9)° (44 %), 
(33 ± 9)° (20 %), and (70 ± 9)° (36 %) (Figure 47B and Table 22). The two major populations with bend 
angles of ~ 0° and ~ 70° are in agreement with previous AFM studies performed with hOgg1 (Chen et al., 
2002). The straight DNA conformation can be interpreted as SC (with a bend angle of ~ 0° matching the 
DNA conformation of the target site) and the strongly bent conformation (with a bend angle of ~ 70°), 
may represent the IC with the flipped out base. Similar as observed in the distribution of nonspecific 
hTDG complexes (Figure 40A,B), the bend angle distribution of hOgg1 suggests an equilibrium between 
the SC and IC during damage search likely involving an additional intermediate state (reflected by the 
small population of slightly bent hOgg1-DNA complexes with a bend angle of ~ 30°). The presence of the 
kinked IC (with bend angle of ~ 70°) in the AFM studies (Figure 47B and (Chen et al., 2002)) is consistent 
with the requirement for DNA flexibility (resulting in the strong DNA bending) for DNA repair activity by 
hOgg1 as discovered in high speed AFM experiments using DNA nanochips as scaffolds (Endo et al., 
2010). In addition, the same DNA bend angle of ~ 70° was also observed in co-crystallographic studies of 
hOgg1 bound to its target site 8oxoG:C (Bruner et al., 2000) or bound to a nonspecific base with the base 
flipped into an exo-site in close proximity to the enzyme’s active site pocket (Banerjee et al., 2005). 
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Figure 47: Characterization of hOgg1-DNA complexes by AFM and fluorescence experiments. 
A) AFM image of hOgg1 binding to nsp DNA (1813 bp). Arrows point to hOgg1-DNA complexes. B) Distribution of 
DNA bend angles for hOgg1 bound to nonspecific DNA. A triple Gaussian fit (R
2
 = 0.87) centered at ~ 0° (44 %), ~ 30° 
(20 %) and ~ 70° (36 %). C) Intrinsic DNA bend angles at an 8oxoG:C site (target site of hOgg1) in the absence of 
protein. A double Gaussian fit (R
2
 = 0.929) revealed a dominant straight fraction with bend angle ~ 0° (78 %) and a 
small shoulder at ~ 30° (22 %). Bend angle results were pooled from at least two individual experiments. The total 
number of data points is indicated as n. D,E) hOgg1 was titrated to 2-AP DNA substrates containing D) 8oxoG:C or 
E) nonspecific 2-AP DNA substrates. The fluorescence intensities in the absence (black curve) and in the presence of 
hOgg1 (blue curve at 5 µM [protein]) are shown. Steady-state fluorescence emission spectra (340 – 400 nm) were 
recorded at ʎex = 320 nm. The insets show schematics of the employed 2-AP (cyan) DNA substrates containing 
either an 8oxoG:C pair (D, yellow) or a stable Watson-Crick base pair (E, yellow). F) Quantification of the 2-AP 
fluorescence intensity changes in D) and E). Results are averages from two individual titrations with error bars 
indicating the standard deviations. Significances are calculated with a one-tailed student’s t-test and are classed as 
* P < 0.05. 
In the 2-AP fluorescence base flipping assays, large fluorescence increases can be observed for hOgg1 
both with DNA substrates containing oxoG:C lesion sites and with non-damaged DNA (Figure 47D,E and 
Table 23). This finding suggests considerable stabilization of the flipped out base by hOgg1 both at its 
target sites and at nonspecific homoduplex DNA sites. The relative 2-AP fluorescence increase for hOgg1 
is consistently higher than for hTDG, most likely due to the different chemical environments of the two 
proteins (see Methods 4.5.3). In addition, the increase in 2-AP fluorescence for the specific DNA 
substrate (containing 8oxoG:C) compared to nonspecific, homoduplex DNA is significant (P = 0.018). This 
is not the case for hTDG which induces a larger degree of 2-AP destabilization for nonspecific DNA 
relative to specific (G:UF containing) DNA (P = 0.085, not significantly different).  
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Notably, in my AFM studies (Figure 36A,C, Figure 40A,B, Figure 47B), the bend angle conformations of 
the ICs of hTDG and hOgg1 closely resemble each other (DNA bend angle of ~70° for both proteins), 
which is also in line with a comparable degree of DNA bending in a number of crystal structures of 
different DNA glycosylases bound specifically to their flipped targets (Hollis et al., 2000, Parikh et al., 
2000, Bruner et al., 2000, Zharkov et al., 2002, Fromme and Verdine, 2002, Bowman et al., 2010). 
In contrast, the degree of DNA bending in the SC, which is difficult to capture by crystallographic studies 
due to its transient nature, differs between the two proteins: search complexes of hOgg1 are 
predominantly straight while those of hTDG are slightly bent consistent with the innate confirmations of 
their target sites in the absence of protein (Figure 36B,D, Figure 38B and Figure 47C). The difference in 
DNA bending of the SC between the two glycosylases hence corroborates the hypothesis that DNA 
glycosylases have adapted to the native DNA structure of their target lesions. 
Table 22: DNA bend angle analysis for hOgg1-DNA complexes and free DNA substrate 8oxoG:C. 
protein DNA substrate straight slightly  bent strongly bent n 
hOgg1 wt Nsp DNA (1813 bp) 0 ± 9 (44 %) 33 ± 9 (20 %) 70 ± 9 (36 %) 450 
none 8oxoG:C -2 ± 15 (78 %) 36 ± 15 (22%) NA 181 
Depending on DNA bending (in degrees), (~ 0°, ~ 30° and ~ 70°), complexes are classed as ‘straight’, ‘slightly bent’ 
or ‘strongly bent’. The given values represent the maxima of single, double or triple Gaussian fits to pooled bend 
angle distributions. The different degree of population of the different bend angle states is given in brackets as % of 
total area from integration of the Gaussian peaks. The total number of data points is indicated as n. NA = not 
applicable. 
Table 23: Quantification of 2-AP fluorescence based base flipping assay for hOgg1. 
Protein DNA substrate rel. intensity change P 
hOgg1 dsDNA 2-AP nsp 145780 ± 14425 0.018 
hOgg1 dsDNA 2-AP oxoG 908275 ± 208547 / 
2-AP fluorescence intensity changes for hOgg1 (5 µM) and the indicated DNA substrates. Values represent means ± 
SD derived from two individual experiments. Significances are calculated with a one-tailed student’s t-testfor the 
differences between hOgg1 with specific 8oxoG:C DNA versus hOgg1 with nonspecific DNA substrate. 
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6. Final conclusions 
Altogether, this thesis provided novel insights into damage search and recognition of two different DNA 
repair mechanisms. Detailed single molecule analysis from AFM imaging experiments complemented 
with biophysical ensemble techniques unraveled different lesion search and verification strategies of 
central players in NER and BER. In contrast to conventional ensemble methods, which represent an 
averaged sum of all molecules, single molecule analysis can resolve different populations and 
conformational states of individual molecules (Record et al., 1991). In addition, AFM can directly visualize 
protein-DNA interactions. Hence, AFM imaging has been exploited here to improve the understanding of 
fundamental steps in DNA repair. 
More specifically, my AFM and BLI data on the archaeal homolog of the NER helicase XPD, taXPD, 
revealed different strand selectivity for two different types of lesions accounting for the high substrate 
versatility of NER. My data on taXPD resulted in a simplistic model for damage verification, which lays 
the foundation for understanding the role of XPD in eukaryotic NER in the context of the multi-subunit 
TFIIH complex and other NER factors. Recently, the genome of the thermophilic fungus Chaetomium 
thermophilum has been published (Amlacher et al., 2011), which can serve as a more adequate model 
for the human NER system in future AFM studies. Unlike archaea, the fungus contains all members of 
TFIIH. Proteins from C. Thermophilum are closely related to their human homologs, but more stable and 
hence more amenable to purification and in vitro studies (Johnson et al., 1985, Amlacher et al., 2011). 
The sequence of XPD from the fungus, for instance, shares a high homology of 74 % and an identity of 
55 % (as defined by BLAST, NCBI) with the sequence of its human counterpart (Kuper et al., 2014). 
The second part of the thesis demonstrates an essential role of base flipping in damage search and 
recognition by DNA glycosylases both by AFM imaging studies and 2-AP fluorescence based base flipping 
assays. hTDG serves as representative from the glycosylase family to investigate the poorly understood 
processes of initial damage sensing prior to nucleotide flipping in BER. The AFM data suggest that hTDG 
uses the enhanced intrinsic flexibility at G:T and G:U mispairs for initial damage sensing. Notably, the 
results from AFM and fluorescence analyses indicate a dynamic equilibrium between two different 
conformational states of hTDG-DNA complexes involving continuous base flipping during search. The 
findings for hTDG are summarized as a general model for damage search and recognition in BER, which is 
supported by the data on a second glycosylase, hOgg1, which recognizes structurally less flexible DNA 
lesions. 
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8. Supplement 
8.1 Abbreviations 
2-AP  2-Aminopurine 
8-oxoG  8-oxoguanine 
(6-4)PP  (6-4) pyrimidine-pyrimidone photoproduct 
°C  degree Celsius  
µl  microliter 
µg  microgram  
A  Adenine 
AA   Acrylamide 
AFM  Atomic Force Microscopy 
AlkA  3-methyladenine DNA glycosylase 
Amp   Ampicillin 
AP  apurinic site 
APE1  AP endonuclease 1 
APS   Ammonium peroxydisulfate 
ATP  Adenosine triphosphate 
ATPƴs  Adenosine 5′-[γ-thio]triphosphate 
AUC  Analytical Ultracentrifugation 
BAA   Bisacrylamide 
BER  Base excsion repair 
BLI  Biolayer Interferometry 
bp  base pair 
BSA   Bovine serum albumin 
CAK   Cdk-activiating kinase 
Cam   Chloramphenicol 
CD   Circular dichroism 
CETN2  centrin 2 
CPD  Cyclobutane pyrimidine dimers 
CS   Cockayne Syndrome 
CSA   Cockayne Syndrome A 
CSB   Cockayne Syndrome B 
C  Cytosine 
CV   Column volume 
DDB   Damaged DNA-binding protein 
DNA  deoxyribonucleic acid 
DNase   desoxyribonuclease 
dRP  5′-deoxyribose phosphate 
dsDNA   Double stranded DNA 
DTT   dithiothreitol 
E.coli   Escherichia coli 
EDTA  ethylenediaminetetraacetic acid   
EM  Electron microscopy 
EMSA  electrophoretic mobility shift assays  
ERCC1  Excision repair cross-complementation group 1 
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F  Fluorescein 
FCS  Fluorescence correlation spectroscopy 
FEN-1  5′-flap endonuclease 1 
FeS   Iron-sulfur 
G  Guanine 
GDP  Guanosine 5′-diphosphate 
GG-NER  Global genomic NER 
GTP  Guanosine-5'-triphosphate 
HhH  helix-hairpin-helix 
hTDG  human Thymine DNA glycosylase 
hOgg1  human 8-oxoguanine DNA glycosylase 
HS-AFM high-speed AFM 
IC  Interrogation complex 
IPTG   Isopropyl-β-thiogalactoside 
ITC   Isothermal titration calorimetry 
kb  kilobase 
kDA  kilo Dalton 
LB   Luria broth 
Lig  DNA ligase 
LP-BER  Long-patch BER 
M  molar 
mM  millimolar  
mRNA  messenger RNA  
MWCO   Molecular weight cut off 
NEIL  Endonuclease VIII-like protein 
NER   Nucleotide excision repair 
Nsp  nonspecific 
NTH1  Endonuclease III-like protein 1 
OD   Optical density 
P  Phosphate 
PAGE   Polyacrylamide gel electophoresis 
PCNA   Proliferating cell nuclear antigen 
PCR   Polymerase chain reaction 
PEG   Polyethylenglycol 
PNK  polynucleotide kinase 
Pol  Polymerase 
PUA  3′ phosphor-α,β-unsaturated aldehyde 
RAD23B RAD23 homologue B 
RFC  replication factor-C 
RMS  root mean square 
RNA    ribonucleic acid 
RPA  replication protein A 
RT   Room temperature 
S  specificity 
SC  search complex 
SDS  sodium dodecyl sulfate 
SEC   Size exclusion chromatography 
SF2   Superfamily 2 
SN-BER  Single-nucleotide BER 
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SP-BER  Short-patch BER 
Spec  specific 
SPM  Scanning probe microscopies  
SPR  surface plasmon resonance 
ssDNA   Single stranded DNA 
STM  Scanning tunneling microscopy 
taXPD   Thermoplasma acidophilum XPD 
T  Thymine 
THF  Tetrahydrofuran 
TCR   Transcription coupled repair 
TEMED   tetramethylethylenediamine 
TFIIH   Transcriptionfactor II H 
TTD   Trichothiodystrophy 
U  Uracil 
UF  2’-deoxy-2’-flouroarabinouridine 
UDG  Uracil DNA glycosylase 
USP7  ubiquitin-specific-processing protease 7 
UV  ultraviolet light  
UVSSA  UV-stimulated scaffold protein A 
WT  wild type 
XP   Xeroderma Pigmentosum 
XP(A-G)  Xeroderma pigmentosum complementation group (A-G) 
XRCC1  X-ray repair cross-complementing protein 1 
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anderen Prüfungsverfahren vorgelegen hat. 
 
 Ort, Datum Unterschrift  
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8.6. Oral presentations and posters 
 
02/2014  4th Euro AFM Forum in Göttingen 
Talk: ‘Atomic force microscopy studies of XPD–DNA interactions provide insights into 
Nucleotide Excision Repair substrate versatility.’ 
 
10/2013 Annual Summer Retreat of the Rudolf-Virchow-Center, University of Wuerzburg 
  Poster: ‘Target site search of the human Thymine DNA Glycosylase’ 
 
10/2013 8th International Student Symposium of the Graduate School of Life Sciences, SCI, 
Scientific Crosstalk 
Poster: ‘Towards an understanding of damage recognition and verification in the DNA 
repair mechanism of nucleotide excision repair.’ 
 
10/2012 7th International Student Symposium of the Graduate School of Life Sciences, EPOS, 
Everything’s Part Of Science 
Poster: ‘Mechanistic AFM‐studies provide new insights in DNA damage recognition 
strategies of XPD; implications of disease‐relevant mutations.’ 
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strategies of XPD; implications of disease‐relevant mutations.’ 
 
09/2011  Annual Summer Retreat of the Rudolf-Virchow-Center, University of Wuerzburg 
  Poster: ‘How does Nucleotide Excision Repair work at the level of single molecules?’ 
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